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Primary human hepatocytes are a scare resource with limited lifespan and variable 
function which diminishes with time in culture. As a consequence, their use in tissue 
modelling and therapy is restricted. Human embryonic stem cells (hESC) could 
provide a stable source of human tissue due to their self-renewal properties and 
their ability to give rise to all the cell types of the human body. Therefore, hESC 
have the potential to provide an unlimited supply of hepatocytes. To date, the use 
of hESCs-derived somatic cells is limited due to the undefined, variable and xeno-
containing microenvironment that influences the cell performance and life span, 
limiting scale-up and downstream application.  Therefore, the development of 
highly defined cell based systems is required if the true potential of stem cell 
derived hepatocytes is to be realised. In order to replace the use of animal derived 
culture substrates to differentiate and maintain hESCs-derived hepatocytes, an 
interdisciplinary approach was employed to define synthetic materials, which 
maintain hepatocyte-like cell phenotype in culture. A simple polyurethane, PU134, 
was identified which improved hepatocyte performance and stability when 
compared to biological matrices. Moreover, the synthetic polymer was amenable to 
scale up and demonstrated batch-to-batch consistency. I subsequently used the 
synthetic polymer surface to probe the underlying biology, identifying key 
modulators of hepatocyte-like cell phenotype. This resulted in the identification of a 
novel genetic signature, MMP13, CTNND2 and THBS2, which was associated with 
stable hepatocyte performance. Importantly, those findings could be translated to 
two hESC lines derived at GMP.  In conclusion, hepatocyte differentiation of 
pluripotent stem cells requires a defined microenvironment. The novel gene 
signature identified in this study represents an example of how to deliver stable 





Current animal and cellular hepatocyte models present limitations that make them 
unsuitable for clinical and toxicological applications. In the other hand, pluripotent 
stem cells under the correct stimuli can generate any cell type found in the human 
body including hepatocytes, the mayor cell type found in the liver. The ability to 
generate renewable sources of human hepatocytes has enormous potential to 
improve human health and wealth. One major obstacle to the routine deployment 
of stem cell-derived cells is their instability in culture due to the use of animal-
derived culture substrates. To tackle this issue, I combined a synthetic polymer 
culture surface, polyurethane 134, previously identified as a surface that supports 
and promotes the generation of hepatocytes from pluripotent stem cells, with an 
animal-free and clinical grade hepatocyte differentiation approach to obtain stem 
cell-derived hepatocytes.  This defined system represents a platform that permits 
informative and mechanism analysis of liver biology. The aim of this project is to 
understand how the synthetic polymer stabilise the pluripotent stem cell derived 
hepatocytes. From this study, I identified genes associated with stable hepatocyte 
function. Moreover, these findings were successfully translated to clinical grade 
human pluripotent stem cells. These findings hold a potential to manufacture stable 
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1.1 Human embryonic stem cells 
Human embryonic stem cells (hESCs) are pluripotent cells which give rise to all 
somatic cell types found in the body. hESCs represent a real alternative to generate 
unlimited amount of somatic cells. hESCs possess two properties that make them 
ideal candidates: the unlimited self-renew ability that allows them to make identical 
copies of themselves without developing chromosomal abnormalities or undergoing 
growth arrest, and the pluripotency capacity to differentiate into any cell of the 
human body (Cai et al., 2006; Hoffman and Carpenter, 2005; Vazin and Freed, 
2010). In addition, the known genetic background of the cells allows the obtaining 
of the desire cell type with a known and stable genotype. These characteristics 
make hESCs a valuable tool with different applications, including understanding the 
complex mechanism involved during the development of specialised cells and 
establishment of organ structures, drug discovery, predictive toxicology and 
regenerative medicine (Greenhough et al., 2010; Rippon and Bishop, 2004). 
1.1.1 hESC derivation 
Human embryonic stem cells (hESCs) are derived from the inner cell mass of 
blastocyst stage embryos (Thomson, 1998). The formation of a diploid zygote, 
known as blastocyst, results from the fertilisation of an egg. The blastocyst consists 
on an inner layer of cells called the embryoblast that develops into the embryo; and 
an outer layer of cells called trophoblast which will eventually give rise to the 
placenta, chorion and the umbilical cord. Pioneers studies in mouse ESCs and in 
culturing techniques developed in non-human ESC lines (Josephson et al., 2006; 
Thomson et al., 1996),  lead to the generation of human ESC lines by Thompson and 
colleagues (Thomson, 1998) and Reubinoff and colleagues (Reubinoff et al., 2000). 




and upon injection into immunodeficient mouse they generated germ layers 
containing cell from the three germ layers. 
Isolation of the ICM has been traditionally performed using two different 
techniques: immunosurgery and mechanical dissection. Immunosurgery requires 
the use of animal-derived products that prevent the use of the hESCs in 
transplantation therapies; while mechanical and enzymatical isolation do not 
required these animal-derived products, obtaining hESCs at a suitable grade for 
clinical applications.  
However, the use of the ICM at the blastocyst stage involves ethical issues. In order 
to avoid these issues, different groups tried to isolate cells at the morula or 
blastomere stage with variable success rates, obtaining hESCs with inefficient 
differentiation capacity (Klimanskaya et al., 2006; 2007; Strelchenko et al., 2004). 
This issue was resolved by Chung and collaborators by supplementing the culture 
media with laminin, mimicking the stem cell niche (Chung et al., 2008). 
1.1.2 Characterisation of hESCs 
hESCs are characterized using an array of stem cell specific markers including; the 
expression of the ES specific transcription factors Sox 2 (Avilion et al., 2003), 
Octamer binding protein 4 (Oct-4) (Pesce et al., 1999; Schöler et al., 1989) and 
Nanog (Chambers et al., 2003; Mitsui et al., 2003); the cell surface markers 
including the globoseries glycolipid antigen designated stage specific embryonic 
antigens (SSEA)-4 (Kannagi et al., 1983); the keratin sulphate related antigens (or 
tumour recognition antigens) TRA -1-60 and TRA-1-81 (Andrews et al., 1984) and 
their morphology. hESC morphology in vitro is characterized by the display of tightly 
packed colonies with well-defined edges and a high nucleus to cytoplasm ratio with 
a pronounced nucleoli (Pera et al., 1999). 
Different from human somatic cells, hESCs display an unlimited life span 




pathways (Brandenberger et al., 2004; Rosler et al., 2004). However, prolonged 
maintenance in vitro can lead to karyotypic abnormalities in processes similar to the 
tumorigenic events that occurs in vivo (Baker et al., 2007; Draper et al., 2003; 
Mitalipova et al., 2005). Therefore, different techniques including giemsa-stained 
karyotyping (Campos et al., 2009), DNA microarrays, short tandem repeat analysis, 
fluorescent in situ hybridization and whole genome single nucleotide polymorphism 
(SNP) can also be employed to confirm the precise hESC signature within the 
population (Brimble et al., 2005; Josephson et al., 2006; Mitalipova et al., 2005). 
The pluripotency ability of the hESCs confers them with the capacity to differentiate 
to cell types  of the three primary germ layers; ectoderm, mesoderm and 
endoderm; and cell types derived from these primary germ layers, including from 
ectoderm neurons (Schuldiner et al., 2001) and keratinocytes (Guenou et al., 2009), 
from the mesoderm skeletal muscle (Abujarour et al., 2014), cardiomyocytes (Kehat 
et al., 2001) and hematopoietic cells (Chadwick et al., 2003), and from the 
endoderm liver (Hay et al., 2008a), lung (Wong et al., 2012) and pancreas (Cho et 
al., 2012). 
1.1.3 In vitro growth and maintenance of hESCs 
A successful hESC culture requires the maintenance of indefinite self-renewal 
properties. Mouse embryonic fibroblasts (MEFs) were firstly used to support 
propagation of hESCs in the undifferentiated stage (Reubinoff et al., 2000). Since 
then, in order to move to a xeno-free hESC culture system various approaches using 
human-derived cell types have been used, including feeder cells derived from 
fallopian tube epithelium (Bongso et al., 1994), foetal foreskin, muscle (Amit et al., 
2004; Richards et al., 2002), bone marrow (Cheng et al., 2003) or amniotic 
epithelium (Gumbiner et al., 1996). 
If hESCs are to be employed in clinical or therapeutic applications, generation of 
fully defined culture systems are required. As a result, great efforts were put in 




feeder free culture condition using Matrigel™, a matrix secreted by Engelbreth-
Holm-Swarm (EHS) mouse sarcoma cells, but still in the presence of a culture media 
conditioned by embryionic fibroblast cells supplemented with basic fibroblast 
growth factor (bFGF). Subsequently, different approaches have been successfully 
applied on maintaining hESC pluripotency on recombinant proteins including, 
vitronectin (Braam et al., 2008), laminin (Rodin et al., 2010) or a combination or 
laminin 521 and E-Cadherin (Rodin et al., 2014), resulting in improved hESC 
cultures. 
In addition to culture substrate optimisation, studies have focused on identifying 
the secreted factors released by the feeder layers responsible for the maintenance 
of the hESC pluripotent state. Overall, studies have shown the following proteins to 
be essential for sustaining undifferentiated proliferation of hESCs in serum-free 
media: high concentrations of bFGF, Activin A, transforming growth factor beta-1 
(TGFβ-1) and the bone morphogenic protein (BMP) repressor Noggin (Levine et al., 
2005; Wang et al., 2005;  Beattie et al., 2005; Pera et al., 2004). In order to 
standardise the hESC culture techniques, companies have released to the market 
defined xeno-free media, being StemPro® (Invitrogen) and mTeSR1™ (Stem Cell 
Technologies) the most effective (Hannoun et al., 2010). Recently, the new fully 
defined E8™ media has been shown to promote efficient self-renewal and 
differentiation of hESCs and iPSCs (Chen et al., 2011).  
Despite all the advances made in developing feeder-free and serum-free defined 
conditions for maintenance of hESCs, a deeper understanding of the mechanism 
involved in the stabilisation and maintenance of the pluripotency in hESCs is still 
required. 
1.1.4 Methods for expansion of hESCs 
The high self-renewal capacity of hESCs, which is dependent on the culture 
conditions and the hESC line itself, involves the necessity of performing frequent 




be mechanically, enzymatically or chemically disaggregated, using collagenase IV, 
dispase, trypsin or EDTA (Chen et al., 2011; Hoffman and Carpenter, 2005; Mei et 
al., 2010). The potential clinical applications of the hESCs require the use of 
recombinant animal-free enzymes such as human collagenase (Crook et al., 2007), 
which has shown to be equally successful. However, there are disadvantages 
associated with either method. While mechanical passaging is labour intensive and 
cannot be accurately reproduced; enzymatic or chemical passaging can damage 
cells by the removal of important surface proteins or ions and have been linked to 
genetic abnormalities (Brimble et al., 2005; Draper et al., 2003; Mitalipova et al., 
2005; Shirahashi et al., 2004). Different alternatives have been proposed as a 
solution to avoid genetic instability including bulk passaging and single cell 
dissociation (Ellerström et al., 2006). As such, manufacturing of a robust and reliable 
large-scale expansion of undifferentiated hESCs requires the development of an 
automated approach  (Joannides et al., 2006). 
1.1.5 The hESC microenvironment  
Stem cells are surrounded by their specific microenvironment in vivo, composed of 
cells, cytokines, and extracellular matrix (ECM). Cell-to-microenvironment 
interactions trigger the activation of various cell functions; including proliferation, 
self-renewal, differentiation and maintenance of the undifferentiated state of the 
cells (Joddar et al., 2014). As such, mimicking the niche and the cell natural 
environment are required for the maintenance of the ‘stemness’. For this purpose, 
the use of biological-derived substrates represents an attractive approach. For 
example, Melkoumian and colleagues reported that conjugation of components of 
the extracellular matrix including, vitronectin, laminin, fibronectin and bone 
sialoprotein to a peptide-acrylate surface (PAS) retained hESC specific properties. 
The resulting cells were efficiently differentiated into functional cardiomyocytes in a 
scalable manner (Melkoumian et al., 2010). In addition to the use of biological 
derived substrates for the maintenance of the ‘stemness’, researches have focused 




combination with biological-derived substrates, to simulate the hESC 
microenvironment. Villa-Diaz and colleagues described a synthetic polymer, poly [2-
(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] (PMEDSAH) 
that supported long term self-renewal and pluripotency of undifferentiated hESCs 
when cultured in a number of serum containing and serum-free media (Villa-Diaz et 
al., 2010). The structure–function relationship between material properties and 
biological performances was highlighted by Mei and colleagues as they showed that 
combination of vitronectin with high-acrylate content polymers could successfully 
maintain the pluripotency properties and colony formation of the hESCs for a 
prolonged period of time (Mei et al., 2010). Hydrogels, structures composed of 
cross-linked and hydrophilic polymer scaffolds which expand into an ECM-like gel 
state when exposed to water, have been also employed in hESC cultures. A 
synthetic polymer hydrogel made by crosslinking acrylic acids and acrylate peptides 
with an independently tuned matrix stiffness and ligands density was found to 
support short term hESC self-renewal (Li et al., 2006). Zhan and colleagues 
described a synthetic thermoresponsive acrylate based hydrogel that supported 
long term hESC growth and pluripotency, involving reagent free dissociation 
passaging in response to a reduction in ambient temperature (Zhang et al., 2013).  
Despite that most of the hESC culture conditions rely on two-dimensional surfaces, 
different research have shown that three-dimensional cultures provide a more 
accurate culture environment for hESCs, leading to improved maintenance of 
pluripotency, proliferation and cell survival (Yim and Leong, 2005). A study 
performed on mouse ESCs using a synthetic polyamide matrix scaffold mimicking 
the basement membrane, demonstrated that Nanog expression was enhanced by 
activation of the GTPase Rac and the subsequent induction of the phosphoinositide 
3-kinase pathway (PI3K), that resulted in a gain in proliferative ability (Nur, 2005). 
To date, a hyaluronic acid (HA) hydrogel has been shown to replicate major 
components of the ECM abundant in embryos and stem cells niches, maintaining 
hESCs in undifferentiated state while preserving their differentiation abilities 




1.2 Reprograming and programing  
Somatic adult cells represent an alternative source to hESCs to obtain tissue specific 
cell types. This can be achieved by two different strategies; either by reprograming 
somatic adult cells into induced pluripotent stem cells (iPSCs) prior to their 
differentiation into specific cell types; or by directly reprograming adult somatic 
cells to another type of cell in a process known as transdifferentiation. The use of 
adult somatic cells to obtain differentiated cell types represents a promising 
alternative for downstream applications; including disease modelling, drug 
discovery and personalised cell therapies as it reduces the complications associated 
with the immune-rejection. Moreover, the use of adult somatic cells overcomes the 
controversy associated with the ethical issues associated to the origin of hESCs 
(Chakraborty et al., 2010). 
1.2.1 iPSCs 
Induced pluripotent stem cells (iPSCs), like hESCs, possess the capacity to self-renew 
and differentiate into any cell type of the adult body. Different techniques have 
been developed to reprogram cells to a pluripotent state. Gurton and colleagues, 
pioneers in these reprograming techniques, employed somatic cell nuclear transfer 
(SCNT) to obtain totipotent cells by earing lineage-specific signatures in the nuclei of 
a somatic cell. Despite that this approach has been successfully employed in mouse 
cells; it has not been reported in humans. Fusion of somatic cells with pluripotent 
cells represents another approach employed to obtain pluripotent cells. Still, the 
karyotyping abnormalities of the resulting cells limit their use (Yamanaka and Blau, 
2010).   
The limitations of these techniques were overcome by employing a new strategy 
developed by Yamanaka and colleagues, in which mouse embryonic fibroblasts 
(MEFs) and adult mouse tail-tip fibroblasts were reprogrammed to induce 
pluripotent stem cells (iPSCs). The authors employed retrovirus-mediated 




namely POU5F1 (Oct 4), SOX2, KLF4 and c-Myc (Takahashi and Yamanaka, 2006), 
subsequently reported in human adult fibroblasts (Takahashi et al., 2007). While the 
resulting mouse iPSCs generated were able to form embryoid bodies as well as 
teratomas containing all three germ layers, when cells were injected into a donor 
mouse blastocyst they could not form chimeric mice, the most thorough test of 
pluripotency. This issue was solved by using Nanog to select reprogramed cells 
instead of FbX15, a gene expressed during co-expression of the Yamanaka factors 
(Okita et al., 2007).  
The trasnfection of the reprograming factors into the terminally differentiated 
somatic cells can be done by two types of methods accordingly to the integration of 
the viral vector into the host cell genome: integrating viral vector systems and 
integrating free vectors systems. Integrating viral vector systems such as retroviral 
and lentiviral transduction are highly efficient (Brambrink et al., 2008; Stadtfeld et 
al., 2008; Takahashi et al., 2006; Touboul et al., 2010). However, these techniques 
possess the risk of tumour formation. Non integrating methods include the use of 
viral vectors such as Adeno virus (dsDNA) and Senday virus (RNA) ( Takahashi et al., 
2006; Touboul et al., 2010), transfer of plasmids containing reprograming factors 
(Yu et al., 2009), direct delivery of reprograming proteins by fusing them with a cell 
penetrating peptide (Kim et al., 2009) or the use of self-replicating RNA replicon 
(Yoshioka et al., 2013). Recently, it has been shown that iPSCs can be generated 
from a variety of terminated somatic cell populations including pancreatic cells, 
keratinocytes, ESCs derived hematopoietic cells and primary human hepatocytes 
(Liu et al., 2010; Okita and Yamanaka, 2010). 
1.2.2 Transdifferentiation 
Transdifferentiation, like reprograming of adult somatic cells, represents a 
promising approach to obtain different cell types. Transdifferentiation possesses 




the risk of pluripotency-associated tumorigenesis and immunogenicity, recently 
identified in iPSCs (Zhao et al., 2011). 
Traditional methods of transdifferentiation of somatic cells into another cell type 
have relied in the expression of single transcription factor (TF) or a core of tissue 
specific TFs. Transient expression of a single TF has been successfully applied in 
transdifferentiating different cell types, including fibroblasts into myoblast by 
ectopic expression of MyoD (Davis et al., 1987; Huang et al., 2011), pancreatic cells 
into hepatocytes by inducing the expression of C/EBPβ (Shen et al., 2000) or a 
reciprocal transition between myeloid cells and megakaryocytes induced by the 
expression of GATA1 (Pang et al., 2011). However, the use of a single TF to induce 
transdifferentiation is restricted to certain cell lineages.  
Therefore, researches successfully explored the possibility of employing several 
tissue specific TFs to transdifferentiate somatic cells into different cell types of the 
three germ layers. For example, human and mouse fibroblasts have been converted 
into functional neurons (Pang et al., 2011; Pfisterer et al., 2011; Vierbuchen et al., 
2010), macrophages-like cells, hepatocyte-like cells (Huang et al., 2011) and 
cardiomyocyte-like cells (Ieda et al., 2010). In addition, other types of somatic cells 
have been transdifferentiated using lineage specific transcription factors; including 
pancreatic exocrine cells to obtain beta-cells (Zhou et al., 2008) and mesoderm to 
cardiac myocytes (Takeuchi et al., 2009). However, the use of these lineage specific 
transcription factors does not allow isolation, expansion and characterisation of the 
reprogrammed cells, limiting their use in clinical applications.  
As such, combinations of iPSC transcription factors (iPSC-TFs) with cell-type-specific 
signals represent an alternative to directly generate differentiated cells from 
somatic cells. This technology possesses advantages compared with conventional 
iPSC reprograming processes, which are generally slow, involving several steps with 
low efficiency, which results in populations of pluripotent cells displaying unstable 
epigenetics. In addition to the use of iPSC-TF, direct conversion of somatic cells into 




into terminated differentiated cells. This technology has been successfully applied 
to directly transdifferentiate fibroblasts to cardiac (Efe et al., 2011), neural (Kim et 
al., 2009) and blood progenitor cells (Szabo et al., 2010). 
1.3 Current sources of hepatocytes 
Currently, freshly isolated primary human hepatocytes represent the current gold 
standard model to study human hepatocyte biology in vitro and recapitulate the 
functional response of the liver, especially for studies to predict in vivo drug 
metabolism and clearance (Hewitt et al., 2007; Obach, 2009). While primary 
hepatocytes offer significant functional benefits, the methods employed to isolate 
and culture hepatocytes represent a limitation for their use. Collagenase digestion 
followed by a series of density-gradient centrifugation steps represents the most 
effective and standardise method to isolate primary hepatocytes from intact liver 
tissues (LeCluyse et al., 2005). However, during the initial stages of isolation, 
primary hepatocytes undergo a process of dedifferentiation denoted by changes in 
cell morphology, structure, polarity, a drastic decrease in liver specific gene 
expression and liver specific functions, including CYP-activity and albumin 
production (Bader et al., 1992; Dunn et al., 1989; LeCluyse, 2001; LeCluyse et al., 
1996; Nelson et al., 1982), in a process referred as dedifferentiation, which 
represents an important limitation for the use of primary hepatocytes. In an effort 
to extend culture longevity, both in terms of liver specific functions and basic 
cellular functionality, a number of approaches have been developed; including 
adjustment of the culture medium and the extracellular matrix, changes in the cell 
culture format and culturing hepatocytes with other cell types ( Griffith and Swartz, 
2006; LeCluyse, 2001; LeCluyse et al., 1996; Meng et al., 2010). Despite advantages 
observed with certain approaches, the scarcity, low proliferative capacity and 
quality still hinder the use of human hepatocytes in the study of the human biology 
and toxicity studies (Fox and Strom, 2008). As a result, low quality fragments 
displaying high levels of phenotypic variation are frequently used for research, 




consequence, alternative models are used, including human cell lines, progenitor 
cells from adult liver and animal liver models.  
Hepatocarcinoma derived cell lines and immortalised human hepatocyte cell lines 
have been widely used in an attempt to enhance cell availability. In contrast to 
primary cell cultures, human tumour-derived cell lines, including the well 
characterised hepatocellular carcinoma derived cell lines HepG2 and HepaRG 
(Guillouzo et al., 2007), are not restricted to a limited number of cell divisions (Mees 
et al., 2009; Shay and Wright, 2005). Therefore, they represent a ready available 
and scalable resource of cells that can generate relevant data to humans. However, 
the differentiated cellular characteristics, genomic instability (Wong et al., 2000), 
their cancerous nature and incomplete expression of metabolic enzymes of these 
cells makes them an unreliable cell source to be used in therapy, human biology 
studies and toxicology test (Brandon et al., 2003; Richert, 2006; Rodríguez-Antona 
et al., 2002; Takahashi et al., 2006). As such, researches have focused on 
immortalising human primary hepatocytes (Allen et al., 2001). For this purpose 
different techniques, including transfecting cells with the simian virus 40 Tantigen 
(SV 40 Tantigen) (Li et al., 2005; Schippers et al., 1997), lipofectamine mediated co-
transfection of albumin promoter regulated constructs (Werner et al., 1999) and 
retrovirus mediate transfer of oncogenes (Kobayashi et al., 2003) have been 
employed. However, the risks of tumorigenic effects and possible damages in the 
DNA regulatory transfected regions have not been explored in much detail, limiting 
their use in downstream applications.    
Hepatoblast and hepatic progenitor cells, the resident stem cell population of the 
liver, are cell capable of differentiating into both cholangiocytes and hepatocytes  
(Herrera et al., 2006; Rogler, 1997). However, their low number and limited 
proliferative capacity make them difficult to isolate, expand and purify, limiting 
their use (Alison et al., 2007; Fiegel et al., 2006; Vessey and la M. Hall, 2001). 
As an alternative to human in vitro models, porcine, rodent and other animal 




However, their lack of predictability, the presence of xeno-contaminants and high 
phenotypic variations make them an inaccurate and unreliable substitute for human 
hepatocytes as they do not accurately mimic the mechanisms found in humans 
(Behnia et al., 2000; Guillouzo, 1998). As such, there is an urgent need for reliable 
and predictable in vitro hepatocyte models. 
1.4 Liver development 
Human liver development is a complex process that requires an extensive network 
of signals from the extracellular matrix and nearby mesoderm, acting in a time- 
and/or dose- dependent manner. However, to truly appreciate the potential of the 
hESCs in downstream applications including regenerative medicine and studying of 
the human body development, it is important to understand the origin and function 
of these cells during human development.  
1.4.1 Mammalian embryonic development 
Following fertilisation of an egg the resulting single cell, known as zygote, 
undergoes a series of divisions resulting in a cluster of 4-16 smaller cells called the 
morula (Hardy et al., 1989), which is surrounded by a glycoprotein membrane called 
the zona pellucida (Biswas and Hutchins, 2007). As the development progresses the 
cells of the morula, known as blastomere, continue to divide forming a central fluid 
cavity called the blastocoel (Hardy and Spanos, 2002) that contains a cell mass 
known as blastocyst. The blastocyst, in early embryo development, consists of an 
outer layer of cells known as trophectoderm and an inner cell mass (ICM) developed 
from the primitive blastocyst (figure 1A) (Johnson et al., 1986). Embryonic stem 
cells can be isolated from the ICM at this developmental stage. By the time of 
implantation, the ICM separates from the trophoblast forming a cavity known as 
amniotic cavity. Differentiation of the inner cell mass originates two specialized cell 




(Gardner and Rossant, 1979). While the hypoblast will form the yolk sac, all tissues 
in the adult body will developed from the epiblast (Rossant, 2008).  
The next step in the development, known as gastrulation, involves the formation 
from the epiblast of a thick ridge of cells called the primitive streak (PS). Exposure of 
the cells to signalling pathways such as Activin/Nodal, BMPs, FGFs and Wnt will 
induce the cells to migrate towards or inwards the primitive streak, resulting in the 
formation of the three germ layers. These three layers of cells, ectoderm, 
mesoderm and endoderm, will form all of the cells types found in the adult body 
(figure 1C) (Lawson et al., 1991). 
1.4.2 Hepatic Endoderm Specification 
During the migration of the newly specified endoderm through the primitive streak, 
the embryo undergoes a series of movements and rotations causing the endoderm 
to become the innermost layer (Lawson and Pedersen, 1987). In parallel to the 
migration process, the endodermal cells continue to expand eventually forming the 
anterior, posterior and lateral domains, converging on each other to form a closed 
primitive gut tube (figure 1D). The primitive tube is subdivided into three domains: 
foregut, midgut and hindgut (figure 1E). As development continues the hindgut 
domain develops into the large intestine, the midgut into the small intestine, while 






Figure 1. Early mammalian gut development. (A) Fertilisation of an egg and subsequent cell 
divisions result in the formation of the blastocyst, which consist of an outer layer of trophectoderm 
and an inner cell mass, which (B) flattens into a flattened disk made up of two cell layers: the epiblast 
and the hypoblast surrounding the amniotic cavity. (C) Gastrulation follows soon after implantation 




the epiblast, which results in the formation of the three embryonic germ layers, and (D-E) the 
differentiation into the ectoderm, mesoderm, and endoderm. (F) As development progresses the 
endoderm layer expands forming a primitive gut tube with distinct foregut, midgut and hindgut 
domains. Modified from Gieseck et al., 2001. 
Fate-mapping experiments in mouse embryos at embryonic day 8.0 of gestation 
(e8.0) have revealed the presence of three distinct domains of hepatic progenitor 
cells: two lateral paired domains and a third ventral midline domain of the foregut 
from where the liver originates (Tremblay and Zaret, 2005; Zaret and Grompe, 
2008). At this stage, albumin, alpha-fetoprotein and transthyretin are expressed in a 
portion of the ventral endoderm, representing the first molecular evidence of the 
liver development (Agarwal et al., 2008; Hay et al., 2008a). Migration of the lateral 
domains towards the midline and fusion with the ventral domain initiates the 
closure of the foregut, resulting in a single prehepatic domain lying adjacent to the 
developing heart at e9.0 and in close apposition to regions of lateral plate 
mesoderm, which will ultimately generates the mesothelial cells of the 
proepicardium and septum transversum.   
Previous studies in chick, frog, mouse and zebrafish models revealed that 
coordinate signalling of fibroblast growth factor (FGF) -1 and -2 from the developing 
cardiac mesoderm, and bone morphogenetic proteins (BMP) -2 and -4 from the 
septum transversum mesenchyme (STM) are critical in hepatic induction (Calmont 
et al., 2006; Jung, 1999; Rossi et al., 2001). 
The main source of FGFs is the developing cardiac mesoderm (Deutsch et al., 2001; 
Serls et al., 2005), playing a critical role in the induction of hepatic cells (Gualdi et 
al., 1996). The FGF-mediated hepatic cell fate specification is evolutionarily highly 
conserved and acts in a concentration dependent manner (Cheng et al., 2003; Shin 
et al., 2007). During liver development, the morphogenetic changes observed result 
in the distancing between the hepatic endoderm and the cardiac mesoderm (Jung, 
1999). Consequently, the concentration of FGFs decreases, inhibiting the 




induce varied vital responses for synchronizing developmental events (Serls et al., 
2005). Cultures of ventral endoderm in the presence of absence of different 
members of the FGF family demonstrated that FGF1 and FGF2 can induce the 
expression of the characteristic marker of hepatic cell fate albumin (Gualdi et al., 
1996; Jung, 1999).  The use of signalling inhibitors on embryo tissue explants and 
whole-embryo cultures revealed that the FGF signalling activates the RAS/MAP 
kinase pathway (MAPK) ERK1 and ERK2 (Bottcher, 2005; Corson, 2003; Schlessinger, 
2004) and the phosphoinositide 3-kinase pathway (PI3K/AKT). While ERK is involved 
in enhancing hepatic gene expression and nascent hepatocyte stability, PI3K/AKT 
pathway activation seems to be involved in the hepatic growth (Calmont et al., 
2006). 
Proliferation and complete differentiation of the nascent hepatic endoderm require 
the signalling molecules members of the transforming growth factor beta (TGFβ) 
superfamily, secreted by the septum transversum mesenchyme, the bone 
morphogenic protein (BMP) -2 and -4.  BMP2 and BMP4 cooperate with FGF 
signalling to encourage hepatic competence and specification of the primitive 
endoderm via GATA4, a GATA zinc finger transcription factor (Huang et al., 2008). 
DNA foot-printing analyses of the transcriptional regulatory elements controlling 
the onset of albumin expression during hepatic development revealed bounding of 
GATA4 and the transcription factor Forkhead box (Fox) A at the gene promoter 
(Bossard and Zaret, 1998), making it accessible to additional transcription factors 
such as hepatocyte nuclear factor 1 (HNF1) and CCAAT-enhancer binding protein 
beta (C/EBPβ), resulting in the transcriptional activation of albumin. 
Binding of BMP -2 and -4 to the constitutively active serine/threonine kinase type II 
receptors induces the phosphorylation of the Gly-Ser (GS) domains in the kinase 
type I receptors, leading to their activation. The receptor complex subsequently 
phosphorylates Smad1, Smad5 and Smad8, which is then able to complex with 





The WNT signalling pathway is also implicated during the onset of the hepatic 
development. However, contrary to the clear inductive role for FGF and BMP 
signalling, the contribution of WNT signalling is complex, contributing differently 
depending on the developmental stage (McLin et al., 2007). At early somite stages, 
WNT signalling displays repressive effects in the posterior endoderm inhibiting the 
expression of Hhex, an essential transcriptional regulator of hepatic development; 
in the anterior endoderm, the expression of WNT antagonists relives the expression 
of Hhex, promoting the commitment of the endoderm to a hepatic fate. Following 
specification, WNT signalling appears to promote liver bud growth and 
differentiation in multiple systems including Xenopusand zebrafish (Goessling et al., 
2008; Shin et al., 2007).  
1.4.3 Formation of the Hepatic Bud from Hepatic Endoderm 
1.4.3.1 Proliferation and Migration 
Liver bud originates from the newly specified ventral endodermal cells, called at this 
stage hepatoblast. The liver bud, at e9.5, begins to thicken as the cells transit from a 
simple cuboidal to a pseudostratified columnar epithelium (Bort et al., 2006), 
expressing hepatocyte genes; including albumin, alpha-fetoprotein and hepatocyte 
nuclear factor 4α (HNF4α); all of them considered indicators of early hepatic fate 
(Lemaigre and Zaret, 2004; Zaret and Grompe, 2008). Between e9.0 and e9.5, the 
laminin and collagen IV -rich basal layer surrounding the developing hepatic 
endoderm breaks down (Zaret, 2002; Zhao and Duncan, 2005) and the hepatoblasts 
delaminate and migrate into the STM to form the nascent liver bud (Bort et al., 
2006; Margagliotti et al., 2008; Medlock and Haar, 1983; Shiojiri and Sugiyama, 
2004). This process is controlled by an extensive network of transcription factors 
involved in cell migration and adhesion; including Hhex, Prox-1 and the Onecut 




 The expression of the homeobox transcription factor Hhex, a transcription factor 
critical for proliferation and migration of endoderm cells beyond cardiogenic 
mesoderm, is required to ensure cell pseudostratification (Bort, 2004; Bort et al., 
2006). Transactivation of this factor is induced by GATA4 and/or GATA6 (Denson et 
al., 2000; Watt et al., 2007; Zhao et al., 2005), being the latest required to maintain 
the differentiation state of the hepatoblast (Zhao and Duncan, 2005). Hepatoblast 
delamination is controlled by the homeodomain transcription factor Prox1. The 
prospero-related homeobox 1 (Prox1) is involved in degrading the basal matrix 
surrounding the liver bud, promoting the hepatoblast delamination and migration 
from the surrounding basal layer into the STM (Sosa, 2000), a process involving a 
downregulation in the expression of E-Cadherin (Bort et al., 2006; Medlock and 
Haar, 1983). Onecut factors OC-1 and OC-2 are involved in the morphogenesis and 
expansion of the liver primordium by controlling a gene network involved in cell 
adhesion and hepatoblast migration (Margagliotti et al., 2007). This gene network 
regulates the expression of extracellular matrix (ECM) proteins and ECM 
remodelling enzymes, such as the matrix metalloproteinases (MMPs) -14, expressed 
in the hepatic progenitors, and MMP-2, expressed predominantly in the 
surrounding mesenchyme (Margagliotti et al., 2007; Medico et al., 2001; Papoutsi et 
al., 2007). Endothelial precursor cells lie between the developing hepatic epithelium 
and the STM. The close contact with blood vessels persists as hepatoblasts migrate 
into the stroma. Null mutations in the vascular endothelial growth factor receptor 
gene Vegfr-2 (also known as Flk-1) result in embryos lacking endothelial cells with 
liver buds failing to delaminate (Matsumoto, 2001). In addition, inhibition of 
angiogenesis represses liver bud growth in culture, suggesting that endothelial cells 
provide important paracrine and physical factors which promote hepatoblast 
migration and proliferation.  
1.4.3.2 Liver Bud Growth 
Paracrine signals from surrounding and hepatic mesenchyme induce a tremendous 




PI3K pathway, and BMP4 (Jung, 1999; Rossi et al., 2001; Sekhon et al., 2004), in 
conjunction with Wnt/β-catenin signalling, promotes hepatic growth ( McLin et al., 
2007;; Monga et al., 2003).  
Hepatocyte growth factor (HGF), a potent mitogen expressed by mesenchymal cells, 
is needed in hepatoblast migration (Deutsch et al., 2001; Medico et al., 2001; 
Michalopoulos and Bowen, 1993), in part by activating the small GTPase Arf6 
(Suzuki et al., 2006). HGF binding to the tyrosine kinase receptor c-Met expressed in 
the neighbouring epithelial cells (Iida et al., 2003; Ishikawa et al., 2001), and TGFβ 
signalling activation via Smad2/Smad3 pathway (Weinstein et al., 1994) are also 
required for the stimulation of hepatoblast proliferation (Birchmeier et al., 2003; 
Bladt et al., 1995; Moumen et al., 2007; Sachs et al., 2000; Schmidt et al., 1995). 
Data suggest that HGF and TGFβ signalling act in parallel converging on β1-integrin, 
regulating and controlling hepatic architecture (Weinstein et al., 1994). In addition, 
FGF and HGF signalling stimulate many of the same intracellular kinase cascades, 
including MAPK and PI3K pathways, and both have been reported to stimulate the 
activity of β-catenin in the liver bud, suggesting crosstalk with the Wnt pathway 
(Berg et al., 2007; Monga et al., 2003; Sekhon et al., 2004). β-catenin, best known as 
a mediator of the canonical Wnt signalling pathway, is predominantly expressed  at 
the periphery of the developing liver lobes, which correspond with growth zones. β-
catenin interacts with c-Met in hepatocytes and upon HGF binding, it is translocated 
to the nucleus (Monga et al., 2003). Also, FGF-10, secreted by myofibroblastic cells, 
controls the activation of β-catenin stimulating the proliferation of hepatoblast 





Figure 2. Hepatic endoderm specification. The illustration reflects the onset of liver parenchyma 
cells indicating signalling molecules and transcription factors important in the process. Wnt 
signalling, at early stages in the differentiation process, promotes posterior endoderm identity and 
must be inhibited anteriorly by local Wnt antagonist expression for the progression of the liver 
development. At late stages, Wnt signalling acts in parallel with FGF and BMP signalling, driving 
hepatic specification, expansion and differentiation. Days refer to mouse development. Foregut 
endoderm (End; blue), heart (HE; red), liver bud (LB; blue), septum transversum parenchyme (STM; 
green).  Modified from Duncan et al., 2005. 
1.4.4 Hepatocyte Specification 
When the liver buds out of the endoderm, soon after mesenchyme invasion, around 
e13 in mouse development, the bipotential hepatoblasts soon face a decision to 
differentiate into either hepatocytes or cholangiocytes, also known as biliary 
epithelial cells.  
The decision to differentiate into hepatocytes (AFP+/albumin+) or cholangiocytes 
(cytokeratin (CK)-19+) (Jung, 1999) requires the correct balance of a complex cell 
signalling network acting in a gradient manner. The localisation of the hepatoblast 
within the developing liver determines the differentiation of the cells. While 
hepatoblasts surrounding the liver parenchyma differentiate into hepatocytes, 
cholangiocytes will originate from hepatoblasts found at the portal mesenchymal 




Previous studies have revealed that a gradient of Activin and TGFβ has a crucial role 
in the hepatocyte specification. The gradient in the expression of both factors is 
negatively modulated by the transcription factors Onecut-1 and Onecut-2 (Clotman, 
2005), favouring the hepatocyte differentiation. This pathway acts in coordination 
with Jagged-Notch pathway in supporting biliary differentiation (McCright et al., 
2002; Tanimizu, 2004). 
1.4.5 Hepatocyte Maturation 
Soon after hepatoblasts fate the decision to differentiate into hepatocytes, 
additional signals from haematopoietic cells such as the cytokine oncostatin M 
(OSM), act in combination with hepatocyte growth factor (HGF), regulating 
hepatocyte maturation in a process that goes even after birth. 
Oncostatin M, a member of the interleukine-6 (IL-6) family, by binding the gp130 
membrane receptor promotes morphological maturation into polarized epithelium 
via K-ras and E-cadherin (Matsui et al., 2002; Michalopoulos et al., 2003; Suzuki et 
al., 2003; Tan et al., 2008), through the JAK/Stat3 signalling pathway (Ito et al., 
2000; Kamiya et al., 1999). The hepatocyte growth factor, HGF, promotes the 
organisation of hepatocytes into cord-like structures by regulating the expression of 
diphosphate-ribosylation factor 6 (ARF6), an enzyme involved in actin cytoskeleton 
remodelling. In addition, some evidences suggest that TNFα, via activation of the 
transcription nuclear factor κB (NF-κB), balances HGF and OSM activity, inhibiting 
maturation and maintaining the proliferative capacity of foetal hepatocytes, thus 
allowing the liver to grow to the appropriate size before differentiating (Kamiya and 
Gonzalez, 2004). TNFα repression after birth is necessary to obtain fully mature 
hepatocytes expressing cytochrome P450 genes (Hart et al., 2009).  
During maturation, the liver-enriched transcription factors including C/EBPα, 
HNF1α, HNF3α-γ, nuclear hormone receptors and HNF4α, act in a complex inter-
regulatory network to control hepatocyte gene expression (Cheng et al., 2006; 




hepatocyte cell phenotype (Bulla, 1997; Späth and Weiss, 1997), playing an 
essential role in hepatocyte function by regulating a cascade of essential 
transcription factors involved in the correct development of the foetal liver 
architecture (Chen et al., 1994; Li et al., 2000). Data suggests that HNF4α binds to 
the promoters of nearly half of the genes expressed in the mouse liver (Odom, 
2004), including genes encoding cell adhesion and functional proteins important in 
hepatocyte epithelial structures (Konopka et al., 2007; Satohisa et al., 2005). 
Previous observations suggest that HNF4α could induce expression of HNF1α 
(Taraviras et al., 1994). HNF1α and C/EBPα expression, which is induced by HGF 
(Soriano et al., 1995; Tomizawa et al., 1998) are essential to ensure complete 
hepatocyte maturation and metabolic hepatic functions (Pontoglio et al., 1996; 
Wang et al., 1995). 
HNF4α and Wnt signalling, among other factors, are involved in the liver metabolic 
zonation, which begins after birth (Jungermann and Katz, , 1989). Based on the 
expression of a number of metabolism-regulating genes, within the hepatic lobule a 
periportal zone from a pericentral zone can be distinguished. HNF4α induces the 
expression of certain metabolic related genes in the pericentral zone. Null HNF4α 
livers display the same expression of such metabolic genes in both zones; periportal 
and pericentral zone (Stanulović et al., 2007). Equally, Wnt signalling is involved in 
the regulation of the metabolic zonation, whereas its receptor β-catenin is 
expressed in the perivenous area, and the β-catenin negative regulator APC is 
expressed in periportal hepatocytes (Benhamouche et al., 2006). 
1.5 Liver architecture  
The acquisition of the correct tissue architecture within the organs is crucial in order 
to ensure a normal body function. The liver is the largest internal organ, 
compromising one fiftieth of the total weight of the adult body. The liver exhibits 
both endocrine and exocrine properties. Endocrine functions include secretion of 




blood; while the generation and secretion of bile and drug metabolism are the 
major exocrine function.  
The basic structural unit of the liver is the liver lobule, which displays a polygonal 
structure with a central vein localised in the centre of the lobule and a portal triad 
consisting on the hepatic artery, bile duct and hepatic portal vein. The basic 
functional unit of the liver is called acinus. The acinus is formed by plates or cords of 
hepatocytes, generally one cell thick in mammals, radiating from the central vein 
and lined by sinusoidal capillaries. Blood enters the lobule via the portal triad of 
vessel, flows through the parenchyma and exists via the central vein. This flow 
creates a chemical gradient and distinct microenvironments (Gebhardt and 
Baldysiak, 2007; Ugele et al., 1991) which divides the acinus into three zones 
accordingly to their function. The periportal zone or zone 1, responsible for 
oxidative metabolism, gluconeogenesis and ureagenesis; the pericentral zone or 
zone 3, responsible for glycolysis, liponeogenesis and metabolism of xenobiotics; 
and a mid-lobular region or zone 2 that displays a mixture of zone 1 and zone 3 





Figure 3. Liver architecture. Illustration showing overall structure of a portion of a liver lobule. 
Modified from Si-tayeb et al., 2010.  
The cells comprising the liver can be divided into two categories: parenchymal cells 
and non-parenchymal cells. The parenchymal fraction consists on hepatocytes, the 
major cell type of the liver, making up to 80% of the total liver volume and 60% of 
the total cell population in the liver. The non-parenchymal fraction includes bile 
duct epithelial cells, liver sinusoidal endothelial cells, hepatic stellate cells and 
Kupffer cells.  
Hepatocytes are highly differentiated epithelial cells that perform the major 
functions associated with the liver, including protein, fat, steroids and xenobiotics 
metabolism. The hepatocyte morphology is characterised by the possession of a 
cuboidal shape with one or more nuclei, with polyploidy cells, 4N or 8N, increasing 
in number from zone 1 to zone 3 (Deutsch et al., 2001) and a prominent nucleoli. 
Hepatocytes display abundant mitochondria with Golgi complexes adjacent to the 




reticulums, which are indicative of the hepatocyte secretory nature and enzymes of 
the phase I and phase II drug metabolism, respectively. 
The non-parenchymal cells display important roles in the regulation of the hepatic 
growth and functions, including the production of growth factors and other 
mediators of cellular function. Liver sinusoidal endothelial cells (LESC) are thin and 
elongated cells located in the hepatocyte basolateral surface, delimiting a space 
known as Space of Disse or perisinusoidal space. Their plasma membrane possesses 
abundant fenestrations that increase the contact between the hepatocytes and the 
circulating blood, allowing the diffusion of small substances to the hepatocytes 
(Cogger et al., 2010). Hepatic stellate cells (HSC), also known as Ito cells, are found 
embracing the endothelial cells in the Space of Disse. These cells are involved in the 
sinusoid contractility, matrix remodelling and hepatocyte proliferation during liver 
regeneration by secreting cytokines, including HFG, TGFα and EGF (Friedman, 2008).  
In addition, HSC are responsible for the increase deposition of extracellular matrix 
observed during the progression of liver cirrhosis, which can be resolved by the 
action of cytokines secreted by the resident macrophages of the liver, with a 
mesenchymal origin, the Kupper cells (Jaeschke, 2007).  
The hepatic progenitor cells (HPC) are the epithelial cells that line the bile ducts. 
Hepatoblasts are found in a compartment contained within the canals of Hering. 
These canals represent the smallest and most peripheral branches of the biliary tree 
connecting the bile canalicular system with the interlobular ducts (Gaudio et al., 
2009). Under normal circumstances HPC display a relatively low proliferation rate. 
However, upon continuous damage or severe loss of the epithelial cells of the liver, 
HPC are activated and expand from the canals of Hering to the pericentral zone, 
giving rise to mature hepatocytes or cholangiocytes (Forbes et al., 2002). 
Epithelial organs possess two domains on opposite surface of an epithelial sheet, 
the apical (luminal) and basolateral (blood-facing) domains. However, hepatocytes 
possess two basolateral domains interfacing with the sinusoidal microvasculature 




an apical domain, lying between the lateral domains of opposing epithelial cells 
forming the canalicular domain. The canalicular domain forms a belt like structure 
around the periphery of each hepatocyte that, by interconnecting with canaliculi 
from adjacent cells, forms a network of small tubular compartments terminating at 
the portal triad and interconnecting with bile ducts via the canals of Hering, 
eventually draining into the common bile duct and the gall bladder. Both surfaces 
display different biochemical characteristics critical for maintaining normal hepatic 
function (Chapman and Eddy, 1989): the basolateral domains of the hepatocytes 
are responsible for the exchange of metabolites with the blood and establish 
interactions with the ECM providing support and anchorage for the cells; and the 
apical domain is responsible for the transport of bile acids and detoxification 
products into the canaliculus that surrounds the hepatocyte (Decaens et al., 2008). 
The extracellular matrix (ECM) of the liver is found in the Space of Disee, between 
the hepatocytes and the liver sinusoidal endothelial cells. It has an important role in 
directing and maintaining both architecture and phenotypic gene expression of liver 
cells. The ECM is a thin layer which composition varies in a gradient manner, 
paralleled by those of soluble signals. Generally, the ECM in the liver consists mostly 
of fibronectin, proteoglycans and collagens, mainly type I and minor quantities of 
types III, IV, V, and VI (Martinez, 1995), favouring a rapid bidireccional exchange of 
macromolecules between plasma and hepatocytes. In addition, the niche of the 
hepatic progenitor cells is rich in laminins  (Lorenzini et al., 2010). 
1.6 Generation of in vitro hepatocyte-like cells from 
pluripotent stem cells or somatic cells  
Different sources of hepatocytes, including primary hepatocytes, hepatocyte cell 
lines and non-human derived hepatocytes have been employed to satisfy the 
current high demand. Although the use of these sources is widely extended, they 
possess limitations restricting their use in downstream application. Primary 




phenotype. In addition, the scarcity and quality of the available primary human 
hepatocytes restrict their use (Gómez-Lechón et al., 2010; Hewitt and Lechón, 
2007). Hepatocarcinoma derived cell lines and immortalised human hepatocytes 
display a genomic instability and incomplete expression of hepatocyte specific 
functions (Wong et al., 2000). Non-human hepatocytes show a high phenotypic 
variation, the risk of xeno-contaminants and the difficulty to translate the findings 
to the human hepatocyte biology, which prevent their use as a reliable replacement 
for human hepatocytes (Behnia et al., 2000; Guillouzo, 1998).  
Therefore, there is an urgent need for reliable and predictable in vitro hepatocyte 
models. As such, the self-renewal and pluripotent nature of pluripotent stem cells in 
combination with efficient hepatocyte differentiation approaches make them an 
ideal and reliable source of human hepatocytes. Moreover, the knowledge gained 
from reprograming somatic cells into pluripotent stem cells can be successfully 
applied to directly transdifferentiate somatic cells into another cell type, confers the 
somatic cells with the capacity of becoming a potential source of hepatocytes to be 
used in downstream applications. 
Discoveries in the mechanism of the liver development along with the emergence of 
pluripotent stem cell technologies have allowed the improvement of existing 
differentiation protocols to obtain hepatocyte-like cells (HLCs) from pluripotent 
stem cells and somatic cells, in processes that mimic the patterns and stages 
observed during embryologic development.  The protocols developed generally 
used two different strategies, either cellular aggregation strategies via embryoid 
body formation or differentiation in a monolayer culture.  
1.6.1 Differentiation via Embryoid Bodies (EBs) 
In an attempt to mimic the cell-to-cell and the cell-to-ECM interactions observed 
during development in vivo, researches developed protocols involving aggregation 
strategies through the formation of three-dimensional structures called embryoid 




aggregated ES cells in suspension or using low adhesion specialized plates. EBs are 
characterized by the expression of markers from the three embryonic germ layers.  
Lavon and colleagues developed a strategy to isolate cells primed towards the 
endoderm fate from suspension cultures of hESCs-derived EBs, using hESCs labelled 
with a reporter gene expressed under the control of a hepatocyte specific promoter 
(albumin-eGFP). The resulting isolated cells grown as a monolayer in the presence 
of a media supplemented with bFGF, displayed enhanced expression of albumin, 
suggesting that hepatic cells developed in vivo in a niche next to the cardiac 
mesodermal cells (Lavon et al., 2004). The effect of different components of the 
extracellular matrix (ECM) in hepatic differentiation was tested by several groups. 
Schwartz and colleagues observed an improvement in the gene expression of 
endodermal markers in hESCs-derived EBs on collagen I coated plates in the 
presence of FGF4 and HGF (Schwartz and Linehan, 2005). Sirahashi and colleagues 
highlighted the importance that the culture conditions, including medium, 
substrates, foetal bovine serum (FBS) and growth and differentiation factors 
possess in the hepatocyte differentiation of both, human and mouse ESc (Shirahashi 
et al., 2004). Baharvand and colleagues revealed that three-dimensional cultures 
enhanced hepatocyte differentiation when compared with two-dimensional 
cultures as 3D resembles more closely the in vivo environment (Baharvand et al., 
2006). 
Despite the initial promising findings, the stochastic and spontaneous 
differentiation that EBs undergo result in heterogeneous population of different 
cells lineages with poor hepatocyte differentiation efficiency. To address this issue, 
research have focused in developing differentiation protocols in a stepwise manner 





1.6.2 Direct differentiation of hESC into hepatocyte-like cells (HLC) 
There are a big number of differentiation protocols for deriving functional 
hepatocyte-like cells from hESC in a step-wise manner, using animal derived 
matrices including, collagen, gelatin or Matrigel™ as basement membrane. Most of 
the available differentiation protocols try to mimic the hepatogenesis processes 
that occur during development in vivo, consisting in different steps; priming of the 
hESC towards definitive endoderm prior to hepatic endoderm induction and 
followed by inducing hepatocyte maturation in the hepatic endoderm generated. 
The resulting HLCs are characterized using a number of specific assays, including 
gene and protein expression, urea production, cytochrome P450 activity, serum 
protein production and glycogen storage. However, the exact approach varies 
between laboratory groups.  
1.6.2.1 Endoderm specification 
The existing protocols to induce endoderm differentiation on an EB independent 
manner tried to mimic the processes that occur during development in vivo. 
D’Amour and colleagues developed an efficient differentiation protocol to derived 
hESCs into definitive endoderm using high concentrations of Activin A (D'Amour et 
al., 2005). Activing A mimics nodal signalling, a member of the transforming growth 
factor-β (TGFβ) superfamily that plays a critical role in the initiation of the 
development of the endoderm during gastrulation (Green and Smith, 1990). 
Treatment with Activin A resulted in over 80% of the cells expressing the endoderm 
marker Sox 17 and FoxA2 (Cereghini, 1996; Cirillo et al., 2002). Ishii and colleagues 
studied the endoderm differentiation under the presence of several factors 
including HGF, BMP4, FGF4 and ATRA (all-trans-retinoic acid) on different 
extracellular matrix components. They found that sequential addition of Activin A 
and HGF on Matrigel coated dishes produced higher yield of AFP positive cells (Ishii 




The WNT signalling pathway is also implicated during the onset of the hepatic 
development. Studies in the role of Wnt and β-catenin signalling during the 
differentiation and proliferation of pre-hepatic endodermal cells have led to 
improvements in the endoderm specification from hESCs (Burke et al., 2006; 
Fletcher et al., 2008; McLin et al., 2007). Hay and colleagues studied the expression 
of Wnt signalling during liver development. Their findings reveal the importance of 
Wnt3a signalling in Primitive Streak (PS) and endoderm development. Wnt3a 
expression during liver development during the first trimester is restricted to the 
portal system, while in the second trimester it is also detected in the liver 
parenchyma suggesting a potential role in early hepatogenesis. By applying this 
knowledge, they found that a treatment of Activin A in combination with Wnt3a 
leaded to a more rapid and enhanced endodermal differentiation that resulted in 
more functional HLCs (Hay et al., 2008a). 
1.6.2.2 Hepatic specification and differentiation   
Cai and colleagues developed a differentiation protocol that mimicked the in vivo 
situation. After priming hESCs towards definitive endoderm employing Activin A, 
they generated hepatic endoderm by treating cells with FGF4 and BMP2. The 
resulting cells were differentiated towards HLCs in a two-stage differentiation 
strategy. The hepatic endoderm was committed to the hepatocyte fate by using a 
media supplemented with HGF, followed by a hepatocyte maturation induced by 
OSM and dexomethasone. The resulting cells expressed a range of adult liver 
markers including CYP7A1, CYP3A4 and CYP2B6, tyrosine aminotransferase, 
tryptophan oxigenase2, phosphoenolpyruvate carboxykinase (PEPCK). Moreover, 
the authors detected hepatocyte functions including albumin secretion, glycogen 
storage and inducible cytochrome P450 activity. Interestingly, these cells were 
susceptible to hepatitis C virus HCV infection (Cai et al., 2007). 
Agarwal and colleagues employed FGF4 and HGF to promote hepatic specification 




hepatocyte differentiation and maturation of the endoderm-derived cells was 
induced using a combination of BSA, FGF4, HGF, OSM and dexamethasone, 
obtaining HLCs expressing a number of hepatocyte specific markers including 
albumin, alpha-fetoprotein (AFP), CYP3A4 and CYP7A1. Hepatocyte functions 
including glycogen storage and albumin secretion were detected. In addition, cells 
were injected in a damaged mouse liver, reporting expansion and repopulation of 
the liver (Agarwal et al., 2008). 
Brolen and colleagues demonstrated that induction of definitive endoderm with 
Activin A and FGF2 excluded the extraembryonic differentiation of hESCs. Following 
hepatic specification using combinations of BMP2 and -4 with FGF1, -2 and -4, 
hepatocyte maturation was induced employing a cocktail of different factors 
including EGF, insulin, transferrin, ascorbic acid, FGF4, HGF, dexomethasone, 
dimethyl sulfoxide (DMSO) and OSM. They successfully applied this differentiation 
protocol to three different hESC lines. The resulting HLCs displayed hepatic 
functions including, urea secretion, glycogen storage and cytochrome P450 activity 
(Brolén et al., 2009). 
Basma and colleagues reported a differentiation approach involving an initial EB 
formation step. The hESCs-derived EBs were plated on matrigel and treated with 
Acticin A and FGF2. Hepatic specification and maturation was induced using HGF 
and DMSO, followed by a treatment with dexamethasone. Enrichment of the HLC 
population was performed employing FACS sorting for ASGPR positive cells, a 
specific feature of mature hepatocytes; obtaining HLC population with comparable 
function to adult hepatocytes. Furthermore, engraftment of the enriched 
population of cells after the splenic injection was observed, displaying proliferation 
and secretion of functional liver-specific proteins (Basma et al., 2009). 
Touboul and colleagues obtained hepatic progenitor cells from hESCs-derived 
definitive endoderm cells by applying a treatment with FGF10, retinoic acid and 
SB431542, a pharmacological inhibitor of activin/nodal pathway. The authors 




synergized by FGF10 and Wnt signalling. The generated bipotential progenitor cells 
could be efficiently differentiated into cholangiocytes displaying structural and 
functional similarities to bile duct cells in normal liver (Dianat et al., 2014). 
Hepatocyte differentiation was induced using FGF4, HGF and EGF, generating HLCs 
that, post-injection, successfully engrafted in a mouse liver secreting human 
albumin (Touboul et al., 2010).  
Hay and colleagues induced hepatic specification from hESCs-derived endodermal 
cells by supplementing the media with DMSO, an organosulfur compound that 
induces the acetylation of the histones. Hepatocyte differentiation was induced 
employing a serum containing media supplemented with HGF and OSM. The 
resulting HLCs were capable of repopulating a damage liver of a mouse, displaying 
biliary duct-like structures, parenchymal hepatocyte markers and myofibroblast 
markers (Hay et al., 2008a). Furthermore, engrafted cells still secreted human 
serum albumin three months post-transplantation (Payne et al., 2010).  
1.6.3 Hepatocyte differentiation of iPSCs 
The self-renewal and pluripotent properties displayed by induce pluripotent stem 
cells (iPSCs) make them an attractive cell source to generate HLCs. In addition, the 
possibility to obtain autologous iPSCs makes them an ideal source of somatic cells 
to be used in disease modeling and transplantation. The existent hepatocyte 
differentiation protocols of hESCs have been successfully fine-tuned to generate 
HLCs from iPSCs. 
Si-Tayeb and colleagues described a four step differentiation protocol in low oxygen 
to obtain functional HLCs with no differences compared with hESCs-derived HLCs 
regarding to morphological features, mRNA fingerprint and integration into the 
mouse hepatic parenchyma in vivo (Si-Tayeb et al., 2010). 
The differentiation protocol developed by Hay and colleagues was successfully 




differentiated three iPSC lines, obtaining HLCs displaying cytochrome P450 activity 
and secreting liver specific protein including albumin, alpha-fetoprotein and 
fibronectin (Sullivan et al., 2009). 
Song and colleagues applied a multi-phasic differentiation approach of iPSC to 
obtain HLCs which displayed liver cell markers and liver related functions including 
urea production, albumin secretion and cytochrome P450 activity comparable with 
hESCs-derived HLCs (Song et al., 2009). 
Despite the encouraging outcomes, most of the current hepatocyte differentiation 
approaches deliver somatic cells in two dimensional cell cultures displaying many 
typical hepatocyte characteristics. While these attributes are promising, they lack in 
mimicking the three dimensional in vivo microenvironment  (Yim and Leong, 2005), 
as demonstrated by a low cellular polarity or limited functionality under standard 
culture conditions for certain toxicity testing. In order to overcome this issue, 
researches have focused on developing differentiation strategies employing three 
dimensional in vitro platforms including spheroids culture plates and bioreactors.   
As such, Takayama and colleagues developed a three-dimensional spheroid culture 
system to obtain hESC- and iPSC-derived HLCs that predicted sensitively drug-
induced hepatotoxicity (Takayama et al., 2013).  Vosough and colleagues described 
a stirred-suspension bioreactor culture to obtain iPSC-derived HLCs that, post-
transplantation into the spleens of a mouse with liver injury, successfully engrafted 
with cells displaying expression of different liver specific enzymes and secreted 
albumin (Vosough et al., 2013). Sivertsson and colleagues compared the efficiency 
in the differentiation towards the hepatocyte lineage of hESCs between a two-
dimensional culture system and a three-dimensional bioreactor system, suggesting 
an improvement in the hepatic differentiation when the three dimensional system 
was applied (Sivertsson et al., 2012). While these approaches marked significant 
progress, their complexity and/or undefined nature limited a large scale 




1.6.4 Hepatocyte differentiation from somatic cells-transdifferentiation 
The knowledge acquired from reprograming somatic cells into induced pluripotent 
stem cells (iPSCs) indicated that somatic cells could be directly reprogramed or 
transdifferentiated into another cell type. As such, this knowledge has been applied 
to successfully transdifferentiate mouse and more recently human fibroblast into 
HLCs.  
Sekiya and colleagues transfected mouse embryonic and adult fibroblast with 
HNF4α plus FoxA1, -A2 or -A3 successfully obtaining induced HLCs (iHLCs) 
expressing hepatocyte functions such as glycogen storage and uptake of low-density 
lipoproteins (LDL). In addition, the resulting cells displayed features of hepatocyte 
polarization including the canalicular membrane protein multidrug resistance-
associated protein (Mrp 2), the basolateral membrane protein Mrp4 and the tight 
junction protein ZO-1. Moreover, post-injection in a fumarylacetoacetate hydrolase-
deficient mouse liver, cells successfully engrafted and reconstituted the hepatic 
tissue, and despite they stopped proliferating after 2 months, cells responded to a 
two-thirds partial hepatectomy (Sekiya and Suzuki, 2011).  
Another independent study performed by Huang and colleagues, employed mouse 
tail fibroblast as starting cell population, and using lentivirus expression of GATA4, 
HNF1α and Fox3, they observed that inactivated p19Arf was a requirement to 
overcome the proliferative limitation of the cells. The resulting population of iHLCs 
expressed hepatocyte genes and proteins including albumin, AFP, HNF4α and 
cytochrome P450 enzymes specific to mature hepatocytes. In addition, iHLC were 
capable of metabolizing toxicological compounds. Moreover, these cells were 
successfully transplanted in vivo and repopulated the livers of mice with acute liver 
failure (fumarylacetoacetate-hydrolase-deficient mice), rescuing more than half of 
the recipients (Huang et al., 2011). 
Moreover, recently the same group reported successful reprograming of human 




resulting iHLCs expressed hepatocyte genes and displayed functional characteristic 
of mature hepatocytes, including biliary drug clearance and cytochrome P450 
activity. In addition, upon transplantation into fumarylacetoacetate-dehydrolase-
deficient mice, iHLCs restored the liver function (Huang et al., 2014). 
Despite all the recent advantages made in the field, most of the current 
differentiation approaches to obtain HLC from pluripotent stem cells and somatic 
cells rely on the use animal derived matrices, which suffer from batch-to-batch 
variation and instability, influencing the reproducibility and phenotypic stability of 
the cells. As such, it is necessary to identify synthetic matrices that can ensure the 
delivery of reliable and stable HLCs without compromising their functional 
capacities.  
1.7 Biomaterials in stem cell technology. 
Since the derivation of human embryonic stem cells (hESCs) from the inner cell 
mass of blastocyst embryos research has put great efforts in using these cells in 
clinical and research applications. Traditionally, human pluripotent stem cells 
(hPSCs) have been cultured in vitro employing feeder layers such as mouse 
embryonic fibroblast (MEFs) or extracellular matrices such as matrigel. These 
matrices successfully maintain the undifferentiated and pluripotent state of the 
cells by secreting or providing essential cytokines and growth factors to the culture 
media, such as TGFβ and activin A, and extracellular matrices (ECM) such as 
laminins (Xu et al., 2001). However, these matrices display inconsistencies in the 
expression and secretions of these factors and pathogenic and immunogenic 
contaminations that can influence the cell function and phenotype (Mallon et al., 
2006). As such, the use of these cells in downstream applications such as treatment 
of human diseases, or interpretation of mechanistic studies designed to understand 
the biology of the PSCs and their relation with the surrounding cells and 
microenvironments is limited (Brafman et al., 2009). Consequently, in an attempt to 




chemically defined substrates (biomaterials) that efficiently replace the use of 
animal-derived culture substrates in hPSC cultures. As such, different strategies 
have been developed, including; recombinant proteins such as collagens, 
vitronectin and laminins (Braam et al., 2008; Brafman et al., 2010; Rodin et al., 
2014; 2010); synthetic peptides such as GAGs (glycosaminoglycans) and heparin 
binding peptides (Klim et al., 2010), and synthetic polymers.  
Synthetic polymers are a type of biomaterials. Broadly, biomaterials can be 
classified into polymers, metals, ceramics and composites. Polymers, physical 
networks made out of monomers subunits, have gained the attention of the stem 
cell field due to their physical properties including their inert nature, diverse 
composition, their extensive forms and their capacity to interact with other 
synthetic or recombinant derived substrates, all of which make them attractive 
substrates for clinical and research applications.  
Due to the anchorage-dependent nature of the pluripotent stem cells, synthetic 
materials employed in the culture of hPSCs must allow cell adhesion, spreading and 
colony formation while maintaining the genetic stability, self-renewal and 
pluripotent state of the cells for a high number of passages (Villa-Diaz et al., 2013). 
Cell polarity has also been demonstrated to maintain the undifferentiated state of 
hPSC. For example, the cell adhesion molecule E-Cadherin is co-expressed with 
other typical undifferentiated markers, including the cell surface markers SSEA-4, 
TRA-1-60 and TRA-1-81 as well as pluripotency factors Oct-4, Nanog and Sox2 (Li et 
al., 2012). In addition, these materials require being compatible with the 
sterilisation treatment of the culture plates, being cost-effective and having the 
potential to be scaled-up for commercial purpose. 
1.7.1 Polymers in pluripotent stem cell cultures 
Several materials have been combined with polymers and employed as stem cell 
culture substrates, including peptide, protein-based systems and biomolecules, with 




2010). However, the presence of peptides or recombinant proteins can increase the 
cost of the substrates, possess risk of xeno-contaminant, batch-to-batch variations 
and have the risk of going under degradation from the metalloproteinases secreted 
by the cell cultures, all of which compromise the cell performance (Villa-Diaz et al., 
2013). As such, attention has focussed on developing fully synthetic substrates for 
the maintenance of PSCs. 
Poly [2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] 
(PMEDSAH) represents one of the most extended synthetic substrates studied in 
the maintenance of PSC. It has been shown to successfully support long-term 
culture of several hESC and iPSC (Villa-Diaz et al., 2010). 
Aminopropylmethacrylamide (APMAAm) represent another example of synthetic 
substrate that has been successfully employed in the long-term maintenance of 
undifferentiated PSCs, by promoting the adsorption of different proteins presented 
in the culture media, mainly bovine serum albumin (BSA), which was identified as 
an essential component to promote cell adhesion (Irwin et al., 2011).  The 
importance of media protein adsorption in the maintenance of PSCs was also 
revealed by Mei and colleagues, by identifying a polymer generated from 
monomers with high acrylate content that displays the capacity of fixing vitronectin 
from the culture media to promote colony formation, revealing the importance of 
physical parameters of the polymers including wettability, surface topography and 
surface chemistry (Mei et al., 2010).  
Although synthetic polymers represent a more economical and stable approach to 
culture hPSCs, these platforms are still applied in 2D systems, which limit the 
mimicking of the three dimensional in vivo cell-to-cell and cell-to-ECM interactions. 
As such, different approaches have been employed to emulate a three dimensional 
culture system, including the use suspension cultures, bioreactors and hydrogels.  
Amit and colleagues developed a free serum culture media supplemented with 
IL6RIL6 (interleukin-6 receptor interleukin-6 fusion protein) that supported long-




pluripotency abilities (Amit et al., 2010).  Steiner employed similar approach and 
obtained suspension cultures of hPSCs that maintained their pluripotency capacity 
by using a neurobasal media supplemented with serum replacement and ECM 
components (Steiner, 2010). Despite the culture improvements observed in this 
system, the complexity of the media employed and the dependence on biological 
derived components for both, the media and cell passaging, represent a limitation 
for their use. As such, the use of hydrogels, that due to their physical properties can 
be easy tuned in two or three dimensional topography, have been explored as hPSC 
culture substrates, including hyaluronic acid (Liu et al., 2012), polyacrylamide-based 
(Brafman et al., 2009) and amino-propylmethacrylamide hydrogels (Irwin et al., 
2011). Of interest, Zhan and colleagues identified a thermoresponsive and animal 
free passaging acrylate based hydrogel for the maintenance of PSCs compatible 
with the use of serum-free defined media, which represents a hallmark in the 
possession of defined and animal free culture system of hPSCs (Zhang et al., 2013). 
1.7.2 Polymers in stem cell differentiation 
During cell differentiation, the nature of the microenvironment plays a critical role 
in guiding stem cell specification towards the desire cell fate. Therefore, the use of 
well-defined synthetic cell microenvironments that mimic the stem cell niche in vivo 
represents an important step towards a well-defined and scalable cell culture 
system for applications. There are several examples of polymers either alone or in 
combination with peptides that have been employed in promoting the 
differentiation of PSCs into cells of the three germ layers while revealing the insights 
of developmental cues. For example, neural differentiation has been achieved by 
combining polycacrilamides hydrogels combined with glycosaminoglycans (GAG)-
binding peptides which favored the attachment and neural differentiation of hESCs 
in the absence of neurogenic factors by only tuning the mechanical properties of 
the underlying matrix, which have revealed the importance of mechanical cues to 
control the differentiation of pluripotent stem cells (Musah et al., 2012). Also, these 




adhesion molecules to the culture substrate promoting neural differentiation (Yang 
et al, 2014). The polymer technology has also allowed the identification of key 
extracellular membrane receptors, namely integrins, involved in the differentiation 
into early mesodermal fate (Li et al., 2011).  In addition to elucidate early 
developmental signals, polymers can also replace differentiation factors. Gelatin 
methacylate-based matrices have shown to promote osteogenic differentiation in 
the absence of typical osteoinductive factors, both on 2D surfaces and 3D scaffolds 
(Kang et al., 2014). 
Polymers, both alone or in combination with proteins or peptides, have been also 
applied to promote hepatocyte differentiation of PSCs, and have been used to 
explore mechanistic processes of hepatogenesis. As such, Yamazoe and colleagues 
observed that hepatocyte differentiation from hESCs was promoted in the presence 
of a three dimensional polyamide nanofiber that induces the continuous activation 
of Rac 1, a protein involved in the remodeling of the cytoskeleton (Yamazoe et al., 
2013). Hydrogels have been also employed in studying hepatocyte differentiation. 
Malinen and colleagues employed a three dimensional system made out of 
nanofibrillar cellulose and hyaluraonan-gelatin hydrogel to differentiate the HepaRG 
liver progenitor cells towards hepatocytes, revealing the importance of cell density 
in hepatocyte differentiation efficiency (Malinen et al., 2014). Another study 
performed by Takayama and colleagues combined stage-specific transient 
overexpression of hepatocyte-related transcription factors and a spheroid culture 
plate (Nanopillar Plate) to perform hepatocyte differentiation of hPSCs, obtaining 
hepatocytes that responded to hepatotoxic compounds. However, the complexity 
of the differentiation approach and the requirement of matrigel in the culture 
substrate represent a limitation for large-scale manufacturing (Takayama et al., 
2013). More recently, Celiz and colleagues employed high-throughput technology to 
perform an extensive screening to identify a synthetic polymer substrate that 
supported both hPSC culture and differentiation into the three germ layers in a 
defined environment. From this screening they identified one in particular, HPhMA-




hydroxyphenyl)methacrylamide) and poly(2-hydroxyethyl methacrylate) 
(polyHEMA) that supported both, maintenance of undifferentiated hPSCs and their 
differentiation capacity into cells of the three germ layers, providing a robust 
platform for the large-scale production of stem cell derived somatic cells for clinical 
and research applications (Celiz et al., 2015).  
1.7.3 Polymer screening approaches 
Identification of new biomaterials compatible with the desired biological application 
or biological response represents a slow and time consuming process. To overcome 
this issue, high throughput or combinatorial polymer based approaches to polymer 
synthesis, fabrication and screening have been developed.  
Menger and colleagues pioneered in employing high throughput technology to 
identify new organic catalysts with phosphatase activity (Menger et al., 1995). In 
parallel, Brocchini and colleagues employed this technology to create a library of 
structural related polymers by combination of monomers (Brocchini et al., 1997). 
Polymer libraries possess the potential to increase the number of polymeric 
candidate materials for any specific application and systematize the study of 
existent correlations between polymer structure, material properties and 
performance. Refining of the technique was subsequently developed by Boussie 
and colleagues by deposition and analysis of polymer spots on a surface, resulting in 
the possession of microarrays compromising a large number of polymers (Boussie 
and Devenney, 2004). The technology was further translated to the biology field by 
Meredith and colleagues, who generated a polymer microarray employing 
variations in temperature during polymer synthesis on a glass slide, to identify 
polymer hits that increased alkaline phosphatase expression in osteoblasts 
(Meredith and Sormana, 2003) (Meredith et al, 2003). How and colleagues applied 
this technology to identify DNA delivery systems for cell transfection using a 
microarray containing polymers with high DNA binding affinity (How et al., 2004). 




which automatized the mixing process of the monomers forming the polymer in a 
process in which physical parameters are highly regulated, therefore ensuring a 
high reproducibility between experiments. Anderson and colleagues translated this 
technology to the stem cell field. The authors identified polymer hits that supported 
hESC attachment and promoted epithelial differentiation from a polymer 
microarray compromising 1728 different acrylate-based polymer candidates 
(Anderson et al., 2004).  
Subsequently, polymer arrays have been applied in a number of applications 
including, synthesis of scaffold libraries for screening cell–material interactions in a 
three dimensional format (Yang et al., 2008), identification of polymers that enable 
adhesion and proliferation of a suspension cell line (Pernagallo et al., 2008) and 
identification of thermoresponsive polymer hydrogels for cellular capture, 
proliferation and release upon temperature reduction with applications to several 
cell types (Zhang et al., 2009). As such, the possession of a defined culture system 
for the culturing and differentiation of hPSC will undoubtedly provide information 
on novel mechanisms of action with the possibility of developing stable culture of 
somatic cells for clinical, therapeutic and research applications. 
1.8 The objectives of the thesis 
The thesis initially focuses on establishing a serum-free hepatocyte differentiation 
approach from hESCs compatible with the use of the polyurethane 134 (PU134) as a 
culture substrate. The culture system was used as a platform to study the 
mechanism of action of the PU134 in stabilising the hepatocyte phenotype 
observed on cells under the defined conditions and identifying key genes involved 
in this stabilisation process. The final investigation was carried out by translating the 























2.1 Materials and solutions 
2.1.1 Cell culture media 
Table 1. Cell media culture employed. 
Cell line Growth 
media 






10ng basic fibroblast growth 
facto(bFGF) 
R & D System 











20% KnockOut Serum 
Replacement 
1% Glutamax 




















RPMI 1640  
B27 
100 ng/ml Activin A 




R & D System 
Peprotech 
Life Technologies 
SR/DMSO 20% Knock Out Serum 
Replacement 
0.5% Glutamax 
1% Non-Essential Aminoacids 
0.1mM β-Mercaptoethanol 












8.3% Tryptose phospate 
broth 
8.3% FBS 
10 µM hydrocortisone 21-
hemisuccinate 
1 µM Insulin ( bovine 
pancreas) 
1% L-glutamine 
0.2% Ascorbic Acid 
















10 µM hydrocortisone 21-
hemisuccinate 







Table 2. Antibodies used for immunostaining. 
Primary Antibodies 
Antibody Host Dilution Supplier 
Alpha-fetoprotein Mouse Mono 1/500 Abcam 
Muscle Actin Mouse Mono 1/200 DAKO 
β-tubulin III Mouse Mono 1/1000 Sigma-Aldrich 
Octamer 4 Rabbit Poly 1/200 Abcam 
Nanog Rabbit Poly 1/200 Abcam 
Sox 17 Goat Poly 1/500 R&D Systems 
HNF4α Rabbit Poly 1/100 Santa Cruz 
GATA 4 Goat Poly 1/200 R&D Systems 
GATA 6 Goat Poly 1/200 R&D Systems 
Cytokeratin 19 Mouse Mono 1/50 DAKO 
Albumin Mouse Mono 1/200 Sigma 
Vimentin Mouse Mono 1/200 DAKO 
Ki67 Mouse Mono 1/400 DAKO 
CYP3A Sheep Poly 1/500 University of Dundee* 
CYP2D6 Sheep Poly 1/200 University of Dundee* 
E-Cadherin Mouse Mouse 1/200 Abcam 
OZ-1 Mouse Mouse 1/200 Abcam 
IgG Mouse Mouse 1/400 DAKO 
IgG Rabbit Poly 1/400 DAKO 




IgG Goat Poly 1/400 DAKO 
Secondary Antibodies 
Anti-Rabbit 488 Donkey 1/400 Life Technologies 
Anti-Mouse 488 Rabbit 1/400 Life Technologies 
Anti-Mouse 568 Goat 1/400 Life Technologies 
Anti-Sheep 488  Donkey 1/400 Life Technologies 
Anti-Goat 488 Rabbit 1/400 Life Technologies 
Anti-Goat 568 Rabbit 1/400 Life Technologies 
Anti-Rabbit 568 Donkey 1/400 Life Technologies 
* Kind gift of Dr R. Hay, College of Life Science, University of Dundee, Dundee, UK. 
 
Table 3. Antibodies used for FACS. 
Antibody Conjugated Type Dilution Supplier 
SSEA-1 FITC Mouse IgM 1/50 Biolegend 
SSEA-4 PE Mouse IgG 1/50 Biolegend 
TRA-1-60 PE Mouse IgM 1/50 Biolegend 
TRA-1-81 Alexa Fuor® 647 Mouse IgM 1/50 Biolegend 
Table 4. Antibodies used for Western Blot 
Antibody Host Dilution Supplier 
HNF4α Rabbit Poly 1/100 Santa Cruz 
Albumin Mouse Mono 1/100 Sigma 
β-actin Mouse Mono 1/10000 Sigma 
Anti-mouse IgG HRP Goat 1/1000 (ALB 1/2000) R&D Systems 






All custom design primers were purchased from Applied Biosystems. 
Table 5. Oligonucleotides used in this study 
Gene Primer 
Octamer 4 Hs00742896 – s1 
Nanog Hs02387400 – g1 
Sox17 Hs00751752 – s1 
Alpha-fetoprotein Hs01040607_m1 
Sox 9 Hs01001343_g1 
EpCAM Hs00158980_m1 
HNF1β Hs01001604 – m1 
HNF3β Hs00232764 – m1 
cytokeratin 19 Hs00761767_s1 
Prox 1 Hs00896294_m1 
Albumin Hs00910225 – m1 
HNF4α Hs01023298 – m1 
E-Cadherin Hs01023894_m1 













2.1.4 Small-interference RNAs 
Table 6. siRNAs used in the study 
Gene Part number UniGene ID 
NCAM s9294 Hs.503878 
CTNND2 s3728 Hs.314543 
THBS2 s8865 Hs.2258 
MMP10 s224726 Hs.371147 
MMP13  s8874 Hs.2936 
 
2.2 Mammalian cell culture and differentiation 
All cell culture reagents were GIBCO® products supplied by Life Technologies (UK) 
unless stated otherwise. Corning (UK) supplied the plastic ware utilised throughout 
the cell culture. Cell culture media employed in this thesis are described in Table 1 
2.2.1 Human embryonic stem cell culture 
2.2.1.1 Gradual transition of hESCs to MT 
The human embryonic stem cell H9, hESCs H9, was maintained on Matrigel™ (BD 
Biosciences, UK) coated plastic ware with mouse embryonic fibroblast Conditioned 
Media (CM) (R&D systems) supplemented with 10 ng/ml of bFGF (Prepotech, USA) 
on a mouse feeder layer (VH Bio Ltd, UK) before being transferred into mTeSR1™ 
(MT) (Stem Cell Technologies, UK). The cells were split at 1:3 ratio and allowed to 
settle down overnight. They were transferred into 75:25 ratio of CM to MT for 48 




2.2.1.2 Culturing hESCs 
hESCs H9 were cultured for over 30 passages on Matrigel™ coated 6 well plates 
were fed with 3 ml of MT. The media in the plates was changed daily. The cells were 
incubated at 37 oC in 5% (v/v) CO2, 95% (v/v) air, for optimal growth. The hESCs Man 
11 and Man 12 were always cultured in mTeSR1™ media and maintained for over 
30 passages on Matrigel™ coated 6 well plates, and no gradual transition from MEF-
CM to MT media was performed.  
2.2.1.3 Passaging hESCs 
hESCs were split at a ratio of 1:3 using collagenase IV (Life Technologies) diluted in 
KO-DMEM at a 200U/ml . The existing media was aspirated off, and the cells were 
washed once with PBS (Sigma-Aldrich). 1 ml of collagenase was added and cells 
incubated at 37 oC for about 5 minutes until the edges of the colonies rounded up. 
The enzymatic solution was aspirated off and the cells were washed once with PBS. 
3 ml of fresh media was added to the cells and they were subsequently scrapped off 
and triturated 1-2 times before transferring 1 ml into a new plate containing 2 m of 
fresh media for a 1:3 split. 
2.1.1.4 Freezing and thawing hESCs 
The freezing mix used consisted of knock-out serum replacement and 10% dimethyl 
sulfoxide (DMSO). At 80-90% confluence, hESCs cultured on a mouse embryonic 
fibroblast layer in CM, were scrapped off, placed into a 15 ml tube, and centrifuged 
at 1,000 rpm for 5 minutes. The supernatant was aspirated and the cells were 
resuspended in 0.5 ml of the freezing mix and transferred to liquid nitrogen.  
The cells were routinely thawed by placing the cryotube in a water bath at 37 oC. 
The hESCs H9 were then taken up in 1 ml of CM and were resuspended in 6 ml CM 
and centrifuged at 1,000 rpm for 10 minutes. The supernatant was aspirated and 




layer on Matrigel™ coated well. The supernant of ESCs Man 11 and Man 12, after 
centrifugation, was aspirated and the cells were resuspended in 3 ml of MT. 
2.2.2 Embroid body formation 
Embroid bodies (EBs) can be generated with hESCs when they are at about 80-90% 
confluent. The media was aspirated off and the cells were washed once with PBS. 4 
ml of EB media was added. The cells were scraped off using a cell scraper. The full 4 
ml containing hESCs were placed in low cluster plates to promote cell aggregation. 
The EBs were fed with fresh EB media every other day for 7 days until the EBs were 
defined and vacuolated. The EBs were then transferred to 0.5% gelatine coated 
chamber slides (BD Biosciences, UK). The plate down EBs were allowed to 
differentiate spontaneously for 14 days and fed every other day with EB media. 
After 14 days the differentiated cells were fixed with 100% ice cold methanol (Sigma 
Aldrich) at -20 oC for 30 min. Post fixation, cell monolayers were washed twice with 
PBS at room temperature, and were stained using antibodies for the three germ 
layers (Fletcher et al., 2008).  
2.2.3 Hepatic differentiation of hESCs  
2.2.3.1 Hepatoblast specification of hESC 
hESCs were cultured and propagated on propagated on Matrigel™ coated plates 
with mTeSR1™. Hepatic differentiation was initiated when hESC reached a 
confluence level of approximately 30-40%, by replacing the culture media with 
priming medium RPMI 1640-B27 supplemented with 10 ng/ml activin A and 50 
ng/ml Wnt3a. The cells were cultured in priming medium for 3 days (the medium 
was replaced every 24 hours) and final priming medium with Activin A and Wnt3a 
was made up fresh each day. After 72 hours the media was replaced by 





2.2.3.2 Hepatocyte maturation of hESCs 
For experiments no involving replating of the cells, hepatocyte maturation of the 
hESCs-derived hepatoblasts was induced at day 8 in the differentiation process. 
Cells were cultured either on the presence of the serum containing maturation 
medium L-15 or the serum-free medium HepatoZYME™-SFM medium (Life 
Technologies), both supplemented with 10 ng/ml hHGF (Peprotech) and 20 ng/ml 
OSM, for 9 days (L-15 medium) or 13 days (HepatoZYME™-SFM medium). The 
medium was changed every 48 hours. Maturation and maintenance medium with 
hHGF and OSM was made up fresh each day.  
2.2.3.3 Hepatic endoderm replating and hepatocyte maturation of hESCs 
For experiments involving replating of the cells on Matrigel™ or polyurethane 134 
(PU134) surfaces, cell were maintained on HepatoZYME-SFM media supplemented 
with 10 ng/ml HGF (Peprotech) and 20 ng/ml OSM (R&D Systems) for 24 hours (day 
9).  Then, the existing media was aspirated off and cells were washed once with 3ml 
PBS without calcium chloride and magnesium chloride (Invitrogen). The existing PBS 
was washed off and replaced with 1 ml of TrypLE™ (Life Technologies) followed by 
an incubation at 37 oC for about 5 minutes until cells started to round up. The 
enzymatic solution was aspirated off and the cells were washed once with 3 ml of 
PBS. 3 ml of fresh medium HepatoZYME™-SFM medium supplemented with 5% KO-
SR, 20 ng/ml hHGF, 40 ng/ml of OSM and 10 ng/ml of EGF (Prepotech) was added to 
the cells. The cells were subsequently scrapped off and triturated 1-2 times before 
transferring into a new Matrigel™ or polymer PU134 coated surface; using a 1,2:1 
split ratio when 48 well plate format was used; or 1,5:1 split ratio when 24 well 
plate format was used. The medium was replaced after 48 hours for HepatoZYME™-
SFM medium supplemented with 5% KO-SR, 10 ng/ml hHGF and 20 ng/ml OSM for 
up to 23 days. Matrices made out of the major components of the extracellular 
matrix were purchased from BD Biosciences (Becton, Dickinson and Company, 




Maturation and maintenance medium with HGF and OSM was made up fresh each 
day.  
2.3 Characterisation of hESCs, hESCs-derived hepatic 
endoderm and hESCs-derived HLCs  
2.3.1 Immunofluorescence 
hESC, hESCs-derived hepatic endoderm and hESCs-derived HLCs were fixed in 100% 
ice-cold methanol (Sigma-Aldrich) at -20°C for 30 min (cells can then be stored in 
PBS at 4 oC and stained at a later date). Post fixation, cell monolayers were washed 
three times with PBS, 5 minutes each wash at room temperature. PBS-0.1% Tween 
(PBS/T) containing 10% BSA was used to block the cells for 1 hour at room 
temperature. The serum was removed and the respective primary antibody diluted 
in 1% BSA (made up in PBS/T) was added and incubated at 4°C overnight with 
agitation (For primary antibody details, see Table 2). The cells were washed 3 times 
with PBS/T at room temperature, 5 minutes each wash. Following this, the cells 
were incubated with the appropriate secondary antibody diluted in PBS/T / 1% BSA 
for 1 hour at room temperature in the dark with agitation (For secondary antibody 
details, see Table 2). The cells were washed three times with PBS/T. Following this, 
wells were incubated with DAPI (1:1000) (Sigma-Aldrich) for 20 minutes at room 
temperature following manufacturer’s instructions. Following this, media was 
removed, and wells with cells at different stages in the differentiation approach 
were subsequently mounted with 50 µl of PermaFluor aqueous mounting medium 
(Thermo Scientific).  Well containing hESCs-derived hepatocytes replated on 
Matrigel™ or PU134 coated surface were placed on a glass slide containing with 50 
µl of PermaFluor aqueous mounting medium. In all cases, wells were stored at 4 oC 




2.3.1.1 Imaging and acquisition 
All images were collected using a Zeiss Axio Observed Z1 microscope, with LD Plan-
Neofluar objectives lenses (Carl Zweiss Ltd, Welwiyn garden City, UK). The 
microscope was couple to a Zeiss AxioCamMR3 camera. The image acquisition and 
processing software used was Zeiss Axiovison Rel 4.8 and Axiovision version 4.7.1.0, 
respectively. All images were collected at room temperature. 
2.3.2 Fluorescence activated cell sorting 
Fluorescence activated cell sorting (FACS) was used to confirm the cells surface 
marker expression of hESCs cultured in MT. hESC were washed once with 3ml PBS 
without calcium chloride and magnesium chloride. The existing PBS was washed off 
and 1 ml of TrypLE™ was added to the cells for 7 minutes, until cells lifted as single 
cells. Single hESCs were harvested and resuspended in FACS-PBS (PBS 
supplemented with 0.1% BSA and 0.1% sodium azide), counted, and resuspended at 
1 x 106 cells/ml for use. Aliquots of 1 x 105 cells were incubated for 30 minutes at 4 
oC with the fluorochrome conjugated antibodies (For antibody details, see Table 3). 
Cells were then washed once with PBS, removing any unbound antibody, and spun 
down at 1,500 rpm for 10 minutes. Following centrifugation, cells were 
resuspended in 100 µl of FACS-PBS. Binding of the conjugated antibody was 
detected using the optimum concentration (determined by titration) of an 
appropriate fluorochrome conjugated isotype specific antibody. Unstained cells 
were used as controls.  
Dead and apoptotic cells along with debris were not included in the analysis. This 
was carried out by using an electronic live gate on forward scatter and side scatter 
parameters. Data for 20,000-50,000 “live” events were acquired for each sample 
using a FACS Calibur Flow Cytometry System (Becton, Dickinson and Company, 
Biosciences, San Diego, CA) equipped with a 488-nm laser and analysed using 




2.3.3 ELISA assay 
HepatoZYME™-SFM medium was added to the cells at different points in the 
differentiation and incubated for 24 hours at 37 oC in 5% (v/v) CO2, 95% (v/v) air. 
The supernatants were collected after 24 hours and could be store at -80 oC for 
later use. Presence of albumin in the media was detected using commercial 
available microwell plates pre-coated with immobilized human anti albumin 
antibodies (Alpha Diagnostic Intl. Inc., San Antonio, USA). The supernatant were 
diluted 1:3 or 1:10 on the Working Sample Diluent and pipetted into the wells in 
duplicate followed by one hour incubation at room temperature accordingly to 
manufacturer’s instructions. Following this, microwells were washed four times 
with Working Wash Solution and an anti-human albumin HRP conjugated diluted on 
Working Sample Diluent was added to the microwells, followed by incubation at 
room temperature for 30 minutes. Subsequently, the microwells were washed 5 
times using Working Wash Solution, and the substrate for the HRP enzyme TMB, 
was added and incubated for 15 minutes in the dark. Stop Solution was added to 
each well in order to stop the enzyme reaction, and the plates were read at 450 nm 
with a reference wavelength of 630 nm using a FLUOstart Omega plate reader 
(BMG LabTech, Germany). Tissue culture media incubated for 24 hours at 37 oC, 
diluted 1:3 or 1:10 was used as a negative control. The data was then normalised to 
per ml per 24 hours per mg protein as determined by the BCA Assay (Pierce, UK). 
2.3.4 Cytochrome P450 assays 
hESC-derive HLCs at different time points were incubated with the luciferin 
conjugated specific CYP3A (1:40) and CYP1A2 (1:50) substrate (P450 P-Glo® 
Luminescent Kit, Promega, UK) for 5 hours at 37 oC. The tissue culture media was 
used as a negative control. The supernatant were then collected and could be 
stored at -80 oC for later use. The Luciferin detection reagent was reconstituted by 
mixing the buffer into the bottle containing the lyophilised Luciferin detection 




reagent in a white 96 well plate and incubated at room temperature in the dark for 
20 minutes. The relative levels of basal activity were measure using a luminometer 
(POLARstar optima). Unless indicated, units of activity were expressed as relative 
light units per ml per mg protein (RLU/ml/mg) as determined by the BCA Assay. 
2.3.5 Drug toxicity on the cells 
2.3.5.1 Cytochrome P450 induced drug toxicity-BMS compounds 
hESCs-derived hepatocytes maintained on either matrigel or PU134 coated surfaces 
were incubated at day 17 post-replating with compounds metabolised by specific 
P450s - BMS-827278 and BMS-835981. BMS compounds stock solution was 
prepared by dissolving in DMSO to a concentration of 50 mM. Stock solution was 
diluted on the final maturation media to a final concentration of 50 µM and applied 
to the cells for 72 hours at 37 oC in 5% CO2 without replacing the media. Control 
cultures did not receive the BMS compounds but had their media supplemented 
with the appropriate vehicle.  
ATP levels within the cells were used as a measure of cell viability at 72 hours post 
treatment using CellTiter-Glo® (Promega, UK) following the manufacturer’s 
instructions. The CellTiter-Glo® Reagent was reconstituted by mixing the CellTiter-
Glo® Buffer into the bottle containing the lyophilized CellTiter-Glo® Substrate. 
CellTiter-Glo® Reagent and culture media was mixed at a 1:1 ratio and the media on 
the cells was replace with this solution. The solution without cells was used as a 
negative control. The content was mixed for 2 minutes on an orbital shaker to 
induce cell lysis, and the plate was incubated at room temperature for 10 minutes 
to stabilize luminescent signal. Following this, 100 µl of media was placed in a white 
96 well plate. Basal luminescence was measured using a luminometer (POLARstar 
optima) and units of activity were expressed as relative light units (RLU). Every 




2.3.5.2 Cytochrome P450 activity drug inducibility  
hESCs-derived HLCs maintained on either matrigel or PU134 coated surfaces were 
incubated at Day 18 post-replating, for 48 hours, with compounds that induce the 
activity of specific P450s, CYP1A2 and CYP3A. Stock solution of phenobarbital 
(Sigma-Aldrich) was prepared at a concentration of 1 M in PBS and diluted in fresh 
maturation media to a final concentration of 1 mM or 2 mM. Dexamethasone 
(Sigma-Aldrich), prepared to a stock concentration of 2 mM in DMSO; and 
rifampicin (Sigma-Aldrich), prepared to a stock concentration of 10 mM or 20 mM in 
H2O, were diluted together in fresh maturation media to a final concentration of 2 
µM dexamethasone and 10 µM or 20 µM of rifampicin. Media containing drug 
inducers was changed on a daily basis. Control cultures did not receive the drug 
inducers, but had their medium changed daily which was supplemented with the 
appropriated vehicle, either PBS or DMSO and H2O. The activity of CYP3A and 
CYP1A2 was measured using the luciferin conjugated specific CYP 3A (1:40) and 
CYP1A2 (1:50) substrate (P450 P-Glo® Luminescent Kit, Promega, UK) for 5 hours at 
37 oC. pGlo technology and activity was measured on a luminometer (POLARstar 
optima). Units of activity were expressed as relative light units/ml/mg protein 
(RLU/ml/mg), as determined by the BCA Assay. 
2.4 Molecular techniques 
2.4.1 RNA isolation and extraction 
RNA isolation was performed using RNAeasy® Mini Kit (Qiagen, UK) accordingly to 
manufacturer’s instructions. The cells of interest were washed with PBS and 
resuspended in 350 µl of lysis buffer (buffer RTL, RNEasy MiniKit, Qiagen) containing 
β-mercaptoethanol (Gibco, UK).  The cells were collected and placed in a 1.5 ml 
eppendorf (store at -80 oC for later use if required). Lysis was performed using a 
vortex for 30 seconds before addition of an equal volume of 70 % Ethanol. The 




After centrifugation at 10,000 rpm for 20 seconds, flow through was discarded and 
700 μl Buffer RW1 was added followed by centrifugation at 10,000 rpm for 20 
seconds, discarding flow through. Following this, 500 μl of Buffer RPE was added. 
After centrifugation (10,000 rpm, 30 seconds), 500 μl buffer RPE was added 
followed by centrifugation at 10,000 rpm for 2 minutes. Then the RNeasy Spin 
Column was transferred to a new collection tube and centrifuged at 16,000 rpm for 
1 minute. The spin column was placed into an RNAse free 1.5 mL tube and 100 μl 
RNAse free H2O was added to the membrane. After 3 minutes incubation at room 
temperature, the tube was centrifuged at 10,000 rpm for 1 minute and store at -80 
oC for later use. All RNA and DNA sequences were quantified using the Nanodrop, 
concentration and purity were measured.  
2.4.2 Reverse transcription (RT) 
Reverse transcription (RT) was carried out using the QuantiTect Reverse 
Transcription Kit (Qiagen), accordingly to manufacturer’s instructions. Up to 1 µg of 
RNA was reverse transcribed. Genomic DNA contamination was performed by 
adding 7 µl of gDNA Wipeout Buffer to the purified RNA and RNase-free water up to 
14 µl. The reaction was incubated at 42 oC for 5 minutes and then place on ice. 1 µl 
Quantiscript Reverse Transcriptase, 4 µl 5x Quantiscript RT Buffer and 1 µl RT 
Primer Mix were added to the reaction and incubate at 42 oC for 30 minutes, 
followed by a 95 oC heat treatment for 5 minutes and finally cool to 4 oC for 5 
minutes.  
2.4.3 Quantitative polymerase chain reaction (qPCR) 
The resulting cDNA was used for further analysis. Quantitative real-time PCR (qPCR) 
was carried out using the Taqman Fast Advance Mastermix and appropriate primers 
(Applied Biosystems). Each qPCR reaction was set up using 0.5 µl of specific primers, 
(for primer details see Table 5), 5.5 µl of Taqman Fast Advance Mastermix and 5.5 µl 




in triplicate. The qPCR reaction consisted of an initial denaturation step at 95 oC for 
10 minutes followed by 40 cycles of denaturation at 95 oC and annealing/extension 
at 60 oC for 1 minute in conjunction with the manufacturer’s instructions. qPCR was 
used to investigate the expression of specific genes within the cells. This is defined 
as qPCR and utilises cDNA as the template. The samples were analysed using Roche 
LightCycler 480 Real-Time PCR System and data analysis was performed using Roche 
LightCycler 480 Software (version 1.5) in the form of cycle threshold (Ct) values. This 
value represents the point at which fluorescence intensity generated in the PCR 
reaction reaches a set threshold above the background signal. Relative expression 
was calculated by the ΔΔCt method (Schmittgen and Livak, 2008) and normalised to 
GAPDH and expressed as relative expression over the control sample. Quantitative 




∆Target Ct (Ct control−Ct sample)
(E)Housekeeping
∆Housekeeping Ct (Ct control−Ct sample)
 
 
Where the ETarget and EHousekeeping are the PCR amplification efficiencies (calculated 
from the standard curve) of the real-time PCR reactions for the gene of interest and 
housekeeping gene, respectively. Δ Target Ct (Ct control – Ct sample) is the 
difference in Ct value of the gene target between the control and test samples. 
Δ Housekeeping Ct (Ct control – Ct sample) is the difference in Ct of the 
housekeeping gene between the control and test samples. This equation presents 





2.4.4 PCR array 
Reverse transcription (RT) of RNA samples used on the PCR array were performed 
using RT2 First Strand Kit (Quiagen, UK), and RT2 Profiler PCR array (Qiagen) was 
used to analyze the gene expression. 
cDNA was synthesized using the RT2 First Strand Kit (Quiagen) according to the 
manufacturer’s instructions. For each condition, equal amounts of purified RNA 
from a triplicate were pulled together to make 900 ng of RNA. Genomic DNA 
elimination was performed by adding to the RNA 84µl of Buffer GE and RNase-free 
water up to 20 µl. The reaction was incubated at 42 oC for 5 minutes and then place 
on ice. 16 µl of 5x Buffer BC3, 4 µl of Control P2, 8 µl of RE3 Reverse Transcriptase 
Mix and 12 µl of RNase-free water were added to the reaction and incubate at 42 oC 
for 15 minutes, followed by a 95 oC heat treatment for 5 minutes. Prior to PCR Array 
analysis, 182 µ of RNase-free water was added to each reaction, gently mixed by 
pipetting up and down several times and placed on ice until PCR array immediately 
was performed.  
Real time PCR reactions were performed using RT2 Profiler PCR array (Qiagen, UK) in 
a 384-well optical plates. A master mix consisting on 1,300 µl of 2x RT2 SYBR Green 
Mastermix, 1,096 µl of RNase-free water and 204 µl of cDNA synthesis reaction was 
prepared. Following this 10 µl of the master mix reaction was added to each well of 
the RT2 Profile PCR Array. Real-time reactions were conducted on an ABI 7900HT 
(Applied Biosystems) and consisted of an initial denaturation step at 95 oC for 5 
minutes followed by 40 cycles of denaturation at 95 oC and anneling/extension at 60 
oC for 1 minute. Results were PCR reactions were performed in duplicate for each 
target gene. The gene expression was analysed by RT2 Profiler PCR array Data 
Analysis version 5.0 (Qiagen) in the form of cycle threshold (Ct) values. This value 
represents the point at which fluorescence intensity generated in the PCR reaction 
reaches a set threshold above the background signal. Relative expression was 




the average Ct values of 5 housekeeping genes (β2M, HPRT1, ACTβ, GAPDH and 
RPLP0).  
2.4.5 Transfection of the cells  
hESCs-derived hepatocytes maintained on PU134 coated surfaces in a 48 well plate 
format were transfected at Day 13 post-replating with commercial available 
Silencer® Select siRNAs (Life Technologies), containing sequences to specifically 
reduce the expression of the candidate genes identified in the PCR array using 
Lipofectamine® 2000 (Invitrogen) and Opti-MEM® I Reduced Serum Medium (Life 
Technologies) following manufacturer’s instructions. For siRNA details refer to table 
6. 
The siRNA were diluted in the Opti-MEM Medium to a final concentration of 160 
µM (16 pmol of siRNA representing 214 ng of siRNA). The reaction was incubated 
for 5 minutes at room temperature. Following this, equal amount of Opti-MEM 
medium containing Lipofectamine® 2000 (10 µl of Lipofectamine® 2000 per 1 µg of 
genetic material) was added to the mixture, obtaining a final siRNA concentration of 
80µM. The reaction was incubated for 20 minutes at room temperature in order to 
allow the formation of the lipofectamin-genetic material complex. Subsequently, 
the existing media presented on the wells was removed and the mixture was added 
drop wise. Accordingly to manufacturer’s instructions, the media was incubated for 
5 hours at 37 oC and replaced for fresh maturation media supplemented with 
factors and antibiotic free. The procedure was repeated 24 hours later. Cells and 
supernatant were collected at Day 15 post-replating for further analysis. Each 
condition was done in triplicates. Two different Scramble siRNA controls (Silencer® 
Select Negative Controls No. 1 and No.2 siRNA, parts number 4390843 and 




2.4.6 SNP analysis 
H9 were maintained in mTeSR1™ for at least three passages before cells were 
harvested and genomic DNA was collected for SNP and karyotyping analysis. 
Collection of genomic DNA was performed using Gen Elute® Mammalian Genomic 
DNA Miniprep (Sigma Aldrich), accordingly to manufacturer’s instructions. The 
existing media was aspirated off and cells were washed once with 3ml PBS without 
calcium chloride and magnesium chloride (Invitrogen). The existing PBS was washed 
off and replaced, and 1 ml of TrypLE™ (Life Technologies) was added and incubated 
at 37 oC for about 5 minutes until cells started to round up. The resulting suspension 
cell culture was spun down at 1,500rpm for 5 minutes and the media was removed 
completely. Following this, the cell pellet was resuspended using 200 µl of 
Resuspension Solution and mix thoroughly. 20 µl of the Protein K solution was 
added to the sample, followed by 20 µl of Lysis Solution C. The mix was then 
vortexed thoroughly and incubated for 10 minutes at 70 oC  In parallel, 500 µl of the 
Colum Preparation Solution was added to the pre-assembled GenElute Miniprep 
Binding Column and centrifuged at 10,000 rpm for 1 minute. The flowthrough liquid 
was discarded. 200 µl of 100% ethanol was added to the lysate and mixed 
thoroughly by vortexing 10 seconds obtaining and homogeneous solution. Following 
this, the lysate was transferred to the treated binding column and centrifuged for 1 
minute at 8,000 rpm, discarding the collection tube containing the flow-through 
liquid and then the binding column was placed in a new 2 mL collection tube. A 
second wash was applied to the binding column by adding 500 µl of Wash Solution 
and centrifuged for 3 minutes at 10,000 rpm, discarding the collection tube 
containing the flowthrough liquid and then, the binding column was placed in a new 
2 mL collection tube. DNA elution was performed by adding 200 µL of the Elution 
Solution directly into the centre of the binding column, followed by 1 minute 
centrifugation at 8,000 rpm for 1 minute. The elute contained pure genomic DNA 
that was stored at 4 oC until it was shipped for analysis to an external company. The 





2.5 Protein biochemistry techniques 
2.5.1 Cellular protein extraction 
Cells grown in different plate wells format were lysed in 150 µl of RIPA buffer 
(Millipore) with proteinase and phosphatase inhibitors at 1% final concentration 
(Sigma-Aldrich). The cell extract was span for 15 minutes at 10,000 rpm at 4 oC in a 
microcentrifuge, and the supernatant was transferred to a new 1.5 ml eppendorf 
tube. 
2.5.2 Measuring protein concentration 
The Pierce BCA (bicinchoninic acid) protein assay kit (Thermo Fisher Scientific, UK) 
was used to quantify the protein concentration in the cell protein extract samples. 
Protein extracts were diluted 1:2 using nuclease free water (5 µl of sample extract 
and 5 µl of water) in a 96 well plate, each sample was pipette in triplicate. Reagents 
A and B were mixed at a 1:50 ratio and a volume of 200 µl was transferred into each 
sample well in addition to wells containing bovine serum albumin standards ranging 
from 20-2,000 µg/ml, as per manufacturer’s instructions. The plate was incubated 
at room temperature for 10 minutes and the absorbance was read at 562 nm. The 
protein concentrations were calculated by linear extrapolation using the standard 
curve generate from the protein standards. 
2.5.3 SDS-NuPAGE® polyacrilamie gel electroforesis 
The SDS NuPage® gel electrophoresis (SDS-PAGE) was used to separate proteins of 
varying molecular weights. The Xcell SureLock® Mini-Cell System (Life Technologies, 
UK) was used with 4-12% Bis-Tris pre-cast polyacrylamide gels (Life Technologies, 
UK). 20 µg of each sample was denatured at 70 oC for 10 minutes in 4x NuPAGE® LDS 
Sample Buffer (Life Technologies). Once the gel was fitted in the chamber, the tank 
was filled with 1x NuPAGE® MES-SDS running buffer in addition to 0.5 ml of 




were loaded, including SeeBlue® Plus2 Pre-Stained Standard (Invitrogen).  A current 
of 200 V was applied and the samples were run for approximately 1 hour. The gels 
containing proteins were carefully removed from the cassette and were used in 
western blotting. 
2.5.4 Western immunoblotting 
2.5.4.1 Protein transfer 
Western blotting was used to detect the presence of specific proteins in samples 
extracts using XCell SureLock® Mini-Cell system, as per manufacture’s instruction. 
Proteins were separated via SDS-PAGE followed by subsequently transfer from the 
polyacrylamide gel to the Polyvinylidene fluoride (PVDF) membrane, that prevents 
protein cross over if the transfer time was over run and provides long-term 
durability (Millipore, UK). The membrane was then probed with antibodies specific 
to the target protein. The transfer sack was assembled in the following order from 
cathode to anode: 2x sponge; filter paper soaked in 1x NuPAGE® Transfer Buffer; 
SDS-PAGE gel; PVDF membrane pre-soaked in methanol and then transfer buffer on 
top of the gel; filter paper soaked in transfer buffer; 3x sponge, and the beginning 
sequence was repeated for a second gel. It is vital that the membrane is positioned 
accurately between the gel and the anode as the samples and current will be 
moving in that direction. The stack was assembled andn the XCell Blot II module and 
was tightly sealed and placed into the transfer SureLock® tank containing 1x transfer 
buffer and 0.25 ml antioxidant in the inner chamber and cold water in the outer 
chamber. A constant current of 160 mA was applied for 90 minutes.  
2.5.4.2 Immunoblotting 
Once the proteins have been successfully transferred onto the PVDF membrane, the 
membrane was blocked to prevent non-specific antibody binding. The membrane 
was blocked in 10 ml of Odyssey Blocking Buffer (LI-COR Biosciences Ltd, UK) for 1 




to 3 ml of Odyssey Blocking Buffer at the appropriated dilution of the antibody, and 
incubated overnight at 4 oC with gentle agitation. Unbound antibody was removed 
by three, 5-minute washes with 50 ml of 0.1% PBS Tween (PBST). A horseradish 
peroxidase (HRP)-conjugated secondary antibody was diluted in 10 ml of Odyssey 
Blocking Buffer at the appropriated dilution, and incubated for 1 hour with gentle 
agitation at room temperature. Unbound antibody was, once again, removed by 
three 5- minute washes with 50 ml of PBST. For antibody details refer to Table 4.  
2.5.4.3 Enhanced Chemiluminescence (ECL) 
The proteins of interest were detected using enhanced chemiluminescence (ECL), 
the HRP substrate reacts with the conjugated HRP group present on the secondary 
antibody specifying the target protein. Protein bands were visualised using the 
Pierce Enhanced Chemiluminiscence Reagent Kit (Pierce, UK). Peroxidase Buffer and 
the Luminol/Enhancer Solution was mixed at a 1:1 ratio and spotted on to the 
membrane (2 ml for each membrane), ensuring it was evenly spread. The 
membrane was exposed to Odyssey™ Fc Imaging System (LI-COR Biosciences Ltd, 
UK) for the appropriated length of time, typically 1-10 minutes. 
2.6 Synthesis and production of polyurethane 134 (PU134)  
Synthesis and identification of the monomer PHNAGAD and the polyurethane 134 
(PU134) as a suitable polymer with desirable properties for the culture of HLC was 
was perfomed by Hay and colleagues, including Prof Mark Bradley, and it is 
described in Hay et al., 2011.   
2.6.1 Synthesis of PHNAGAD  
PHNGAD (Poly[1,6-hexanodiol/neopentyl glycol/di(ethylene glycol)-alt-adipic 
acid]diol) was synthesized by applying a heat treatment to the monomers 1,6-
hexanediol, di(ethylene glycol) (Sigma Aldrich) and neopentyl glycol (Sigma Aldrich) 




allowed to cold down to room temperature under vacuum. Following this, 22 mmol 
of each monomer and 55 mmol of adipic acid (Sigma Aldrich) were added to a two-
necked round bottom flask connected to a Dean-Stark apparatus. The whole 
assembly was placed under a vacuum and the glassware was gently heated at 40 oC 
for 6 hr, in order to avoid any moisture absorption during the addition of the 
chemical into the flask. Then, 0.055 mmol of the catalyst titanium (IV) butoxide 
(Sigma Aldrich) was added via syringe drop wise. The reaction mixture was stirred at 
180 oC, under an N2 atmosphere, and residual water was collected in the Dean-Stark 
trap. Finally, the product was allowed to cool to room temperature. For schematic 
representation refer to Figure 4. 
2.6.2 Synthesis of PU134 
The synthesis of the polyurethane 134, PU134, was started by mixing one 
equivalent of the polyol PHNGAD (Mn~1,800 Da, 3.2 mmol) with two equivalents 
(6.4 mmol) of 4’4-Methylenebis (phenyl isocyanate) (Sigma Aldrich) in 12ml of 
anhydrous N,N-Dimethylformamide (Sigma Aldrich). The reaction mixture was 
stirred at 70 oC, under an N2 atmosphere. Following this, the catalyst titanium (IV) 
butoxide (0.8% wt) was added, via syringe, drop wise. After 1 hour, one equivalent 
(3.2 mmol) of the chain extender 1,4-butanediol (Sigma Aldrich) was added. Then, 
the temperature was increased at 90 oC and the mixture was stirred for 24 hr under 
an N2 atmosphere. Following the reaction, the polyurethane was collected by 
precipitation by adding hexane (Sigma Aldrich), drop wise into the reaction solution 
until the precipitation occurred. Subsequently, the solution was centrifuged at 5300 
x g for 5 min. The supernatant was decanted and dried off at 40 oC in a vacuum oven 
until the solvent evaporated (Mn PU134~1235 Da). For schematic representation 
refer to Figure 5. Various analytical techniques were employed to characterised the 
final product; including, gel permeation chromatography, NMR, FTIR, spectroscope 
and differential scanning calorimeter, ensuring the oolecular weight distribution 




2.7 Production of PU134 coated surfaces 
2.7.1 Preparation of PU134 solutions 
Preparation of the solutions of PU134 on the different solvents were performed by 
dissolving PU134 into a glass bottle containing a number of solvents: chloroform, a 
combination of chloroform and toluene in 1:1 ratio, tetrahydrofuran, and 
combination of tetrahydrofuran and dichloromethane in 1:1 ratio (Sigma Aldrich), 
to a final concentration of 2%. Following this, the solution was shaken vigorously for 
20 min at room temperature using a shaker (Edmun Bühler, Germany) at 200 
mot/min, until the solution became homogeneous and no precipitate was observed.  
2.7.2 Coating of culture surfaces with PU134 
The surfaces (glass slides) were coated with the different PU134 solutions by placing 
the glass slide on the spin coater (Specialty Coating System, USA). 50 μl of the 
PU134 solution was applied to the 15 mm in diameter surface using a pipette. The 
volume of PU134 solution was adjusted accordingly for the required coverslip size 
keeping the volume to surface ratio proportional. Subsequently, the surface was 
spun for 7 sec at 23 x g, allowing the obtaining of a polymer coated layer of 1 to 
1.25µm of thickness. Following this, PU134 coated surfaces were vacuum dried at 
room temperature for at least 24 hr before sterilisation.  
2.7.3 Irradiation of PU134 coated surfaces 
2.7.3.1 Gamma-irradiation 
Gamma- irradiation of PU134 coated surfaces were performed by applying a dose of 




2.7.3.2 UV- irradiation   
UV- irradiation PU134 coated surfaces were performed by using a 30W, UVC bulb 
(ESCO, UK) with a wavelength between 290nm and 100nm for 16 min each side.  
2.7.4 Scanning Electron Microscopy  
Samples that were used for Scanning Electron Microscopy, SEM, were firstly gold 
coated prior to the SEM acquisition. Gold coating was carried out by sputtering for 
200 sec in an atmosphere of 5 x 10-1 millibars of pressure in a Bal-Tec Sputter Coater 
SCD 050 (Capovani Brothers Inc. NY, USA). Subsequently, samples were examined 
with a Philips XL30CP Scanning Electron Microscopy at an accelerating voltage of 20 
kV in secondary electron imaging mode. 
2.7.5 Atomic Force Microscopy 
An atomic force microscope DimensionV Nanoscope VEECO (VEECO, Instruments 
Inc, NY, USA) was used to scan the polymer surface within an area 20 μm × 20 μm. 
The scan rate ranged from 1.32 Hz to 1.60 Hz, and the height values of the surface 
were obtained with a resolution of 512 × 512 pixels in the scanned region. The root 
mean square (RMS or Rq) of all the spots in the hit array was calculated through the 
NanoScope analysis software (VEECO version 1.20) by using the average of height 






 Where Zi is the current Z value and N is the number of points within the given area.  









Where Z (x) is the function that describes the surface profile analysed in terms of 
height (Z) and position (x) of the sample over the evaluation length “L”. Ra 





Figure 4. Schematic representation of the synthesis of PHNAGD. PHNAGD was prepared by the reaction of 1,6-Hexanodiol, diethylene glycol, neoppentyl glycol 





Figure 5. Schematic representation of the synthesis of polyurethane 134. PU134 was prepared by the reaction of 1.0 equivalent of a PHNGAD with 2.0 equivalent 








DEFINING hESCs PLURIPOTENCY 















3.1.1.1 Properties of hESCs 
Human embryonic stem cells (hESCs) possess two attributes that make them ideal 
candidates to provide an inexhaustible supply of somatic cells (Wobus and Boheler, 
2005): the capacity for self-renewal and the ability to differentiate into cell types 
from all three germ layers (Pera et al., 1999; Semb, 2006). This two attributes make 
hESCs a potential source of unlimited amount of cells of known genotype 
background for clinical and biological downstream applications, including disease 
modeling, drug toxicity, predictive toxicology and cell based therapies (Greenhough 
et al., 2010; Rippon and Bishop, 2004; Vazin and Freed, 2010). 
hESCs are isolated from the inner cell mass of blastocyst stage embryos that are not 
suitable for human implantation (Peura et al., 2006; Reubinoff et al., 2000; 
Thomson, 1998). The blastocyst formation occurs after the fertilization of an egg 
and the formation of the diploid zygote during early embryogenesis. The blastocyst 
possesses two layers; the outer cell layer, known as the trophoblast, which forms 
the supporting tissue for the developing embryo and the inner cell layer, referred as 
the embryoblast or inner cell mass (ICM), that retains the ability of differentiate into 
all cell types of the embryo body (Cai et al., 2006; Hoffman and Carpenter, 2005; 
Vazin and Freed, 2010). The establishment of hESC lines begins with the dissociation 
of the ICM from the embryo body, which is performed by different techniques 
including immunosurgery, mechanical or enzymatic dissection. Subsequent culture 
of the isolated cells permits the establishment of hESC lines (Semb, 2006).  
3.1.1.2 Characterization of hESCs 
Undifferentiated hESCs form tightly packed colonies that are typically multi-layered, 




and a prominent nucleoli (Pera et al., 1999). hESCs are also defined by the 
expression of a number of stem cell specific markers, including the transcription 
factors Octamer 4 (Oct-4) (Pesce et al., 1999; Schöler et al., 1989), Nanog 
(Chambers et al., 2003; Mitsui et al., 2003) and Sox 2  (Avilion et al., 2003); the cell 
surface the globoseries glycolipid antigen 4 or stage specific embryonic antigen 
(SSEA)-4 (Kannagi et al., 1983) and the keratin sulphate related antigens  TRA-1-60 
and TRA-1-81 (Andrews et al., 1984); and absence of hESC negative markers such as 
lactoreries oligosaccharide antigen SSEA-1 (Kannagi et al., 1983).  
Like human somatic cells, hESCs display an unlimited life span independently from 
genetic alterations or inactivation of tumour suppressor pathways ( Rosler et al., 
2004). However, prolonged maintenance in vitro can lead to the acquisition of 
karyotypic abnormalities in processes similar to tumorigenic events observed in vivo 
(Baker et al., 2007; Draper et al., 2003; Mitalipova et al., 2005). Therefore, different 
techniques including sequencing single nucleotide polymorphism (SNP) and 
karyotyping are frequently performed to ensure the correct hESC genetic signature 
within the population and no major mutations occurred (Campos et al., 2009). DNA 
microarrays, short tandem repeat analysis and fluorescent in situ hybridization can 
also be applied to ensure the correct hESC signature within the population (Brimble 
et al., 2005; Josephson et al., 2006; Mitalipova et al., 2005). The pluripotency nature 
of the hESCs can be measured by testing their abilities to form all three germ layers 
in vitro (Cai et al., 2006; Hannoun et al., 2010; Mallon et al., 2006). Expression of 
specific proteins defines each germ layer. Alpha-fetoprotein (AFP) defines 
endoderm, the mesoderm is usually defined by the presence of alpha-smooth 
muscle actin (α-SMA) and the ectoderm stains positive for β-tubulin (Hannoun et 
al., 2010). hESCs have also been directly differentiated into cell types of the three 
germ layers including hepatocytes, cardiomiocytes, neural precursor cells and 
pancreatic beta-cells (Hay et al., 2008a; Kaufman and Thomson, 2002; Kehat et al., 




3.1.1.3 hESC culture conditions 
hESCs represent an ideal candidate to obtain somatic cells for the study of human 
biology, in vitro modelling and cell based therapy. For this purpose, maintenance of 
the pluripotent and self-renewal properties of hESCs requires defined and 
optimized culture systems. The use of monolayers of mitotically inactive mouse 
embryonic fibroblast (MEFs) feeder cells represents the most common and effective 
method of maintaining hESCs in vitro, as they provide extra-cellular matrix 
attachment and growth factors required to support undifferentiated proliferation of 
the hESCs (Ilic, 2006; Vazin and Freed, 2010). However, the use of MEFs in the 
culture system presents some  disadvantages, including the presence of xeno-
contaminants, lack of definition and variability between batches of cells  (Mallon et 
al., 2006), all of which limit the scale up and application of the cells. In order to 
create xeno-free hESC culture environments, human feeders have replaced the use 
of animal feeders (Amit et al., 2004). However, the high variability, limited sourcing 
and the impure hESC population associated with the use of feeders can alter the 
accuracy of the derived product (Mallon et al., 2006). These observations suggest 
that the development of fully defined culture systems is required if hESCs are to be 
employed in clinical or therapeutic applications. 
Xu and collage were pioneer in establishing a feeder free hESC culture system. They 
employed Matrigel™ as a basement membrane to provide to the culture with the 
extra cellular matrix attachment and growth factors required for the maintenance 
of hESCs (Xu et al., 2001). Matrigel is a membrane preparation extracted from a 
murine Engelbreth-Holm-Swarm (EHS) sarcoma composed of a myriad of ECMs, 
growth factors and xenobiotics. Despite the improvements observed under this 
culture condition, this feeder free system still requires the employment of a culture 
media conditioned by MEFs (CM), supplemented with basic fibroblast growth factor 
(bFGF) (Braam et al., 2008). To tackle this issue, a number of companies released 
xeno-free and defined culture media. The most popular media used to date include 




been previously reported that the self-renewal, pluripotency and hepatocyte 
differentiation abilities of the hESCs are sustained on these defined media in a 
similar manner than on CM (Hannoun et al., 2010), providing a more defined 
culture system capable to sustain hESC self-renewal whilst maintaining 
pluripotency. Recently, the newly fully defined E8™ media has been shown to 
promote efficient self-renewal and differentiation of hESCs and induced pluripotent 
stem cells (iPSCs) (Chen et al., 2011). 
3.1.2 Hepatocyte differentiation of hESCs 
hESCs possess unlimited self-renewal and differentiation capacities, thereby 
represent a potentially unlimited source of hepatocytes with a known genetic 
background. The recent emergence of iPSCs supports the use of pluripotent stem 
cells in generating functional hepatocyte-like cells (HLCs). A better understanding of 
the development of the liver in vivo has allowed the generation of differentiation 
approaches to obtain HLCs from pluripotent stem cells in a step-wise manner, 
mimicking the stages observed during liver development: anterior definitive 
endoderm induction, hepatic endoderm specification, hepatocyte specification and 
hepatocyte maturation. The existing differentiation approaches of pluripotent stem 
cells to the hepatic lineage tend to replicate hepatocyte development in discrete 
stages, by using combinations of various soluble growth factors that mimic the 
dynamic cues observed during hepatogenesis in vivo. However, like any other tissue 
in vivo, the development of the liver is a continuous process. As a consequence, the 
duration and media composition of the stages varies between different approaches. 
However, most protocols share the use of certain growth factors and the duration 
of each of the stages. 
Liver development requires the priming of the primitive streak towards the 
endoderm lineage in a process primarily driven by Activin/Nodal, BMPs, FGFs and 
Wnt signalling (D'Amour et al., 2005; Duboc et al., 2010). In most of the available 




by supplementing the media with Activin A alone or in combination with Wnt3a or 
different FGFs (D'Amour et al., 2005; Gadue et al., 2006; Hay et al., 2008a). 
Endodermal progenitor maintenance and expansion are controlled in vivo by the 
action of different FGFs and BMPs (Chen et al., 2012; Josephson et al., 2006; Jung, 
1999; Zaret and Grompe, 2008). Therefore, these factors are commonly used in the 
hepatic specification from pluripotent stem cells to definitive endoderm in vitro 
(Basma et al., 2009; Brolén et al., 2009; Gai et al., 2010; Soldatow et al., 2013; 
Touboul et al., 2010). Specification of the primitive streak to endoderm depends on 
the duration and magnitude of nodal signalling (Lowe et al., 2001), triggered in vivo 
by BMPs ( Zorn and Wells, 2009), which is replaced by activin A; Wnt3a maintains 
the nodal expression and mediates brachyury expression, critical in the specification 
of the anterior region of the primitive streak (PS) to definitive endoderm. 
Hepatic endoderm specification results in the formation of the liver bud, which 
contains the bipotential progenitor cells called hepatoblasts. This process requires 
further activation of signalling pathways by FGF and BMP family molecules, 
specifically BMP4, FGF2, and FGF4. Commitment to the hepatic fate is induced by a 
treatment with a mixture of FGFs (Agarwal et al., 2008; Cai et al., 2007; Sekhon et 
al., 2004). Hepatic specification can also be induced by modifying the acetylation 
state of the histones by supplementing the media with DMSO (Duan et al., 2010; 
Hay et al., 2008a). 
Following liver bud formation and expansion, the hepatoblasts are stimulated to 
differentiate towards hepatocyte fate by inductive signals, including hepatocyte 
growth factor (HGF) and oncostatin M (OSM). This process can be recapitulated in 
vitro by a treatment with cocktail of soluble factors including these cytokines in 
combination with insulin and glucocorticoids such as dexamethasone and 
hydrocortisone. OSM, an IL-6 related cytokine produced by hematopoietic cells 
present in mid-fetal livers, favours the hepatocyte differentiation over 
cholangiocytes, via STAT3 signalling (Kamiya et al., 2002). Upon binding of 




is activated (Ito et al., 2000; Kamiya et al., 1999), promoting morphological 
maturation into polarized epithelium via K-ras and E-Cadherin (Kamiya et al., 2001; 
Matsui, 2002; Michalopoulos et al., 2003),  whereas HGF mimics the hepatic 
environment (Clotman, 2005; Kim and Rajagopalan, 2010) in a STAT3-independent 
manner (Kamiya et al., 2001), promoting hepatoblast migration and proliferation 
within the liver bud (Block et al., 1996; Medico et al., 2001; Michalopoulos and 
Bowen, 1993). HGF binding to the c-Met receptor activates both the SEK1/MKK4 
and c-Jun signalling cascades resulting in glucose-6-phosphate, tyrosine amino 
transferase, carbamoyl-phosphate synthase and albumin expression, all of which 
are associated with mature liver phenotype (Duncan, 2003; Fiegel et al., 2008; 
Zaret, 2001). While insulin promotes hepatocyte attachment and morphology via 
PI3K-Akt and MAPK pathways (Kim et al., 2001), glucocorticoids upon binding to the 
glucocorticoids receptors, enhance the differentiation state of the cells through 
activation of liver specific transcriptional programs by either, increasing the DNA-
binding activity of key transcription factors such as C/EBPα, -β, -γ, HNF1α,-1β and 
HNF4α (Elaut et al., 2006; Matsuno et al., 1996; Sinclair et al., 2008) or by binding to 
promoters found upstream of hepatic genes including albumin, thus increasing the 
secretion of this liver specific protein (Dich et al., 1988).  
3.1.3 Characterization and functional evaluation of pluripotent stem cells 
derived definitive endoderm and hepatic lineages 
Cell morphology, expression of stage specific mRNAs, protein markers and 
functional abilities are common techniques used to define the cells obtained at 
different stages during differentiation. Undifferentiated pluripotent stem cells 
express the well established pluripotency markers Octamer 4, Sox 2 and Nanog; Sox 
17 and FoxA2 expression is characteristic of definitive endoderm (D'Amour et al., 
2005; Snykers et al., 2009). Hepatoblasts display a characteristic cobblestone-like 
morphology. However, there is not a specific marker that defines hepatoblasts. 
Therefore, characterization of the hepatoblast stage can be determined using a 




factors such as Hhex, GATA 4, GATA 6, HNF6, Prox1 and Sox9 (Wells and Melton, 
1999), and proteins including alpha-fetoprotein, albumin and cytokeratin 19 (Zaret, 
2008). Finally, hepatocytes are defined by markers such as albumin, HNF4α and 
specific CYPs (Snykers et al., 2009). Assessment of functional abilities on the HLCs 
includes measurement of the liver specific protein production and secretion, 
measurement of the cytochrome P450 activity, drug induction by pleiotropic P450 
inducers, assessment of the metabolism of toxic compounds, glycogen storage and 
uptake of indocyanine green and low density lipoproteins (Behbahan et al., 2011).      
3.1.4  Phenotypic instability of the cells in culture 
Currently, HLCs generated from pluripotent stem cells represent a reliable source of 
hepatocytes, making this technology a potential alternative to primary human 
hepatocytes tissues. However, improvements in cell fidelity are required (Godoy et 
al., 2015). A common problem in both stem cell derived HLCs and primary human 
hepatocytes are cell dedifferentiation (Beigel et al., 2008; Binda and Lasserre, 
2003). Thus, the applications of HLCs, like primary human hepatocytes, are limited 
due to phenotypic instability in culture. 
In primary human hepatocytes, the disruption of the liver tissue integrity occurred 
during isolation, which activates inflammatory and proliferative responses mediated 
by the nuclear factor κB (Nf-κβ) and mitogen-activated protein kinase (MAPK) 
respectively. These events initiate a transdifferentiation process from a epithelial to 
a mesenchymal phenotype, which leads to negative effects in the expression of liver 
specific genes, especially in genes encoding phase I and phase II biotransformation 
enzymes and liver-enriched transcription factors (LETFs) (Beigel et al., 2008; Boess 
et al., 2003). These alterations are at the most pronounced between 24 and 48 
hours in both, the number of affected genes and the level of expression, which 
often parallel with a reduction in the expression of the corresponding protein and 
the enzymatic activity (Beigel et al., 2008; Boess et al., 2003; Rodriguez, 2002). 




and the time-dependent loss of hepatocellular morphology (Rowe et al., 2010), 
denoted by a lost in the cell polarity, an increase in the expression of acute-phase 
enzymes and proteins involved in the cytoskeletal remodelling ,including β-actin, α-
tubulin and vimentin. These events affect the hepatocyte homeostasis leading to an 
apoptosis mediated cellular death, thus shortening survival and life span of the cells 
(Elaut et al., 2006; Paine and Andreakos, 2004; Vinken et al., 2006). 
Reversion of the dedifferentiation process has been induced by modifying the 
culture media and/or the microenvironment surrounding the cells. Media 
supplementation with differentiation promoting factors, including insulin and 
glucocorticoids, have been extensively applied either alone or in combination with 
strategies that involve the modulation of the extracellular environment, using 
biological derived matrices and/or co-culture strategies (Fraczek et al., 2013).  
 
The above section summarises the characteristics of hESCs, the culture conditions 
required to maintain the cells in an undifferentiated pluripotent state and the 
strategies used to generate hepatocytes from pluripotent stem cells. One of the 
main challenges associated with HLCs derived from pluripotent stem cells is the 
functional and phenotypical instability of the cells in culture. The next section of this 
chapter highlights the investigation carried out to overcome the above issues. The 
employment of a defined, serum- and xeno-free hepatocyte differentiation media 
will improve the reproducibility of the culture system, as it reduces batch-to-batch 
variations and allows for scalability. Furthermore, this system could be 
implemented as an accurate model for understanding the mechanisms underlying 







3.2   Results 
3.2.1 Characterization of the hESC population 
Developing a culture system that supports the proliferation of undifferentiated and 
pluripotent hESCs requires a large amount of time and effort. The latest advances in 
developing successful defined culture approaches have allowed the possession of 
standardised, reproducible, scalable and efficient methods to culture hESCs, 
conferring the culture with suitable conditions for maintaining the self-renewal and 
the pluripotent abilities of the hESCs. 
3.2.1.1 Culture and characterisation of hESCs maintained in mTeSR1™ 
hESC line H9 was thawed and cultured on conditioned media (CM) supplemented 
with bFGF on a monolayer of mitotically inactive mouse embryonic fibroblast feeder 
cells (MEFs) plated on matrigel coated surfaces, and gradually transitioned into 
mTeSR1™ (MT). At the first passage after thawing, hESCs cultured on MEFs were 
transferred into a feeder free matrigel surface containing 100% CM for 48 hours. 
Afterwards, cells were cultured in a mixture of CM:MT at the following ratios; 75:25, 
50:50, 25:75 and finally 100% MT, 48 hours in each mixture. hESCs were then 
maintained in MT for a minimum of 5 passages before they were characterised for 
their ES cell identity and pluripotency capacity. For hepatocyte differentiation, cells 
were maintained for up to 30 passages in MT media. hESC identity was assessed by 
morphological analysis, examination of the expression of transcription factors 
ascribed to pluripotency; Oct 4 (Octamer 4) and Nanog, and their cell surface 
expression of SSEA-1, SSEA-4, TRA-1-60 and TRA-1-81. In addition, analysis of the 
pluripotency capacity of the cells was measured by studying their ability to 
spontaneously differentiate into all three germ layers, the ectoderm, mesoderm 
and endoderm, and directly differentiation into HLCs using a standardised protocol. 
Morphological analysis of the hESCs in culture was used as a guide to assess culture 




colonies with well-defined edges and no observable spontaneous cellular 
differentiation. Cells displayed the characteristic hESC morphology, defined by the 
possession of a large nucleus to cytoplasm ratio with well-defined and pronounced 
nucleoli (Figure 6A). Further to morphological analysis, the ‘stemness’ nature of the 
hESCs cultured in MT was investigated by analysing the gene and protein expression 
of two well established transcription factors associated with ‘stemness’, Oct 4 
(Octamer 4) and Nanog, employing quantitative PCR and immunofluorescence. 
Gene expression levels of these transcription factors in the hESC H9 were 
comparable to the expression observed in the  hESC H7, a well described hESC line 
used as a control and cultured under the same conditions as H9 (Figure 6B). In 
addition, the protein expression, as depicted by the immunofluorescence, revealed 
that 97% and 98% of the cells stained positive for Oct 4 and Nanog, respectively 
(Figure 7). The high level of expression of Oct 4 and Nanog confirmed the 





Figure 6. Analysis of hESCs in culture. A) hESC line H9 maintained in mTeSR1
™
 media displayed 
morphological features typical of hESCs, showing a large nucleus to cytoplasm ratio. hESCs formed 
colonies with well-defined edges and little to no differentiation observed between the colonies. Images 
were taken at 4x magnification (left) or 10x magnification (right), and scale bar represents 200 µm 
and 100 µm respectively. B) Gene expression analysis of the pluripotent markers Octamer 4 (Oct 4) 
and Nanog by quantitative PCR in hESCs H9 revealed comparable gene expression levels to hESC 
line H7, with no statistically significant difference between both cell lines. Relative expression refers 
to fold of induction normalised to the housekeeping gene GAPDH and to H7 cultured under the same 
conditions.  The results represent the mean ± SD of three different samples, and each run in triplicate. 
Levels of significance were measured by student’s t-test where p<0.05 represents non-significant 
difference. Abbreviations: Oct4-Octamer 4. GAPDH is not the best housekeeping gene to be used as 





Figure 7. Immunofluorescence analysis of pluripotent markers in hESCs. Pluripotent marker 
expression in hESCs H9 was confirmed by immunofluorescence, with 97% and 98% of the cells 
expressing Oct 4 and Nanog respectively, further supporting the stem cell status of hESC maintained 
in mTeSR1™ media. The corresponding IgG control demonstrated the specificity of the staining. For 
each condition five random fields of view, containing at least 500 cells, were counted. Images were 
taken at 20x magnification and the scale bar represents 100 µm. Abbreviations: Oct4-Octamer 4, IgG-
Immunoglobulin G. 
Fluorescence activated cell sorting (FACS) is another technique employed to 
characterise the stem cell identity of hESCs. As such, the expression of cell surface 
antigens in hESCs at different passage ranges (p41 to 50, p51 to 60 and p61 to 70) 
was investigated by FACS. The surface markers used to identify hESCs within a 
population included SSEA-1 and -4 and the TRA surface antigens 1-60 and 1-81. Cells 
were gated according to their side scatter vs. forward scatter properties in order to 
eliminate dead, differentiated or cell aggregates. The results displayed in Figure 8 
showed background level of SSEA-1 expression (a differentiation marker) in any of 
the cell passage range as expected. The percentage of cells expressing SSEA-4 (98% 
and 95%), TRA -1-60 (93% and 82%)  and TRA-1-81 (95% and 90%) was confirmed in 
greater than 80% of the cells within cell passage range p41 to 50 and p51 to 60, 
respectively, supporting the undifferentiated state of the cells. Despite that cell 
passage range p51 to 60 expressed comparable levels of SSEA-4 to other cell 
passage range (95%), TRA-1-60 and TRA-1-81 expression levels were lower than 
expected (66% and 49% respectively).  Therefore, based on these observations, cells 





                                           
Figure 8. Expression of stem cell surface markers in hESCs. The graph shows the percentage of 
cells at different passage ranges expressing hESC surface markers, including SSEA-4, TRA-1-60 and 
TRA-1-81. Low percentages of cells expressed the differentiation marker SSEA-1 further supporting 
the stem cell nature of these hESCs. Unstained cells were used to define levels of background 
staining. The results represent the mean ± SD of six independent samples for cell passage range p41-
50 and p51-60 and three independent samples for cell passage p61-70. Levels of significance were 
measured by student’s t-test where p<0.05 is denoted as *. 
3.2.1.2 Testing pluripotency of hESCs maintained in mTeSR1™ 
hESCs are able to spontaneously differentiate into cell types from all three germ 
layers; the endoderm, mesoderm and ectoderm. This pluripotency capacity can be 
tested by embryoid body (EB) formation assay, a widely accepted method (Xu et al., 
2001). The cell types associated with the germ layers are frequently identified by 
detecting the expression of proteins associated to each of the three germ layers: 
alpha-fetoprotein (AFP) for endodermal lineage, alpha-smooth muscle actin (α-
SMA) for mesodermal lineage and β-tubulin III for ectodermal lineage.  
To perform the assay, hESCs at 80-90% confluency were lifted and placed into a 
suspension culture, suitable for promoting cell aggregation. After 7 days the EBs 
generated were well defined and vacuolated, suggesting efficient EB formation. 
Following this, the EBs were transferred to gelatin coated wells, where the 




over a 14-day period. The resulting cell cultures were then fixed in ice cold 
methanol and stained with antibodies that are specific for each lineage. Figure 9 
displays the resulting cell types formed following EB spontaneous differentiation 
from hESCs cultured in MT. hESCs formed cell types that were positive for alpha-
fetoprotein (endoderm), alpha-smooth muscle (mesoderm) and β-tubulin III 
(ectoderm). This data demonstrates that the culturing conditions used in this study 
maintained hESC pluripotency.  
 
Figure 9. Analysing hESC spontaneous differentiation. Immunofluorescence analysis shows that 
hESCs were able to form cell types from all three germ layers, demonstrating their pluripotency. 
Smooth muscle actin positive cells represent cells from the mesoderm lineage, AFP represents 
endodermal cells and beta tubulin III defines cells from the ectodermal lineage. The IgG control 
demonstrated the specificity of the immunostaining. Images were taken at 20x magnification and the 
scale bar represents 100 µm. Abbreviations: α-SMA-alpha Smooth Muscle Actin, AFP-alpha-
Fetoprotein, β-Tub III-beta Tubulin III and IgG-Immunoglobulin G. 
In addition, I investigated the genetic stability of founding populations by SNP 
(single nucleotide polymorphism) ensuring that no major mutations compromising 
the results were detected (Supplementary Figure 1 and 2). 
The data here presented shows that mTeSR1™ (MT) represents a suitable culture 
media to provide a stable environment for hESC culture as it supports hESC self-
renewal and pluripotency. The next section will focus on the capacity of hESC line 




3.2.2 Direct differentiation and characterization of hESCs-derived hepatic 
endoderm 
Delivery of pluripotent stem cell derived somatic cells requires the development of 
reliable and efficient differentiation procedures. Undifferentiated hESCs maintained 
in MT were scaled up to the desired quantity and the hepatic differentiation was 
performed using an efficient and well established differentiation procedure (Figure 
10). hESCs were primed towards definitive endoderm in the presence of Wnt3a and 
Activin A prior to the hepatic specification, which was induced in a media containing 
Knock-Out Serum Replacement (KOSR) and DMSO  (SR/DMSO media), resulting in 
liver progenitor cells, called hepatoblasts. Finally, hepatocyte differentiation and 
maturation was driven by culturing the cells in a media supplemented with 
oncostatin M (OSM) and hepatocyte growth factor (HGF). Morphological, 
transcriptional and functional analyses were performed at various time points to 
accurately define the end products obtained in each of the stages. Characterisation 
of the definitive endoderm and the hepatoblast stage of the cells will be described 
in more detail in the following sections.  
 
Figure 10. Flow diagram of the hepatocyte differentiation protocol in serum containing media. 
H9 hESCs were differentiated to hESCs-derived hepatocyte-like cells by using an efficient serum-free 
differentiation protocol for up to 17 days. Abbreviations hESC– human embryonic stem cells; KO 
DMEM – knock out Dulbecco's Modified Eagle Medium; DMSO – Dimethyl sulfoxide; KOSR- 
Knockout serum replacement; L-15-L-15 media; FBS-Foetal Bovine Serum; HGF – Hepatocyte 
growth factor; OSM – Oncostatin M. Protocol described in detail in Hay et al., 2008a 
3.2.2.1 Characterisation of hESCs-derived definitive endoderm.  
hESCs cultured in MT at 40-50% confluency were differentiated towards definitive 
endoderm by transferring the cells to a RPMI/B27 media supplemented with Wnt3a 




migratory and proliferative capacity, and 72 hours post-induction profound changes 
in the cell morphology were observed, with cells adopting the characteristic 
triangular endoderm shape (Figure 11A). In line with changes in cell morphology, 
quantitative PCR analysis showed a decrease in the expression of the pluripotent 
markers Oct 4 and Nanog (≈50 and 30% respectively) (Figure 11B), in parallel with 
an increase in the expression of the endodermal marker Sox 17 (≈14000-fold 
induction) (Figure 11C) when compared to undifferentiated hESCs (p<0.001). 
Analysis of the protein expression levels Sox 17 was performed by immunostaining, 
revealing that 93% of the cells stained positive for this marker (Figure 11D). All 






Figure 11.Characterisation of the hESCs-derived definitive endoderm. The hESCs H9 were 




contrast images of the cells at Day 3 in the differentiation process showed cells adopting the 
characteristic definitive endoderm morphology, denoted by the possession of a triangular-shape. 
Images were taken at 4x magnification (left) or 10x magnification (right), and scale bar represents 200 
µm and 100 µm respectively. B-C) Gene expression analysis of pluripotent and definitive endoderm 
markers in the cells at Day 3 in the differentiation. (B) Quantitative PCR analysis of the pluripotent 
makers Oct 4 and Nanog revealed a decrease in the expression of these makers as the differentiation 
progressed. C) Quantitative PCR analysis of the definitive endoderm marker Sox17 in the 
differentiating cells suggested the commitment of the cells to the endoderm lineage. Relative 
expression refers to fold of induction over hESCs and normalised to the housekeeping gene GAPDH. 
The results represent the mean ± SD of three different samples, each run in triplicate. Levels of 
significance were measured by student’s t-test where p<0.001 is denoted as ***. D) 
Immunofluorescence analysis of Sox17. The commitment of the cells to definitive endoderm was 
confirmed by immunostaining, as 93% of the cells expressed Sox17, further supporting the definitive 
endoderm status of the cells. The corresponding IgG controls demonstrated the specificity of the 
immunostaining. For each condition five random fields of view containing at least 500 cells, were 
counted. Images were taken at 20x magnification and the scale bar represents 100 µm. Abbreviations: 
Oct 4-Octamer 4; IgG-Immunoglobulin G. 
3.2.2.2 Defining the hepatoblast stage of the cells 
Hepatic specification of hESCs-derived definitive endoderm cells was induced by 
transferring the cells to a media containing Knock-Out Serum Replacement (KOSR) 
and DMSO (KOSR/DMSO media) for 5 days. The resulting population of cells were 
then transferred to a hepatocyte maturation media supplemented with oncostatin 
M (OSM) and hepatocyte growth factor (HGF) for 24 or 48 hours. In order to define 
the stage at which the cells displayed the most hepatoblastic phenotype, 
morphological, transcriptional and protein analysis were performed in cells at Day 8 
in the differentiation process (after 5 days on KOSR/DMSO), at Day 9 and Day 10 (24 
or 48 hours on the maturation media, respectively).  
Morphological analysis 
The hepatic specification of the hESCs-derived definitive endoderm resulted in a 
compacted culture of hESCs-derived hepatoblasts (Figure 12), which displayed a 
greater morphological homogeneity at Day 8 and Day 9 (A-B) compared to cells at 
Day 10 (C). hESCs-derived hepatoblasts at Day 8 (D) adopted a cobblestone-like 
morphology, which was more distinct at Day 9 (E), with clearer cellular edges and 




differentiation resulted in the display of a cellular heterogeneity regarding to cells 
length, width and size at Day 10 (F).  
 
Figure 12.Morphological analysis of the hESCs-derived hepatoblast. The hESCs-derived 
definitive endoderm cells were stimulated to differentiate down the hepatic lineage in the presence of 
a media containing Knock-Out Serum Replacement (KOSR) and DMSO for 5 days (Day 8), prior to 
addition of the maturation media for 24 and 48 hours (Day 9 and Day 10, respectively). The resulting 
cell cultures displayed a homogeneous cell population consisting on cell adopting the typical 
hepatoblast morphology, denoted by the display of a cobblestone-like morphology with well-defined 
cell-to-cell contact. The images were taken at 4x magnification (A-C) or 10x magnification (D-F), and 
scale bar represents 200 µm and 100 µm respectively. 
Gene expression profiling of hESCs-derived hepatoblasts. 
To define hepatoblast gene expression stage of the cells, I analysed the expression 
of hepatoblast markers at Day 8, Day 9 and Day 10 using quantitative PCR. The gene 
expression profile is shown in Figure 13.  
The peak in the gene expression of the foetal hepatic marker alpha-fetoprotein 
(panel A) was detected in hESCs-derived hepatoblasts at Day 10 in the 




9, respectively (p<0.001), with statistically significant differences between these last 
two days (p>0.05).  
Analysis in the gene expression of the hepatoblast marker Sox 9 (panel B) indicated 
that hESCs-derived hepatoblasts at Day 8 displayed the highest levels out of the 
analysed days , with 1.75 and 1.5-fold increase compared  to Day 9 and Day 10, 
respectively (p<0.05), with  statistically significant difference between these last 
two days (p<0.05). 
hESCs-derived hepatoblasts at Day 8 in the differentiation approach displayed the 
highest gene expression levels of EpCAM (panel C) with a 1.85 and 1.25-fold 
increase compared to cells at Day 9 and Day 10, respectively (p<0.05), with 
statistically significant differences between these last two days (p<0.001). 
Hepatocyte nuclear factor 1 β, HNF1β, gene expression (panel D) was detected at 
the highest in hESCs-derived hepatoblasts at Day 8 in the differentiation approach, 
with 2.7 and 3.4-fold increase compared to cells at Day 9 and Day 10, respectively 
(p<0.001), with a statistically significant difference between these last two days 
(p<0.001).  
Analysis in the gene expression of the hepatoblast marker hepatocyte nuclear factor 
3 β, HNF3β, (panel E) revealed that hESCs-derived hepatoblasts at Day 8 in the 
differentiation approach exhibited the highest level of expression, with 3 and 2.5-
fold increase compared to cells at Day 9 and Day 10, respectively (p<0.001) and no 
statically significant difference between these two last days (p>0.05).  
Comparable situation was observed when Cytokeratin 19 gene expression (panel F) 
was analysed. Cells at Day 8 displayed the highest level of expression, 1.5-fold 
increase compared to the rest of the days (p<0.001) and no statically significant 
difference between these two time points (p>0.05).  
hESCs-derived hepatoblast at Day 8 in the differentiation approach showed higher 




and 1.3-fold increase compared to Day 9 and Day 10 respectively (p<0.001), with a 
statistically significant difference between these last two days (p<0.001).  
Analysis in albumin expression revealed that the peak in the gene expression in 
hESCs-derived hepatoblasts was reached at Day 10 (panel H), with 2-fold increase 
compared to cells at Day 8 (p<0.05) but no statically significant difference compared 
to cells at Day 9 (1.15-fold increase, p>0.05). 
The hepatocyte lineage marker hepatocyte nuclear factor 4α, HNF4α, gene 
expression (panel I) was at the highest in cells at Day 8 in the differentiation 
approach, with 2.9 and 3.25-fold increase compared to Day 9 and Day 10, 
respectively (p<0.001), with a statistically significant difference between these last 
two days (p>0.01).  
Cells at Day 10 in the differentiation approach displayed the highest epithelial 
marker E-Cadherin gene expression (panel J), with 1.85 and 2.85-fold increase 
compared to cells at Day 8 and Day 9, respectively (p<0.001), with a statistically 
significant difference between these last two days (p<0.001). 
Analysis in the hepatoblast markers gene expression suggests that hESCs-derived 
hepatoblasts at Day 8 in the differentiation procedure display the most 








Figure 13. Hepatoblast gene expression. Expression of the hepatoblast markers (α-fetoprotein, 
Sox9, EpCAM, HNF1β, HNF3β, Cytokeratin19, Prox1, Albumin and HNF4α) and the epithelial 
marker E-Cadherin in hESCs-derived hepatoblasts at Day 8, Day 9 and Day 10 in the differentiation 
approach were analysed by quantitative PCR. Relative expression refers to fold of induction over 
hESCs and normalised to the housekeeping gene GAPDH. The results represent the mean ± SD of 
three different samples, each run in triplicate. Levels of significance were measured by student’s t-test 
where p<0.05 is denoted as *, p<0.01 is denoted as ** and p<0.001 is denoted as ***. Abbreviations: 
HNF4α- Hepatocyte nuclear factor 4α, HNF3β- Hepatocyte nuclear factor 3β, HNF1β- Hepatocyte 
nuclear factor 1β. 
Protein expression profiling of hESCs-derived hepatoblast. 
In addition to quantitative PCR, I also investigated the protein expression of 
hepatoblast and hepatocyte markers and the proliferative marker Ki67 in hESCs-
derived hepatoblasts (Figure 14). Cells fixed at Day 8, Day 9 and Day 10 were 
stained with antibodies to hepatocyte nuclear factor 4α (HNF4α), α-fetoprotein 
(AFP), the transcription factors GATA4 and GATA6, cytokeratin 19 (CK19), albumin, 
and the proliferative marker Ki67.   
Analysis of the percentage yield of hESCs-derived hepatoblasts expressing HNF4α 
(panels A-C) revealed that over 90% of the cells at Day 8, Day 9 and Day 10 
expressed the transcription factor (94%, 94.1% and 92.8% respectively) with no 
statically significant differences (p<0.05) between the analysed days. Similar pattern 
of expression was found when  alpha-fetoprotein expression was analysed (panels 
E-G) as 97%, 99% and 98% of hESCs-derived hepatoblasts at Day 8, Day 9 and Day 
10, respectively stained positive, with no statically significant differences (p<0.05). 
Analysis of the protein expression of the hepatic endoderm transcription factor 
GATA4 (panels I-K) revealed no statistically significant differences between the days 
as ≈97%, 95% and 93% of the cells stained positive at Day 8, Day 9 and Day 10 
respectively (p<0.05). In contrast, GATA6 expression (panels M-O) showed a 
decrease  as the differentiation progressed  as  99%, ≈76% and ≈50% of the cells 
stained positive for this transcription factor at Day 8, Day 9 and Day 10, respectively 
(p>0.01). Cytokeratin 19 (panels Q-S) was expressed in over 96% of the cells, 




marker but with no statically significant differences between the analysed day 
(p>0.05). Analysis of the protein expression of the hepatic lineage marker albumin 
(panels U-W) revealed that the percentage of hESCs-derived hepatoblasts staining 
positive increased as the differentiation progressed, as ≈39% of cells at Day 10 
(p>0.01) expressed albumin compared with ≈20% of cells at Day 9 and Day 8 .  
In addition, I analysed the expression of the proliferative marker Ki67 (panels Y-AA) 
at the previously mentioned days. A decrease in the percentage yield of hESCs-
derived hepatoblasts staining positive as the differentiation progresses was 
observed, as ≈86%, ≈82% and ≈73% of the cells expressed this protein at Day 8, Day 





Figure 14. Immunofluorescence analysis of hESCs-derived hepatoblasts. At Day 8, 9 and 10, 
differentiated cells were stained for hepatoblast markers, including HNF4α (panels A-C), α-




and Albumin (panels U-W). Ki67 staining (panels Y-AA) was used to assess the proliferative state of 
the cells. The corresponding IgG controls confirmed the specificity of the staining. For each condition 
five random fields of view, containing at least 400 cells, were counted. Images were taken at 20x 
magnification and the scale bar represents 100 µm. Abbreviations: HNF4α-Hepatocyte nuclear factor 
4α, AFP-alpha-fetoprotein, CK19-Cytokeratin 19, ALB-Albumin, IgG-Immunoglobulin G. 
As little differences were observed in the protein expression of hepatic markers 
between the analysed days, based on the gene expression and morphology 
features, I concluded that cells at Day 8 in the differentiation protocol displayed the 
most hepatoblastic phenotype out of all analysed days. 
In conclusion, the hepatic endoderm generated from hESCs display markers 
resembling the development observed in vivo. The next section will focus in the 
generation of functional hepatocyte-like cells from human embryonic stem cells.  
3.2.3 Hepatocyte maturation in a serum containing media. 
Hepatocyte specification of hESCs-derived hepatoblasts was performed by 
transferring the cells to a foetal bovine serum (FBS) containing maturation media 
supplemented with oncostatin M (OSM) and hepatocyte growth factor (HGF), 
employing an efficient differentiation (Hay et al., 2008a). To accurately define the 
end product, morphological, transcriptional and functional analyses were 
performed on the hESCs-derived HLCs.  
Morphological analysis of hESCs-derived HLCs at Day 17 in the differentiation 
protocol indicated that cell cultures underwent morphological changes, resulting in 
a homogeneous population of cells displaying morphological trails associated with 
cultures of mature hepatocytes. Cells adooted a hexagonal shape and clear and well 
defined large nuclei. These morphological changes indicated a successful 
hepatocyte maturation process (Figure 15A). 
To further characterise the HLCs, I investigated the expression of different 
hepatocyte markers involved in the maintenance of the hepatocyte phenotype 




antibodies to alpha-fetoprotein (AFP), albumin (ALB), cytochrome P450 3A (CYP3A) 
and the epithelial marker E-Cadherin (Figure 11B). Analysis of the expression 
revealed that 66%, 86%, 74% and 78% of the cells stained positive for alpha-
fetoprotein, albumin, CYP3A and E-Cadherin respectively, demonstrating the high 
purity displayed by the cultures.  
 
Figure 15. Characterisation of hESCs-derived HLCs on a serum containing media. hESCs-
derived hepatoblasts were differentiated to HLCs using a serum containing media supplemented with 
OSM and HGF. A) Phase contrast images of the cells at Day 17 indicated the display of the hexagonal 
cellular shape characteristic of primary adult hepatocyte by the HLCs, suggesting successful 
differentiation into hepatocytes. The images were taken at 4x magnification (left) or 10x 
magnification (right) and scale bar represents 200 µm and 100 µm respectively. B) 
Immunofluorescence analysis of hepatocyte lineage markers. The expression of hepatocyte markers, 
including α-fetoprotein, albumin, CYP3A and the epithelial marker E-Cadherin were analysed by 
immunofluorescence in hESCs-derived HLC at Day 17 on the differentiation procedure, 
demonstrating the cell commitment to a hepatocyte fate. The corresponding IgG controls indicated the 




were counted. Images were taken at 20x magnification and the scales bar represents 100 µm. 
Abbreviations: AFP-Alpha-fetoprotein, ALB-Albumin, E-Cad-E-Cadherin, CYP3A-Cytochrome 
P450 3A, IgG-Immunoglobulin G. 
3.2.4 Necessity of moving to a serum-free maturation media. 
In addition to protein analysis, I measured the activity of the P450 cytochrome 3A 
(CYP3A), a member of the cytochrome P450 that is involved in the drug metabolism 
of xenobiotic compounds and accounts for up to 50% of the total cytochrome P450 
activity in vivo. Therefore, measurement of the activity of this enzyme well reflects 
the functional capacity of the cells. Four parallel and individual differentiation 
experiments using a different batch of FBS in the maturation media were 
performed. CYP3A activity was measured in the resulting individual populations of 
HLCs, revealing differences between 1.5 and 2 fold activity depending on the batch 
of serum used (Figure 16). The values for CYP3A for the different FBS batches are 
follows; 34,068 RLU/ml/mg for batch 1, 39,367 RLU/ml/mg for batch 2, 25,900 
RLU/ml/mg for batch 3 and 20,494 RLU/ml/mg for batch 4. 
 
Figure 16. HLC functional characterisation. Cytochrome P450 function 3A in hESCs-derived 
HLCs was assessed using a commercially available system (pGLO
®
), revealing a high variability on 
the metabolic capacity of the cells depending on the batch of FBS serum used in the maturation media, 
with differences between 1.5 and 2 fold activity. The results represent the mean ± SD of three 




The data presented demonstrate that by applying the serum containing 
differentiation protocol to hESCs-derived hepatoblasts, I obtained homogeneous 
populations of cells committed to the hepatocyte lineage, but displayed variability 
which was associated to the use of serum in the maturation medium. 
3.2.5 Hepatocyte differentiation using a serum-free approach. 
The high level of variability associated with the use of serum containing media 
suggested the necessity of developing a serum-free differentiation protocol to 
obtain HLCs. Therefore, optimisation of the maturation step involved the 
replacement of the serum containing media for a defined serum-free media. The 
resulting population of cells were extensively characterised at different times during 
the differentiation procedure (Figure 17). Morphological analysis of the cells, RNA, 
protein expression pattern and functional analysis were performed.  
 
Figure 17. Flow diagram of the hepatocyte differentiation protocol in serum-free media. H9 
hESCs are differentiated to HLCs by using an efficient serum-free differentiation protocol for up to 27 
days. Abbreviations hESC– human embryonic stem cells; KO DMEM – knock out Dulbecco's 
Modified Eagle Medium; DMSO – Dimethyl sulfoxide; KOSR- Knockout serum replacement; HZM-
HepatoZYME
®
-SFM; HGF – Hepatocyte growth factor; OSM – Oncostatin M. 
3.2.5.1 Morphological analysis  
Images of the HLCs were taken at different time points in the differentiation 
protocol (Figure 18). The resulting HLCs displayed morphological homogeneity 
(panels A-D) up to Day 21 in the differentiation process. By Day 15 (panel E), HLCs 
displayed morphological trails associated with mature hepatocytes, becoming 
clearer as the differentiation progressed. Cells adopted a hexagonal shape, the 
nuclei became larger and more defined, with clear cell-to-cell contact and the 




arrows), all morphological features characteristic of primary hepatocytes in culture. 
These observations supported the hepatocyte maturation in the defined serum-free 
maturation media with comparable morphology previously seen in the serum 
containing media. 
  
Figure 18. Morphological analysis of HLCs in a serum-free approach. The hESCs-derived 
hepatoblasts were differentiated to HLCs in the defined serum-free maturation media. During the 
maturation stage, cells underwent morphological changes mimicking processes observed in vivo. The 
nucleus became more defining and cells acquired a hexagonal morphology with an increase in the 
cell-to-cell contact resembling to cultures of human primary hepatocytes. Parallel to the acquisition of 
the typical primary hepatocyte morphology, the homogeneous cell cultures displayed canaliculi-like 
structures denoting the acquisition of mature hepatocyte morphology. The images were taken at 4x 
magnification (panels A-D) or 10x magnification (panels E-H) and scale bar represents 200 µm and 
100 µm respectively.  
3.2.5.2 Gene expression profiling of HLCs 
To further characterise the in vitro HLCs obtained in the serum-free differentiation 
protocol, I explored the gene expression of hepatocyte markers at Day 15, 17, 19 
and 21 in the differentiation approach by quantitative PCR. The gene expression 
profile is shown in Figure 19. 
Albumin gene expression (panel A) significantly increase (p<0.001) as the 
differentiation progresses with a 50, 3.5 and 2 fold increase at Day 17, 19 and 21 




Analysis in the gene expression of the hepatocyte nuclear factor 4α, HNF4α (panel 
B) showed a stabilisation in the between Day 15 and 17, followed by a significant 
decreases of 1.25 and 2.6-fold (p<0.05) by Day 19 and 21, respectively.  
CYP3A4 gene expression (panel C) reached a peak at Day 19, after an 18.5 and 4.75-
fold increase compared to Day 15 and 17 respectively (p<0.01), followed by a 
decrease of 1.4-fold by Day 21 (p=0.01).  
Alpha-fetoprotein gene expression (panel D) in HLCs showed a stabilisation in the 
expression between Day 17 and 19 after a 1.1-fold increase compared with Day 15 
(p<0.01), and followed by a further 1.6-fold decrease by Day 21 (p<0.001).  
HLCs at Day 15 and Day 17, displayed similar level of HNF1β gene expression (panel 
E) followed by a 1.25 (p=0.01) and 2.5-fold decrease (p>0.0001) observed at Day 19 
and 21, respectively.  
Analysis of the E-Cadherin gene expression (panel F) during the maturation 
approach indicated a maintenance in the expression (p>0.05) up to Day 19, after 
which gene expression decreased by 2-fold at Day 21 (p<0.001).  
Analysis on the gene expression of hepatocyte markers suggested an efficient 





Figure 19. Serum-free derived hepatocytes gene expression. Graphs represent the gene expression 
analysed by quantitative PCR of different hepatocyte and hepatic endoderm markers (Albumin, 
HNF4α, CYP3A4, α-fetoprotein, HNF1β) and the epithelial marker E-Cadherin in the cells 
undergoing hepatocyte maturation at Day 15, 17, 19 and 21 in the differentiation protocol. The up-
regulation in the expression of these hepatic genes suggests the commitment of the cells to the 
hepatocyte fate. Relative expression refers to fold of induction over hESCs and normalised to the 
housekeeping gene GAPDH. The results represent the mean ± SD of three different samples run, each 
run in triplicate. Levels of significance were measured by student’s t-test where p<0.001 is denoted as 
*** versus hESC. Abbreviations: HNF4α-Hepatocyte nuclear factor 4α, CYP3A4-cytochrome P450 




3.2.5.3 Protein expression profiling of HLC. 
In addition to the gene expression analysis, to further characterised the HLCs, I 
investigated the expression of different hepatocyte markers involved in 
maintenance of the hepatocyte phenotype using immunostaining. Monolayers of 
HLCs were fixed at Day 21 and stained with antibodies to hepatocyte nuclear factor 
4α (HNF4α), albumin (ALB), E-Cadherin (E-Cad), cytochrome P450 3A (CYP3A) and 
2D6 (CYP2D6) (Figure 16). Analysis of the expression revealed that 86%, 95%, 97%, 
94% and 98% of the cells stained positive for HNF4α, albumin, E-Cadherin, CYP3A 
and CYP2D6 respectively, demonstrating the high purity displayed by the cultures in 
the serum-free differentiation approach. 
  
Figure 20. Immunofluorescence analysis for hepatocyte lineage markers. The expression of 
various hepatocyte markers including HNF4α, albumin, CYP3A, CYP2D6 and the epithelial marker 
E-Cadherin were analysed by immunofluorescence in HLCs at Day 21 on the serum-free maturation 
media, further supporting the presence of a homogeneous population of cells expressing hepatocyte 
specific markers. The corresponding IgG controls demonstrated the specificity of the staining. For 
each condition five random fields of view, containing at least 500 cells, were counted. Images were 
taken at 20x magnification and the scales bar represents 100 µm. Abbreviations: HNF4α-Hepatocyte 
nuclear factor 4α, E-Cad-E-Cadherin, ALB-Albumin, CYP3A-Cytochrome P450 3A4, CYP2D6-
Cytochrome P450 2D6, IgG-Immunoglobulin G. 
3.2.5.4 Functional characterisation of HLCs. 
The possession of functional hepatocytes derived from hESCs is critical for a number 
of downstream applications ranging from in vitro models to the bio-artificial liver 




with direct implications in the generation of predictive toxicology tools and extra-
corporal devices. As such, I measured important liver functions, including 
cytochrome P450 (CYP3A and CYP1A2) and albumin secretion. 
The cytochrome P450 activity CYP3A and CYP1A2 in HLCs was measured at Day 15, 
17, 19 and 21 in the differentiation procedure (Figure 21). 
HLCs displayed CYP3A activity (Figure 21A) at Day 15, followed by a 3-fold increase 
by Day 17. A further 4-fold increase was observed at Day 19, when a stabilisation of 
the CYP3A activity was observed up to day 21,with not statically significant 
difference (p>0.05) between both days. The values for CYP3A at Day 15, 17, 19 and 
Day 21 are as follows: 1,3x104 RLU/ml/mg, 4,6x104 RLU/ml/mg, 18,1x104 
RLU/ml/mg and 19,5x104 RLU/ml/mg, respectively. 
CYP1A2 activity showed a similar trend than CYP3A (Figure 17B). Following a 6-fold 
increase in the activity observed at Day 17 compared to Day 15, the activity 
increased by 4-fold at day 19 and stabilised up to Day 21 with not statically 
significant difference (p>0.05) between both days. The values for CYP1A2 at Day 15, 
17, 19 and Day 21 are as follows: 3,8x103 RLU/ml/mg, 24,4x103 RLU/ml/mg, 
20,3x103 RLU/ml/mg and 24x103 RLU/ml/mg, respectively. 
 
Figure 21. HLCs display stable stable cytochrome P450 activity in serum-free media. 
Cytochrome p450 function CYP3A (A) and CYP1A2 (B) were assessed using a commercially 
available system (pGLO
®
) in HLCs at Day 15, 17, 19 and 21 in the serum-free differentiation 
approach.. Analysis of the function of both CYPS in HLCs revealed an increase in the activity at Day 
19 that was maintained at Day 21. The results represent the mean ± SD of six individual samples per 
time point per cytochrome P450 analysed. Levels of significance were measured by student’s t-test 




Serum protein production is another vital function of mature hepatocytes required 
for healthy liver metabolism and homeostasis. As the HLCs exhibit mature 
hepatocyte morphological features and stable cytochrome P450 activity at Day 19 
and 21 in the differentiation procedure, the secretion of albumin was analysed at 
these time points on collected supernatant using ELISA. Figure 22 demonstrates the 
production of albumin in HLCs. The levels of albumin maintained constant (p>0.05) 
between both days. The values of albumin produced at Day 19 and Day 21 are as 
follows; 637 ng/ml/24hours/mg and 637 ng/ml/24hours/mg, respectively. 
 
Figure 22. Albumin protein production revealed the maturity of the HLCs. The graph displayed 
shows the level of albumin secreted by HLCs at Day 19 and 21 when the cells displayed 
morphological features typical of mature hepatocytes. This protein is a good indicator of the hepatic 
maturity as it is uniquely produced by hepatocytes. As seen in the graph, there were not statistically 
significant differences between the analysed days.  The results represent the mean ± SD of three 
individual samples per time point. Levels of significance were measured by student’s t-test where 
p<0.05 is denoted as ns. 
The function of the HLCs obtained in the defined serum-free maturation media was 
comparable between individual experiments, and it demonstrated an improvement 
in the function of the HLCs when compared to cells obtained in the serum 
containing protocol, indicating that the possession of a more defined differentiation 





3.2.6 Investigating the dedifferentiation process in HLCs 
The window of activity of the HLCs was limited to Day 23, when a decrease in the 
cytochrome P450 function was observed. As the differentiation progressed, the 
mature hepatocyte morphological features displayed by the cells were gradually 
lost (Figure 23A). The homogeneous population of cells started to show a cellular 
heterogeneity in shape, size and length (panels A-E); intercellular spaces became 
larger and the cellular shape underwent to transition from the characteristic 
hepatocyte hexagonal shape to a large and more fusiform shape resembling to 
fibroblast morphology (panels F-I). Cellular detachment was observed (panels E, H-J, 
white and black arrows). The transition observed in the cellular morphology 
suggested the existence of a process of dedifferentiation from endoderm 
phenotype to mesoderm phenotype.  
In order to study this deterioration process, I investigated the expression of the 
hepatocyte marker HNF4α, an important transcriptional factor in the hepatocyte 
biology, as it is estimated to bind to more than 50% of promoters of actively 
transcribed genes in hepatocytes, and the mesenchymal and dedifferentiation 
marker vimentin. Quantitative PCR was employed to study the gene expression of 
these markers in HLCs at late stages in the differentiation protocol. Analysis of the 
HNF4α gene expression (Figure 23B) showed a 2-fold decrease at Day 21 compared 
to Day 19 (p<0.001), but stabilised between Day 21 and 23 (p>0.05) prior to a 
further 1.35-fold decrease by Day 25 (p=0.01), and an 18-fold decrease by Day 27 
(p<0.001). In parallel with the decrease in the HNF4α gene expression, an increased 
in vimentin gene expression (Figure 23C) of 1.8 and 2-fold from Day 21 to Day 23 
and 25 respectively was detected (p< 0.001). A further 1.27-fold increase was 





Figure 23.  Analysing hESCs-derived HLCs at late stages on the differentiation process. A) 
Phase contrast images of HLCs during the serum- free differentiation process showed the display of 
morphological hepatocyte features, with a prominent nucleus, a hexagonal morphology and canaliculi-
like structures (panels A-B and F-G). These features were gradually lost as the differentiation 
progressed, with cells suffering morphological deterioration, denoted by the acquisition of a fibroblast 
like morphology and increased cell detachment (white and black arrows). The images were taken at 4x 
magnification (panels A-E) or 10x magnification (panels F-J) and scale bar represents 200 µm and 
100 µm respectively. B-C) Gene expression analysis of hepatocyte and mesenchymal phenotype 
markers. Graphs represent the gene expression analysed by quantitative PCR of the hepatocyte marker 
HNF4α (B) and the mesenchymal marker vimentin (C) in HLCs at late stage on the differentiation 
process. The down regulation in the expression of HNF4α was clearly observed from Day 21 onwards, 
and accompanied by an up regulation in the gene expression of vimentin, indicating the presence of a 
dedifferentiation process consisting in a loss of the endoderm phenotype on the cells in favour of a 
mesenchymal phenotype. Relative expression refers to fold of induction over hESCs and normalised 
to the housekeeping gene GAPDH. The results represent the mean ± SD of three different samples 
run, each run in triplicate. Levels of significance were measured by student’s t-test where p<0.001 is 
denoted as ***. Abbreviations: HNF4α-Hepatocyte Nuclear Factor 4α. 
The expression pattern of HNF4α and vimentin was confirmed by immunostaining 
on fixed HLCs (Figure 24). The yield percentage of HLCs staining positive for 
vimentin remained below 13% until day 19, when there was a significant and steady 




64% by Day 23, 85% by Day 25 and 97% by Day 27. In parallel to the increase in 
vimentin expression, a decrease in HNF4α expression was observed. The percentage 
of cells staining positive for HNF4α remained above 80% until Day 23 (95% and 86% 
at Day 19 and 21, respectively), when 79% of the cells stained positive for the 
hepatocyte marker. A rapidly decrease in the yield percentage of cells expressing 
HNF4α was observed by Day 25 and Day 27 when HNF4α was expressed by 56% and 
38%  of cells respectively.  
3.2.7 Stability of the biological substrate used in the hepatocyte 
differentiation.  
One of the main problems associated with the use of biological matrices as 
substrata to differentiate and culture hESCs derive cells is the degradation observed 
in the extracellular matrix components found in matrigel. To investigate if the 
functional deterioration observed in the cells at late stages in the differentiation 
was due to a process of degradation of the matrix at Day 9 in the differentiation 
procedure, cells primed towards hepatocyte fate were replated on matrigel 
surfaces coated on the same day (fresh MG) and on surfaces coated with matrigel 
plated at the start of the hepatocyte differentiation procedure (old MG). Cells were 
matured for 15 days and CYP3A activity was measured. Figure 21 shows the analysis 
of the activity in HLCs replated on fresh and old coated matrigel surfaces. A 2.5-fold 
increase in the CYP3A activity was observed in HLCs replated on fresh matrigel 
coated surfaces compared with old matrigel coated surfaces. The values for CYP3A 
in HLCs replated on freshly coated matrigel and old coated matrigel are as follows; 





Figure 24. Immunofluorescence analysis of the dedifferentiation process. The expression of the hepatocyte marker HNF4α and the mesenchymal marker vimentin 
were analysed by immunofluorescence in HLCs at late stages on the differentiation procedure. The increase in the percentage of cells expressing vimentin was 
accompanied by a decrease in the number of cells expressing HNF4α, further supporting the acquisition of a mesenchymal phenotype previously observed on the 
morphology of the cells and indicated by the gene expression analysis. The corresponding IgG controls demonstrated the specificity of the staining. For each condition 
five random fields of view, containing at least 500 cells, were counted. Images were taken at 20x magnification and the scales bar represents 100 µm. Abbreviations: 






Figure 25. Influence of matrigel in the cytochrome P450 CYP3A activity. hESCs-derived 
hepatoblasts were replated on fresh or old plated matrigel and maintained for 15 days. Analysis of the 
CYP3A activity revealed a significant decrease in the activity of cells maintained on matrigel plated 
when hepatocyte differentiation of undifferentiated hESCs started (old plated matrigel) compared with 
the activity on cells maintained on surfaces coated with matrigel on the same day (fresh matrigel) . 
The results represent the mean ± SD of three individual samples per time point per cytochrome P450 
analysed. Levels of significance were measured by student’s t-test where p>0.01 is denoted as **. 
Abbreviations: MG-matrigel. 
In conclusion, these data demonstrate that at late stages in the hepatocyte 
differentiation, there is a dedifferentiation process partially associated with the 
instability of the biological matrix matrigel. 
 
3.3 Discussion 
Freshly isolated human primary hepatocytes represent the current gold standard 
model to study human hepatocyte biology in vitro and to predict in vivo liver drug 
metabolism and clearance (Hewitt and Lechón, 2007; Lin, 2006; Obach, 2009). 
However, the scarcity, low proliferative capacity and high phenotypic and function 
variation of the available human tissues employed in research limit their use in 




order to relieve the dependence on primary hepatocytes other sources of 
hepatocytes have been explored; unfortunately, each individual substitute has their 
disadvantages: the risk of xeno-contaminates and the low concordances between 
animal and clinical studies restrict the use of non-animal hepatocytes (Behnia et al., 
2000; Guillouzo, 1998). Hepatocarcinoma and immortalised human hepatocyte 
derived cell lines display genetic characteristics and minimal metabolic activity that 
limit their use in therapeutic or clinical applications (Iyer et al., 2010); and the 
scarcity, highly inefficient isolation and sub-optimal purification of adult liver 
progenitor cells restrict their use as an alternative source of hepatocytes (Alison et 
al., 2007; Fiegel et al., 2006; Vessey and la M. Hall, 2001).  As such there is an urgent 
need for reliable and predictable hepatocyte in vitro models. 
Human embryonic stem cells (hESCs) have the potential to provide an inexhaustible 
supply of hepatocytes to be used for applications such as developmental biology 
studies, drug discovery, disease modelling and cell therapy (Greenhough et al., 
2010; Rippon and Bishop, 2004; Sharma and Greenhough, 2010). hESCs possess two 
attributes that makes them an alternative source of hepatocytes: the unlimited self-
renewal ability and the pluripotency capacity to differentiate into any cell of the 
human body (Cai et al., 2006; Hoffman and Carpenter, 2005; Vazin and Freed, 
2010). As a consequence, a number of research groups, including ours, have 
invested large amount of time and resources in defining differentiation strategies to 
obtain functional and viable hepatocyte-like cells (HLCs) from pluripotent stem cells.   
The development of the liver is a continuous process. However, the existing 
hepatocyte differentiation approaches from pluripotent stem cells replicate the 
hepatocyte development in discrete stages. In this study, I employed an efficient 
hepatocyte differentiation that recapitulates the development stages observed in 
vivo: definitive endoderm induction, hepatic endoderm specification and 
hepatocyte specification and maturation 
The induction of definitive endoderm occurs during gastrulation in a process that 




FGF, a stimulator of hepatic gene expression and hepatocyte stability via RAS/MAPK 
pathway (Calmont et al., 2006); and BMP/Nodal signalling secreted by the septum 
transversum mesenchyme. BMP/Nodal signalling sustains the complete induction of 
hepatic endoderm, exerting its effect through a number of downstream 
transcription factors including Sox 17, Forkhead box (Fox) A1 and A2 (HNF3α and β) 
and GATA 4-6 (Clements et al., 2003; Kim et al., 2011). Wnt/β-catenin signalling is 
involved in both differentiation and proliferation of pre-hepatic endodermal cells 
(Burke et al., 2006; Fletcher et al., 2008; McLin et al., 2007); and cooperates with 
BMP signalling in the onset of the liver development (Zorn et al., 1999). The 
inductive role of BMP is mimicked in our system by a treatment with Activin A 
(D'Amour et al., 2005) and Wnt3a (Hay et al., 2008a), that induce the expression of 
the transcription factors Sox 17 demonstrating the generation of hESCs-derived 
definite endoderm cells (Cereghini, 1996; Cirillo and Zaret, 1999; Costa et al., 2003).  
Hepatic specification from the definitive endoderm requires conformational 
changes in the chromatin; party induced by the expression of FoxA and GATA 
factors (Cirillo and Zaret, 1999; Cirillo et al., 2002), resulting in the expression in the 
nascent liver bud of hepatic genes including albumin, alpha-fetoprotein and HNF4α.  
This process can be recapitulated in vitro by either using a cocktail of growth factors 
including BMPs and/or FGFs (Agarwal et al., 2008; Brolén et al., 2009; Cai et al., 
2007; Duan et al., 2010; Touboul et al., 2010), or like in this study, by supplementing 
the media with DMSO, either alone (Basma et al., 2009; Duan et al., 2010; Hay et 
al., 2008a) or in combination with other factors (Duan et al., 2010). Consistent with 
in vivo observations, I observed an increase in the expression of important 
transcription factors in the hepatic specification including HNF1β (Lokmane et al., 
2008) and Prox1 (Papoutsi et al., 2007). 
Hepatic specification results in hepatoblast, bipotential cells  capable to 
differentiate into the liver parenchymal cells or hepatocytes (AFP+/albumin+) and 
cells of the biliary tract or cholangiocytes (cytokeratin 19+) (Jung, 1999). These cells 




epithelial cells adhesion molecules E-Cadherin and EpCAM, alpha-fetoprotein and 
cytokeratin 19 (Schmelzer et al., 2006). Still, hepatoblasts lack in the expression of 
specific markers. Therefore, identification of the hepatoblast stage of the cells was 
performed using a panel of markers. Analysis of the cell morphology, gene and 
protein expression profile revealed that hESCs-derived hepatoblasts displayed the 
most hepatoblastic phenotype at Day 8 in the differentiation procedure. 
Nevertheless, due to the bipotential nature of hepatoblasts, analysis of the 
differentiation ability into hepatocyte and cholangiocytes would represent an ideal 
functional assay to determine the hepatoblast phenotype ( Dianat et al., 2014).  
Hepatocyte specification requires the correct balance of a complex cell signalling 
network acting in a gradient manner and involving several reversible developmental 
stages, with oncostatin M (OSM) and hepatocyte growth factor (HGF) playing a key 
role. While OSM promotes hepatocyte maturation and polarisation, HGF promotes 
cell proliferation and induce organisation of hepatocytes into cord-like structures by 
regulating the expression of diphosphate-ribosylation factor 6 (ARF6), an enzyme 
involved in actin cytoskeleton remodelling. TNFα balance OSM and HGF signal 
activities by inhibiting maturation and maintaining the proliferative capacity of 
foetal hepatocytes, thus allowing the liver to grow to the appropriate size before 
differentiating (Kamiya and Gonzalez, 2004). TNFα repression after birth is 
necessary to obtain fully mature hepatocytes expressing cytochrome P450 genes 
(Hart et al., 2009). 
Existent differentiation approaches use combinations these factors, in combination 
with glucocorticoids to induce hepatocyte differentiation and maturation from 
pluripotent stem cells derived hepatoblasts (Basma et al., 2009; Brolén et al., 2009; 
Cai et al., 2007; Duan et al., 2010; Hay et al., 2008a). The expression of the 
hepatocyte nuclear factor 4α (HNF4α) strongly correlates with hepatocyte 
phenotype and plays a key role in hepatocyte function by regulating the expression 
of essential transcription factors involved in the correct development of the foetal 




(Odom, 2004). Hepatocytes express genes involved in the metabolism of xenobiotic 
including several members of the cytochrome P450 enzymes. Consistently with 
previous observantions (Hay et al., 2008a; 2008b), analysis of the HLCs obtained in 
this study revealed the possession of a homogeneous population of cell expressing 
robust hepatocyte lineage markers and hepatocyte function.   
Like in HLCs, dedifferentiation is a common process observed in primary 
hepatocytes in culture (Beigel et al., 2008; Binda and Lasserre, 2003). In order to 
tackle this issue, researchers have developed approaches involving modification of 
the media and/or the cellular environment. 
Supplementation of the media with differentiation promoting factors, of both 
physiological and non-physiological origin, represents the simples approach to 
preserve the correct cell phenotype. Physiological factors such as insulin, 
glucocorticoids and foetal bovine serum (FBS) are commonly used in both primary 
hepatocytes and stem cells derived hepatocytes (Cai et al., 2007; Godoy et al., 2009; 
Szkolnicka et al., 2014; Touboul et al., 2010). It has been reported that 
supplementation of media with insulin or glucocorticoids, including dexamethasone 
and hydrocortisone, promotes cell attachment, display of hepatocyte morphological 
features and secretion of liver specific proteins (Dich et al., 1988; Kim et al., 2001). 
FBS has also been widely used in culturing hepatocyte as it favours epithelial 
identity, cell attachment and survival. However, long-term culture of hepatocyte in 
the presence of FBS compromise cellular polarisation, canaliculi-like network 
stability and the activity of phase I biotransformation enzymes. Moreover, batch-to-
batch variability, fluctuating variability, cytotoxicity of uncharacterised factors 
contained in the serum, including growth factors and the presence of non-animal 
xeno-contaminants can interfere with the cellular function, growth and the 
phenotypic/genotypic stability of the cultures cells (Erickson et al., 1990). In this 
study cytochrome P450 3A (CYP3A) function was used as an indicator of hepatocyte 
function, as this enzyme is responsible of the metabolism of nearly half of the 




function of the cells associated with the batch of FBS serum employed was 
observed, compromising reproducibility between experiments. Therefore, in order 
to tackle this issue I performed a screening to identify serum-free hepatocyte 
differentiation mediums that supported stable hepatic function in vitro. From this 
screening HepatoZYME®-SFM (HZ, Life Technologies) was identified as the most 
suitable media in promoting hepatocyte differentiation from pluripotent stem cells 
(Szkolnicka et al., 2014). HLCs obtained in the serum-free differentiation approach 
displayed increased life-span, mature hepatocyte morphological features, the 
expected gene and protein patterns expression observed during liver development 
and improved and stable metabolic functions. Furthermore, our group has 
previously reported that HLCs obtained using this defined differentiation approach 
can accurately predict human compounds toxicity in a comparable manner to cryo-
preserve human hepatocytes (Szkolnicka et al., 2014). Other approaches have 
recently shown that supplementing the media with vitamin K2 and microbial 
derived licotid acid induces the expression of a mature hepatocyte phenotype with 
improved metabolic functions (Avior et al., 2015).  DMSO represents one of the 
most common non-physiological additives used in preserving hepatocellular 
phenotype. DMSO like glucocorticoids, possesses an anti-dedifferentiation effect by 
promoting polarization of the cells, albumin secretion and an increase in the 
expression of key hepatic transcription factors including C/EBPα, -β, HNF3α, -β and 
HNF4α (Su and Waxman, 2004; Vinken et al., 2006). Shan and collegaues identified 
small molecules from a high-throughput screening platform that induced functional 
proliferation of primary human hepatocytes in culture and promoted the 
maturation of HLCs (Shan et al., 2013). 
Equally important in the stabilization of the hepatocellular phenotype is the 
microenvironment surrounding the cells. Strategies in the modification of the 
extracellular environment include restoration of cell-to-ECM and cell-to-cell 
interactions. Biological matrices such as collagen I or matrigel have been extensively 
used in preserving primary hepatocytes in culture. While matrigel increases the 




(Elaut et al., 2006), collagen I promotes the maintenance of the liver phenotype by 
enhancing hepatocyte attachment and survival (Skett and Bayliss, 1996). It has been 
shown that hepatocytes, via asialoglycoprotein (ASGR), bind to β-galactosidase 
residues (Wall et al., 1980). Based on this knowledge, Ghodsizadeh and colleagues 
developed a galactosylated collagen substrate that supported hepatocyte 
differentiation of hESCs, with cells displaying hepatocyte markers including albumin 
and alpha-fetoprotein, and hepatocyte functions such as albumin secretion, urea 
synthesis and increased cytochrome P450 activity (Ghodsizadeh et al., 2014).  
These effects on the hepatocytes in culture are promoted when these biological 
matrices are used in three dimensional structures (Page et al., 2007; Rowe et al., 
2010; Tuschl and Mueller, 2006). Still, the use of three dimensional matrigel 
structures have a negative impact on the cellular stress response signalling as 
evidenced by a decrease in the mRNA expression of interleukins, chemokines, stress 
related protein kinases and integrin pathways associated genes (Page et al., 2007) 
(Page et al 2007). Still, the biological nature of these matrices compromises the 
consistence and reproducibility of hepatocyte functions.  
Restoration of cell-to-cell interactions represents another possibility to increase the 
stability of the cell cultures, either using a hepatic or non-hepatic partner. Liver 
sinusoidal endothelial cells (LSEC) are the most widespread hepatic partner for 
both, primary hepatocytes and pluripotent stem cell derived HLCs. LSEC secretes 
ECM components that influence the cytoskeleton organization, ultimately 
regulating the expression of liver-specific genes (Kasuya et al., 2010; Kim and 
Rajagopalan, 2010; McCuskey, 2008). Tabeke and colleagues generated vascularized 
and functional liver buds in vitro by combining iPSC-derived HLCs with human 
mesenchymal stem cells and human umbilical vein endothelial cells (HUVECs) 
(Takebe et al., 2013). Fibroblasts secrete ECM components and growth factors, 
including HGF (Hiramatsu et al., 2005), that affect the organization of the 
surrounding environment and the survival of the hepatocytes. Therefore, 




partner used to restore cell-to-cell contact in cultures of hepatocytes (Leite et al., 
2011; Sugimachi et al., 2004) and pluripotent stem cells derived hepatocytes. 
Berger and colleagues developed a culture system using mouse embryonic 
fibroblasts and PSCs derived HLCs embedded in a matrigel and collagen three 
dimensional matrix, observing an improvement in the hepatocyte phenotype and 
metabolic functions (Berger et al., 2015). Ware and colleagues employed a similar 
strategy to generate micropatterned co-cultures that were able to predict drug-
induced liver injury (DILI) (Ware et al., 2015). 
In this study matrigel, which is considered the gold-standard substrate for culturing 
pluripotent stem cells derived somatic cells, was employed as the culture substrate 
to maintain HLCs. The use of a defined hepatocyte maturation media allowed me to 
improve the life span of the cells while promoting hepatocyte phenotype and 
metabolic function. However, as the differentiation approach progressed, HLCs 
underwent a rapid deterioration, both morphological and phenotypic, losing the 
expression of HNF4α and increasing the expression of vimentin, displaying a limited 
life span and cell performance, all of which suggested the existence of a 
dedifferentiation process on the cells. Observations indicated that this rapid 
dedifferentiation process was partly induced by the instability of the biological 
matrix used, matrigel. Matrigel, like animal derived serums, suffers from batch-to-
batch variations and degradation of the components presented in the mixture, thus 
influencing the cell performance. Despite all the recent advantages made in the 
field, the batch-to-batch variations and stability of the biological matrices and 
partner cell strategies compromise the reproducibility, functionality and purity of 
the cell cultures.  
In conclusion, the use of biological matrices to maintain pluripotent stem cell 
derived HLCs in culture influences the reproducibility and phenotypic stability of 
cells. Therefore, it is necessary to identify stable and fully defined cellular supports 
to ensure the delivery of reliable, reproducible, stable and functional somatic cells 




characterisation of a synthetic defined surface to maintain stem cells derived 




























































The use of defined culture systems is important for the generation of reliable 
hepatocytes from pluripotent stem cells. In recent years, the use of the undefined 
and serum containing mouse embryonic fibroblast condition medium have been 
replaced by defined media such as StemPro®, mTeSR1™ and the xeno-free E8™. Still 
the biological derived matrix matrigel is the preferred culture substrate for the 
maintenance of undifferentiated pluripotent stem cells and stem cells derived 
somatic cells (Xu et al., 2001). However, this biological substrate suffers from batch-
to-batch variations and contains xenogenic contaminants that influence cell 
function and phenotype, limiting the large scale manufacture of cells. In an attempt 
to overcome the limitations associated with the use of matrigel, researches have 
focused on developing more defined biological and synthetic substrates to culture 
and differentiate pluripotent stem cells. 
4.1.1 Use of biological defining culture systems in stem cell technology 
Extracellular matrix (ECM) plays crucial roles in the maintenance of cell phenotypes 
(Hazeltine et al., 2013; Noghero et al., 2010). Matrigel has been widely applied in 
the maintenance and differentiation of hPSC. However, its use limits the generation 
of faithful models of human ‘in a dish’ and cell based therapies. Therefore, it is 
necessary to identify more defined substrates for the maintenance and 
differentiation of pluripotent stem cells.  
The replacement of matrigel with a humanised ECM represents the first approach 
developed to solve the animal origin of matrigel. Pakzad and colleagues recently 
described an extracellular matrix designated “RoGel”, made of conditioned medium 
of human fibroblast under serum- and xeno-free culture conditions that supported 
long-term culture of human pluripotent stem cells (hPSC) in the presence of a 
serum containing media (Pakzad et al., 2013). Despite that this humanised ECM 
supported hepatocyte differentiation with HLCs performing in a comparable 




still limited to the availability and variability of the human fibroblasts and the batch-
to-batch variations of the resulting humanised extracellular matrix. 
Other strategies to identify defined substrates to culture and differentiate hPSCs 
are based on the current knowledge of the existing relation between the structure 
and/or composition of the ECM in vivo and the expected biological response. 
Integrins represent the major cell surface receptors mediating ECM adhesion and 
signalling. As such, integrins play a key role in the interactions between cells and the 
surrounding microenvironment. Collagens, laminins, vitronectin and fibronectin 
represent some of the major proteins found in the ECM; therefore, their use 
represents an attractive alternative in the maintenance and differentiation of 
pluripotent stem cells.  
Despite the fact that collagens interact with a wide range of extracellular and cell 
surface receptors linked to pluripotency (Heino, 2007), collagens have shown a 
limited capacity to support long-term cultures of PSCs (Brafman et al., 2010). 
Gelatin, a collagen derived matrix has been successfully applied in the maintenance 
of hPSCs in culture, but still, under the presence of a heavily supplemented serum-
free medium emulating mouse PSC (mPSC) culture conditions. Consequently, PSCs 
display morphology and gene expression more similar to mPSC than their human 
counterparts (Xu et al., 2010).  
Laminins are a group of extracellular matrix proteins that gained the attention of 
research. Laminins are considered the first extracellular proteins expressed in the 
stem cell niche of the early embryo (Cooper and MacQueen, 1983), interacting with 
hPSCs through α6β1 integrin, an important integrin expressed on stem cells 
(Nishiuchi et al., 2006), making laminins attractive substrates to culture hPSCs. As a 
result, Vouristo and colleagues employed the extracellular matrix secreted by the 
human choriocarcinoma cell line JAR, rich in laminins -111 and -511, as a substrate 
to successfully support hPSCs in culture while preserving the pluripotency capacity 
as revealed by the derivation into neuronal- and hepatocyte-like cells (Vuoristo et 




availability and variability of the tumorigenic cell line employed. The production of 
recombinant proteins represents a solution to the use of cells as a source of 
extracellular matrix. Rodin and colleagues successfully employed recombinant 
laminin-511 in maintaining long-term cultures of hPSCs in xeno-free culture 
conditions, with cells displaying greater adhesive properties than on matrigel (Rodin 
et al., 2010). Further studies from the same group demonstrated that the 
combination of the recombinant laminin isoform 521 with E-Cadherin, both 
proteins widely expressed in the ICM, supported both, derivation and clonal survival 
of hESCs in defined and xeno-free conditions (Rodin et al., 2014), resulting in 
improved culture definition. Vitronectin is a protein expressed in both the ECM as 
well as in serum but not in matrigel. Vitronectin also contains integrin binding 
domains, making it an attractive substrate for the maintenance of pluripotent stem 
cells. Braam and colleagues successfully employed recombinant vitronectin 
matrices in the maintenance of three independent hESC lines (Braam et al., 2008). 
Despite the high cost associated to the use of recombinant proteins, these findings 
represent a significant milestone in the culture of hPSCs as they were one of the 
first examples of defined and xenogenic-free substrates 
4.1.2 Use of synthetic substrates in stem cell technology 
Combinatorial strategies involving biological derived substrates with synthetic and 
defined biomaterials represent an alternative strategy for the culture and 
differentiation of hPSCs. Biomaterials can be defined as a material or a combination 
of materials that can be used to repair, treat, or replace tissues or organs in vitro 
and in vivo and can be classified based on their performance and criteria such as 
polymers, metal, ceramics and composites.  
Polymers are an attractive type of biomaterials with wide applications in stem cell 
biology. Polymers are physical networks composed of any polymer (long chains 
composed of monomers subunits) with high relevance in medical applications due 




be presented in different form including solids, fibers, films and gels. Polymers can 
be applied in various dimensions and can be combined or blended with other 
polymers or with biological derived culture substrates.  All these characteristics 
make them an attractive alternative to biological substrates.  
Combination of Poly (lactic-co-glycolic acid) (PLGA) with laminins isolated from 
Engelbreth-Holm Swarm (EHS) sarcoma represents an example of combinatorial 
approach. Gao and colleagues reported that this substrate supported hESC 
attachment in a more robust manner compared to mixtures of PGLA with rat 
collagen I, human collagen IV or human fibronectin. Moreover, this matrix 
efficiently maintained the differentiation capacity of the hESCs revealed by an 
efficient differentiation into definitive endoderm (Gao et al., 2010). Polymers with 
high acrylate content combined with vitronectin successfully maintained the 
pluripotency properties and colony formation of the hESCs for a prolonged period 
of time, revealing the structure–function relationships between the properties of 
the material and the biological performance (Mei et al., 2010). Combinations of 
biological derived and synthetic material have been also applied in the development 
of hepatic co-culture methods. Du and colleagues recently reported a culture 
system consisting on an alginate hydrogel containing fibres rich in galactose and 
collagen domains that successfully supported encapsulation of hPSCs-derived HLCs 
and endothelial cells. The authors observed enhanced albumin production and cell 
engraftment when injected in a recipient liver mouse (Du et al., 2014). Still, the 
biological derived components employed in these combinatorial approaches are 
expensive and the required post-translational modifications of these proteins may 
results in variability between batches, compromising the large scale manufacture of 
the cells (Villa-Diaz et al., 2013). Therefore, other strategies have explored the use 




4.1.3 Defined culture systems 
The bioactive polymer on which hPSC cultures has been most heavily studied is the 
zwitterionic a sulfonil containing polymer poly [2-(methacryloyloxy) ethyl dimethyl-
(3-sulfopropyl) ammonium hydroxide] (PMEDSAH). It is though that the sulfonic 
group mimics heparin sulphate proteoglycans, which are important extracellular 
proteins relevant in hPSC culture systems (Gasimli and Linhardt, 2012; Klim et al., 
2010; Musah et al., 2012). PMEDSAH has been reported to support long-term 
culture of hPSCs (Nandivada and Villa, 2011; Villa-Diaz et al., 2010) and 
mesenchymal stem cells derived from hPSCs  (Villa-Diaz et al., 2012) in a range of 
media but performing more consistently in serum containing media including CM 
and human cell conditioned medium.  
Two-dimensional culture systems require fewer number of cells which can be 
enough in drug screening and diseases modelling. However, it has been shown that 
three-dimensional systems enhance cell proliferation and self-renewal while 
mimicking more accurately the in vivo environment, providing the required higher 
number of cells in large scale and cost effective manner (Postovit et al., 2006; Yim 
and Leong, 2005). Polymers can be also fine-tuned to satisfy the demand in three 
dimensional culture systems. Hydrogels represents an example of such applied on 
stem cell cultures. They are structures composed of cross-linked and hydrophilic 
polymer scaffolds, when exposed to water, they expand into an ECM-like gel state, 
making them to be easily applied in two or three-dimensional structures by varying 
the thickness of the hydrogel. Hyaluronic acid (Gerecht et al., 2007; Liu et al., 2012), 
polyacrylamide-based (Brafman et al., 2009; Zhang et al., 2013) and amino-
propylmethacrylamide hydrogels (Irwin et al., 2011) have been reported to sustain 
long term cultures of hPSCs.  
Li and colleagues described a hydrogel made by crosslinking acrylic acids and 
acrylate peptides as a suitable substrate to support hESC cultures. Due to their 
physical properties, including matrix stiffness and ligand density, the polymer can 




polymers can also be used to explore the biological cues of differentiation 
processes. As such, Yamazoe and colleagues employed a xeno-free three-
dimensional synthetic polyamide nanofiber that promoted hepatocyte 
differentiation and function of hPSCs in a serum–free culture system to study the 
pattern activation of Rac 1 in undifferentiated and during hepatic differentiation of 
hECs. Rac 1 is a member of the Rho GTPase family protein involved in the 
remodelling of the cytoskeleton, which expression is critical for the self-renewal of 
hESCs (Nur, 2005). The findings suggested that continuous activation of Rac 1 
throughout the hepatocyte differentiation stage is crucial for potentiating 
differentiation (Yamazoe et al., 2013).  
Traditional approaches in identifying defined matrices compatible with 
maintenance of pluripotency and differentiation capacities of pluripotent stem cells 
have been traditionally notoriously slow and low throughput. However, in recent 
years high-throughput (HTP) approaches, such as microarraying, have allowed the 
rapid screening of chemically diverse substrates that modulate or control cell 
biology, thus representing an important tool for both novel material discovery and 
identification of correlations between cell performance and structure. 
4.1.4 High-throughput approaches for biomaterials 
Identification of suitable biomaterials for cell biology requires a deep understanding 
of the existing relation between the structure or composition of the desired 
material and the expected biological cell response. However, to date there are not 
enough theoretical basis for predicting cell performance from the physical and 
chemical parameters of a material. Combinatorial chemistry methodologies allow 
the identification of biomaterials for cell applications. These methodologies involve 
the synthesis, processing and screening of vast number of molecules in parallel in 
high throughput formats (Webster, 2008).  
High throughput technologies allow the identification of polymer materials for 




numbers of monomers and combinations of the monomers (Kohn, 2004). 
Microarray, extensively used for genomics by presenting DNA or protein based 
molecules (Heller, 2002; Venkatasubbarao, 2004), represents the preferred format 
for high throughput screening, as a high number of candidate polymers can be 
rapidly screened in parallel for a particular performance in an application of 
interest. 
4.1.4.1 Polymer microarray fabrication 
Microarrays can be formed using a variety of methods including the reproducible 
and versatile methods of contact printing and ink-jet printing.  
Contact printing is the preferred approach in the fabrication of polymer 
microarrays. It involves the dispensing of pre-synthesised polymers using a metallic 
pin coupled to a robot, which dips the metallic pin into the polymer solution and 
then dispensing it onto the substrate surface by making contact. Parameters such as 
the solvent used, substrate, inking time, stamping time, number of stamps per spot 
and washing conditions affect the shape and uniformity of the printed polymers; 
therefore, influencing the quality and reproducibility of the final polymer 
microarray. Materials used as a surface to print the polymers include plastic 
surfaces, glass slides, gold-coated glass slides and aluminium slides. However, the 
‘non-stick’ properties of agarose, known to supress cellular adhesion thus 
preventing nonspecific adhesions, make this substrate the preferred option 
(Tourniaire et al., 2006). Contact printing technology was firstly applied in 
monitoring gene expression of a large library of complementary DNA (Schena et al., 
1995) and adapted to produce a microarray of polymers (Anderson et al., 2004). It 
has been extensively used in a variety of applications including; the maturation and 
phagocytosis of dendritic cells (Mant et al., 2006), identification of resistant  
materials to bacterial infection (Hook et al., 2013; 2012; Pernagallo et al., 2011), 
platelet activation (Hansen et al., 2013) and isolation of mesenchymal stem cells 




Inkjet printing represents an alternative technique to prepare polymer microarrays. 
Inkjet printing mainly differs with contact printing in the synthesis of the polymers. 
While contact printing requires pre-synthesised polymers, inkjet printing dispenses 
monomers and catalysts forming the final polymer on the same position of the 
microarray where the polymerisation reaction will occur. As such, inkjet printing 
possesses advantages in the properties of monomers to use, as non-water soluble 
monomers can be printed in agarose coated glass slides in the presence of organic 
solvents, with polymerisation triggered by UV radiation (Liberski et al., 2008). This 
technique was employed in the preparation of a polymer array from water soluble 
acrylamides and acrylate monomers, where three monomers were deposited 
sequentially in the same spot of the microarray along with a solution containing the 
catalyst, resulting in the creation of an array compromising thirty-six different 
polymer combinations (Zhang et al., 2009). This approach was further employed in 
the creation of an array compromising 609 polymers by printing mixtures of 18 
monomers. From this array, Zhang and colleagues identified a synthetic 
thermoresponsive acrylate based hydrogel that supported long term hESC growth 
and pluripotency, involving reagent-free dissociation passaging in response to a 
reduction in ambient temperature (Zhang et al., 2013). However, despite hESCs 
maintained on this hydrogel displayed karyotypic abnormalities after 21 passages, 
these findings represent a hall mark in the development of xeno-free and fully 
defined hESC culture systems.  
Independently of the technique employed for the preparation of the microarray, 
most of the detection and analysis systems used in the field of polymer microarray 
rely on the use of fluorescence. Scanning of microarrays consisting of a large 
number of polymer spots requires the use of high resolution high-content screening 
systems bases on fluorescence microscope able to analyse rapidly large number of 




4.1.5 Identification of polyurethane 134  
Microarray has been also employed in the identification of polymers compatible 
with hepatocyte differentiation of hPSCs. Hay and colleagues combined an efficient 
hepatocyte differentiation approach (Hay et al., 2008a) with high-throughput 
technologies to identify a synthetic and defined matrix that supported and 
promoted hepatocyte function and viability (Hay et al., 2011). For this purpose, by 
employing contact printing, the authors synthesised a microarray consisting of 380 
polyacrylates and polyurethanes in an agarose coated aminoalkysilane microscope 
slide. hESCs differentiated towards hepatic endoderm on matrigel coated surfaces 
were replated onto the polymer microarray (Figure 26). Cells were culture for a 
further 9 days in the presence of a serum containing medium that supported 
hepatocyte identify and differentiation in vitro. Identification of polymer hits that 
supported cell attachment and albumin production was performed using phase 
contrast microscopy and immunofluorescence.  
 
Figure 26. Polymer microarray fabrication. 
From this screening 3 polyacrylates (2BG9, 9G7 and 3AA7) and 3 polyurethanes 
(134, 212, and 223) were identified as suitable substrates for hepatocyte 




revealed little to none correlation. On the other hand, polyurethanes contained a 
chain extender that seemed essential in cell binding. In addition, polyurethane (PU) 
134 and PU212 were made of the closely related (Poly[1,6-hexanodiol/neopentyl 
glycol/di(ethylene glycol)-alt-adipic acid]diol) (PHNGAD) and (Poly[1,6-
hexanodiol/neopentyl glycol-alt-adipic acid]diol) (PHNAD) respectively, suggesting 
that this common feature is relevant in promoting hepatocyte binding and function. 
Moreover, physical parameters of the polymer such as elasticity and wettability are 
affected by the composition (Thaburet et al., 2003), which has an impact in the 
capacity of the polymer to absorb key extracellular matrix proteins involved in 
hepatocyte function (Hay et al., 2011).  
Further functional characterisation of the HLCs replated on a scaled up version of 
these polymers was performed at Day 14 post-replating. Analysis in the secretion of 
fibrinogen, fibronectin and transthyretin (TTR) identified PU134 as an effective 
cellular matrix which supported superior hepatocyte function when compared to 
HLCs replated onto matrigel surfaces and freshly isolated human primary 
hepatocytes.  
Studies of the signalling pathways activated in HLCs maintained on the PU134 
surface revealed an increase focal adhesion kinase (FAK), Akt and ERK signalling 
pathways when compared to matrigel surfaces, indicating a strong cell attachment 
to the substrate. In addition, enhanced cytochrome P450 1A2 and 3A activity was 
observed in parallel to an increase in the protein levels of cell cycle inhibitors p15 
and p21, suggesting that inhibition of cell proliferation is a requisite to obtain high 
functional HLCs. Moreover, HLCs replated on PU134 surfaces displayed increased 
expression of hepatocyte markers including albumin, hPXR and epithelial markers, 
such as E-Cadherin and N-Cadherin, compared to HLCs maintained on matrigel 
surfaces. This two-dimensional culture platform was successfully translated into a 
three-dimensional structure, by coating a bioartificial liver (BAL) device (Van de 
Kerkhove and Di Florio, 2002) with a solution of PU134. Scanning electron images 




the presence of PU134. This polymer technology was successfully translated to the 
iPSCs. Both, hESCs and iPSCs-derived HLCs generated on PU134 surfaces displayed 
stable cytochrome P450 activity and predicted cellular toxicity in response to 
specific pharmacological compounds in comparable levels than human primary 
material (Medine et al., 2013). 
The identification of this synthetic polyurethane represents a hall mark in 
hepatocyte biology. It is cost-effective, easly scalable and manufacturable for 
clinical purpose, and has shown to be highlyt efficient in promoting hepatocyte 
function when compared with other polyurethanes (Fukuda et al., 2001). The 
possession of a xeno-free, defined and stable substrate that supports and enhances 
hepatocyte function compared with current biological matrices is a requirement if 
stable hPSCs-derived HLCs are going to be applied in drug toxicology process, 
disease modelling and the study of hepatocyte biology. In addition, no batch-to-
batch variation has been observed between different PU134 batches (Medine et al., 
2013), ensuring the delivery of reliable HLCs for downstream applications. 
Therefore, PU134 represents a novel substrate that can be applied in the 
hepatocyte biology field.  
In this chapter, I will describe the optimization procedure performed on the 
polyurethane 134 surface and the combination with a serum- and xeno-free 
differentiation procedure to obtain long-term and functional cultures of HLCs, with 
implications in the stabilization of the hepatocyte phenotype In addition, a deep 
phenotypic and functional characterization of the HLCs obtained in the defined 
substrate will be described. The findings described in this chapter possess 
significant implications with regard to physical and nutritional parameters of 
defined culture systems 
4.2 Results 
The instability associated with the use of undefined biological additives in 




order to tackle this issue, Hay and colleagues performed an interdisciplinary 
approach to identify synthetic and defined polymers to be used as substrata for 
hepatocyte differentiation and maintenance. From a polymer microarray, the 
polyurethane 134 (PU134) was identified as a superior surface to animal derived 
substrates with regard to hepatocyte differentiation and function. 
I subsequently optimised the polymer coated surface and media formulation to 
study the effect on the function and stability of the cells. The resulting population of 
hESCs-derived hepatocyte-like cells (HLCs) were extensively characterised and 
compared to their matrigel counterpart.   
4.2.1 Optimization of the polymer PU134 coated surface 
The optimisation of polymer surface involved the testing of different solvents to 
solubilise the polymer. The topography of the resulting coated surfaces was 
analysed employing atomic force microscopy (AFM) and scanning electron 
microscopy (SEM), and the effect of the surface topography on the cell function was 
measured by analysing the cytochrome P450 3A activity in HLCs  
4.2.1.1 Polymer solvent influences the topography of the polymer coated 
surface 
A correct solubilisation of the polyurethane 134 is essential in order to obtain a 
homogenous coating of the culture surface. For this purpose, I analyzed the 
topography of surfaces coated with solutions of PU134 dissolved in different 
solvents. I solubilized PU134 on chloroform, either alone or in combination with 
toluene and on tetrahydrofuran, either alone or in combination with 
dichloromethane. Following this, I span coated the culture surface. I employed SEM 
and AFM to characterize the topography of the polymer coated surfaces. 
Scanning electron images of the resulting surfaces (Figure 27) showed that the 
coating obtained using toluene or chloroform was not homogeneous, displaying an 




(black and white arrows), indicating a poor solubility of the polymer on these 
solvents. In contrast, the use of tetrahydrofuran as a solvent ensured the spin 
coating of completed and much more uniform surface. 
 
Figure 27. SEM images of different PU134 coated surface conditions. Culture surfaces were 
coated with a 2% solution of PU134 dissolved in different solvents. SEM was employed to study the 
PU134 coated surface obtained with each of the conditions. Representative images of each of the 
conditions show the presence of a homogeneous coated surface with absence of polymer precipitates 
when tetrahydrofuran was used as a solvent, in contrast chloroform alone or in combination with 
toluene (black and white arrows) which delivered unevenly coated surfaces. The images were taken at 
x1664 magnification and the scale bars represent 50 µm. 
In addition to SEM, AFM was employed to study the topography of the coated 
surfaces. AFM three-dimensional images of the different coating conditions 
demonstrated that only PU134 solubilized in tetrahydrofuran delivered regular 
coated surfaces (Figure 27A).  
The root mean square, RMS, and the mean roughness, Ra (peak to peak value) are 
two of the main parameters used in AFM to study the surface roughness. Analysis of 
these two parameters revealed that the polymer surface obtained by using 
tetrahydrofuran alone exhibited a 40% reduction in the roughness measurement 
comparing with the rest of the conditions (Figure 27B-C), confirming the previous 
observations indicating that out of the four solvents tested, tetrahydrofuran is the 





Figure 28. Topography of PU134 surfaces. A) Atomic force microscopy (AFM) images of different 
PU134 coated surfaces. AFM was employed to analyse the roughness of the PU134 coated surface 
using the selected solvents. High-magnification three-dimensional representative images of the 
different coating conditions show the topography of the surfaces, revealing that PU134 solubilised on 
the presence of tetrahydrofuran resulted in a more regular surface compared to the other solvents or 
combination of solvents. Images represent an area of 20 µm x 20 µm. B-C) Roughness measurements 
of different PU134 surface conditions. The roughness of the PU134 surfaces on selected solvents was 
measured using atomic force microscopy. Analysis of the roughness parameters Ra ( the mean 
roughness) (B) and RMS (the root mean square) (C) of the different PU134 surfaces show that the 
coating obtained by using tetrahydrofuran as a solvent possessed the smoothest surface when 
compared with the rest of the conditions. The results represent the mean ± SD of seven individual 
samples per condition. Levels of significance were measured by student’s t-test where p <0.001 is 
denoted as *** in comparison to glass slides coated with PU134 solubilised in tetrahydrofuran. 
Abbreviations: THF-Tetrahydrofuran, C-Chloroform, D+THF: Dichloromethane and Tetrahydrofuran, 
T+C-Toluene and Chloroform. 
4.2.1.2 HLC function in response to topographical changes  
To assess the implications of the different coating conditions on the function of 
HLCs, hESCs-derived hepatoblasts were detached from matrigel surfaces and 
replated onto the different polymer surfaces. Cytochrome P450 3A function was 
tested at 4 days post-replating. A 2 fold increase in CYP3A activity was observed in 




HLC metabolic activity is improved with a more uniform coating of PU134. 
Consequently, the optimised surface was used in all further experiments. The values 
for CYP3A for tetrahydrofuran, chloroform, dichloromethane/tetrahydrofuran and 
toluene/chloroform are as follows; 4,703 RLU/ml/cm2, 1,737 RLU/ml/cm2, 2,258 
RLU/ml/cm2 and 1,074 RLU/ml/cm2, respectively. 
 
Figure 29. HLC function is topology dependent. Measurement of cytochrome P450 3A activity in 
HLCs maintained on the different surfaces 96 hours post-replating. Units of activity are expressed as 




 of culture surface. The results represent the mean ± SD of six 
individual samples per condition. Levels of significance were measured by student’s t-test where 
p<0.05 is denoted as *, p<0.01 is denoted as ** and p <0.001 is denoted as *** in comparison to 
HLCs maintained on slides coated with PU134 solubilised on tetrahydrofuran. Abbreviations: THF-
Tetrahydrofuran, C-Chloroform, D+THF: Dichloromethane and Tetrahydrofuran, T+C-Toluene and 
Chloroform. 
4.2.1.3 Surface sterilisation impacts on the supportive properties of the 
polymer 
Following the optimisation of the polymer coated surface, we analysed the effect of 
different polymer surface sterilisation procedures on the topography of the coated 
surfaces and measured their implications in cell function. For this purpose, PU134 
surfaces were exposed to UV (UV-radiation) or gamma irradiation (γ-radiation) and 
the effect of these sterilisation treatments on the topography of the coated 




on the cell function in HLCs was analysed by measuring the cytochrome P450 3A 
activity.      
Phase contrast images of PU134 surfaces showed no gross differences in polymer 
coating post UV or gamma irradiation (Figure 30A). These observations were further 
confirmed by SEM analysis (Figure 30B). The biological performance of PU134 was 
examined by analysing cytochrome P450 3A activity in HLCs at Day 10 post-
replating. Analysis of the function displayed a 3-fold increase in the activity in cells 
replated on γ-radiated polymer surfaces over cells replated on UV-radiated PU134 
surfaces (Figure 31). These observations demonstrated that gamma-irradiation 
represents the optimal sterilisation technique. The values for CYP3A for γ-radiated 
or UV-radiated polymer coated surfaces are as follows; 6,590 RLU/ml/cm2 and 
2,042 RLU/ml/cm2 respectively. The optimised surface was used in all subsequent 
experiments. 
 
Figure 30. Polymer sterilisation. A) Phase contrast images of the PU134 surface after UV-radiation 
and γ-radiation show no gross differences on the PU134 surfaces between both treatments. Images 




(SEM) images of the polymer surface after UV-radiation and γ-radiation show no gross differences 
between both sterilisation treatments, confirming the previous observations. The images were taken at 
x1664 magnification and scale bar represents 50 µm. 
 
Figure 31. Functional changes in HLCs following polymer sterilization. Measurement of the 
cytochrome P450 3A activity in HLCs maintained for 10 days on PU134 surfaces sterilized by either 
using UV-radiation or γ-radiation shows a 3.3-fold increase in cytochrome activity in HLCs 
maintained on γ-radiated PU134 surfaces when compared with HLCs maintained on UV-radiated 




 of culture 
surface. The results represent the mean ± SD of three individual samples per condition. Levels of 
significance were measured by student’s t-test where p<0.001 is denoted as ***. 
4.2.2 Optimization of the cellular replating onto polymer coated surface 
Previously we have shown the inherent functional variability associated with the 
use of serum containing media in HLCs, making reproducibility between 
experiments difficult (Figure 16, chapter 3). As a result, I developed a serum-free 
differentiation approach to obtain highly functional, reproducible and reliable HLCs 
from pluripotent stem cells using matrigel surfaces as a culture substrate. 
I translated this technology to PU134 surfaces, obtaining functional HLCs on a fully 
defined environment. However, cells were functional and viable on the PU134 
surfaces for up 10 days post-replating; when cell detachment and death could be 
observed (Figure 32, panels A-C). These observations were not detected when we 
used matrigel surfaces, indicating the presence in matrigel of essential supporting 




increase the life span of the cells while maintaining the serum-free environment, I 
added Knock-Out Serum Replacement (KOSR) to the replating media. 
4.2.2.1 Morphological analysis of HLCs 
Images of the HLCs were taken at Day 8, 12 and 16 post-replating. Phase contrast 
images of the cells (Figure 32) showed that in either condition, PU134 surfaces 
supported the attachment of the cells, displaying typical features of cultured 
hepatocytes in vitro (panels A and D). However, at Day 12 post-replating, the 
absence of KOSR in the medium compromised the viability of HLCs. Hepatic 
morphology began to disappear, with cellular detachment observed (panels B and 
C). Addition of KOSR preserved the integrity of the culture, enhancing hepatocyte 
morphological features, including canaliculi-like structures by Day 12 post-replating 
(panel E, white and black arrows) and the presence of binucleate cells by Day 16 
post-replating (panel E, black arrows)  
       
Figure 32. KOSR supports long term HLC culture on PU134 surfaces. hESCs-derived hepatoblast 
were replated onto PU134 surfaces in the presence of the defined maturation media with or without 
Knock-Out Serum Replacement (KOSR). Phase contrast images of the cells show that by Day 8 post 
replating, the HLCs were attached to the substrata in both conditions with cells displaying typical 
hepatocyte features. In the absence of KOSR and by Day 12 post-replating, HLCs rounded up and 




surfaces with cells displaying typical hepatocyte features such as canaliculi-like structures (white and 
black arrows) and the presence of binucleate cells (black arrows) by Day 16 post-replating. The 
images were taken at 10x magnification and the scale bar represents 100 µm. 
4.2.2.2  Functional characterisation of HLCs 
In addition to morphological analysis, I investigated the metabolic function of the 
cells replated on PU134 surfaces under both conditions. Cytochrome P450 3A and 
1A2 functions in HLCs were examined at Day 8, 12 and 16 post-replating (Figure 33). 
Analysis of the CYP3A activity (Figure 33A) revealed comparable levels of metabolic 
activity in HLCs at Day 8 post-replating independently of the addition of KOSR. 
However, as the differentiation progressed, I observed lower levels of CYP3A 
function without KOSR supplementation. In contrast, in the presence of KOSR 
CYP3A activity increased by 8.6-fold by Day 12 post-replating and maintained at 
least until Day 16 post-replating. The values for CYP3A in the absence or presence of 
KOSR are respectively as follows; 6,951 RLU/ml/cm2 and 18,351 RLU/ml/cm2 at Day 
8 post-replating; 4,428 RLU/ml/cm2 and 158,790 RLU/ml/cm2 at Day 12 post-
replating and; 0 RLU/ml/cm2 and 158,351 RLU/ml/cm2 at Day 16 post-replating. 
Analysis of the CYP1A2 activity (Figure 33B) showed lower levels of CYP1A2 activity 
without KOSR supplementation at Day 8 post-replating and maintained until Day 12 
post-replating. In contrast, in the presence of KOSR, CYP1A2 activity increase 2.4-
fold at Day 12 post-replating and remained stable at least until Day 16 post-
replating.  The values for CYP1A2 in the absence or presence of KOSR are 
respectively as follows; 577 RLU/ml/cm2 and 4,795 RLU/ml/cm2 at Day 8 post-
replating; 580 RLU/ml/cm2 and 11,200 RLU/ml/cm2 at Day 12 post-replating and; 0 
RLU/ml/cm2 and 12,536 RLU/ml/cm2 at Day 16 post-replating. 
These data demonstrate that the addition of Knock-Out Serum Replacement (KOSR) 
to the free serum maturation medium enhances cell attachment, cell morphology 
and possesses a clear effect on the cytochrome P450 function of HLCs. As a result, 






Figure 33. Addition of KOSR supports cytochrome P450 function in HLCs. Cytochrome P450 
CYP3A (A) and CYP1A2 function (B) were assessed using the pGLO™ system on PU134 surfaces in 
the presence of the serum-free maturation media with or without Knock-Out Serum Replacement at 
Day 8, 12 and 16 post-replating. Analysis of the function of the cells revealed an increase in the 
activity of both CYP3A and CYP1A2 in media supplemented with KOSR, and this activity was 
maintained by Day 16 post-replating.  Media without KOSR did not support the activity on the cells 





culture surface. The results represent the mean ± SD of three individual samples per time point per 
cytochrome P450 analysed. Representative experiment is displayed. Levels of significance were 
measured by student’s t-test where p<0.001 is denoted as *** and p<0.05 is denoted as *. 
4.2.3 Cell performance is improved on PU134 surfaces compared with 
other biological substrates 
Collagen, fibronectin and laminin are the main extracellular matrix (ECM) 
components found in the liver. I investigated HLCs on those matrices and compared 
with HLCs differentiated on matrigel and PU134 surfaces. For this purpose, hESCs-
derived hepatoblasts were lifted and replated onto surfaces coated with collagen I, 
fibronectin and a mixture of the major types of laminins found in the human body. 
Following this, hepatocyte differentiation continued for 15 days.  
Phase contrast images of the HLCs on each substrate revealed that cell attachment 
was supported in all substrata, but with differences in the cell morphology (Figure 
34A). HLCs maintained on collagen I or laminin surfaces displayed a defined nucleus 
surrounded by a dense cytoplasm, resembling mature primary hepatocytes in 
culture (white and black arrows), with certain grade of cell morphological 
heterogeneity observed. HLCs on fibronectin surface exhibited a morphological 




morphological features, suggesting that fibronectin did not support an efficient 
hepatocyte differentiation. HLCs on matrigel displayed typical hepatocyte 
morphology. Finally, HLCs obtained on PU134 surfaces displayed characteristic 
hepatocyte morphology features and high morphological homogeneity with the 
presence of canaliculi-like structures (black arrows).  
In addition to morphological analysis, I investigated the metabolic function of the 
HLCs replated on the different surfaces. For this purpose I measured cytochrome 
P450 3A function at Day 15 post-replating (Figure 34B) as it represents the major 
P450 acitivity of the cells. No other functional measurements were performed. 
Analysis of the metabolic function revealed that HLCs maintained on PU134 
surfaces displayed the highest CYP3A activity, with a 3.6 and 4.3-fold increase 
compared with HLCs maintained on fibronectin or laminin respectively; and 8 and 
9.5-fold increase compared with HLCs replated on collagen I and matrigel 
respectively, indicating that morphology is not always a good indicator of the 
hepatic function. The values for CYP3A in HLCs maintained on collagen I, 
fibronectin, laminin, matrigel and PU134 surfaces are respectively as follows; 
1,24x105 RLU/ml/mg, 2,80x105 RLU/ml/mg, 2,3x105RLU/ml/mg, 1,05x105 




Figure 34. Improved cell performance on PU134 compared with other biological substrates. A) 
Phase contrast images of HLCs maintained on different biological matrices and PU134 surfaces. 
HLCs were replated in the serum-free maturation media supplemented with KOSR on biological 
matrices made out the major components of the extracellular matrix of the liver, on matrigel or on 
PU134 surfaces. Phase contrast images of HLCs at Day 15 post-replating revealed that all the tested 
substrates supported cell attachment but with cells displaying different morphology depending on the 
substrata. The acquisition of typical hepatocyte morphological features was displayed more notorious 
on collagen I, laminin and especially on PU134 surfaces. The images were taken at 10x magnification 
and scale bar represents 100 µm. B) CYP3A activity in HLCs is improved on PU134 surfaces 
comparing with biological substrates. The analysis of the hepatocyte cytochrome P450 function 3A in 
HLCs replated on different biological substrates and PU134 surfaces was assessed using the pGLO 
system, revealing an increase in the functional capacity of the cells when PU134 surfaces were used as 
substrate. An increase in the activity on PU134 surfaces between 3.6 and 9.5 fold compared with the 
rest of the substrates was observed. The results represent the mean ± SD of five individual samples per 
condition. The significance between differences in function of the cells replated on the different 
matrices was measured using ANOVA, and denoted on the graph by an asterisk (*). Abbreviations: C 




4.2.4 Detailed characterization of the hepatocyte differentiation on 
PU134 versus matrigel surfaces 
As matrigel is considered the current ‘gold standard’ substrate to maintain PSCs-
derived HLCs, I performed an extensive characterisation of HLCs obtained on PU134 
surfaces and compared them with their matrigel counterparts. For this purpose, 
hESCs-derived hepatoblasts were replated onto matrigel or PU134 surfaces in the 
presence of the serum-free maturation media containing KOSR. The resulting 
population of cells were extensively characterised at different times during the 
differentiation procedure (Figure 35). 
Figure 35. Flow diagram of the hepatocyte differentiation protocol on PU134 surface. H9 hESCs 
are primed towards the hepatic endoderm cells using an efficient differentiation protocol. hESCs-
derived hepatoblasts at Day 9 on matrigel (MG) are replated on PU134 surfaces using a serum-free 
replating approach. Hepatocyte maturation on PU134 surface is induced using a serum-free 
maturation media supplemented with KOSR. Abbreviations hESC– human embryonic stem cells; 
KOSR- Knock-Out Serum Replacement; HZM-HepatoZYME-SFM; EGF-Epithelial Growth Factor; 
HGF – Hepatocyte growth factor; OSM – Oncostatin M. 
4.2.4.1 Morphological analysis of HLCs on PU134 and matrigel surfaces 
Morphological analysis of HLCs replated on matrigel or PU134 surfaces was 
performed at Day 5, 10, 15 ,20 and 25 post-replating in the differentiation approach 
(Figure 36). Phase contrast images of the resulting population of HLCs showed that 
both substrata supported cell attachment. At Day 5 and 10 post-replating there 
were no gross differences in the morphology of the cells replated on either 
substrate. The compacted and homogeneous resulting population of cells displayed 
a hexagonal morphology, with well-defined nucleus and clear cell-to-cell contacts, 
all features of primary hepatocytes in culture (panels A-B, F-G). As the 




these hepatocyte characteristics, displaying a morphological heterogeneity, with 
cells rounding up and detaching (white arrows panels C-E). However, on PU134 
surfaces, cell morphology was improved. Hepatocyte morphological features were 
preserved up to 25 days post-replating, with cells displaying canaliculi-like 
structures (black arrows, panels H-J). 
4.2.4.2 Gene expression profile in HLCs on PU134 and matrigel surfaces  
To further characterise HLCs obtained on PU134 and matrigel surfaces, I measured 
the gene expression of hepatocyte markers (albumin, HNF4α and alpha-
fetoprotein), and the epithelial marker E-Cadherin at Day 5, 10, 15, 20 and 25 post-
replating by quantitative PCR. The gene expression profile is shown in Figure 37.  
No significant differences were observed in the albumin gene expression (panel A) 
between either substrate until Day 20 post-replating, when a 2-fold increase in HLCs 
maintained on PU134 surfaces compared with matrigel surfaces was observed 
(p<0.001). Following this, albumin gene expression could not be detected on 
matrigel surfaces at Day 25 post-replating, while it was still expressed on PU134 
surfaces. 
Hepatocyte nuclear factor 4α, HNF4α, gene expression (panel B) was stabilised in 
HLCs replated on PU134 surfaces in comparison with matrigel surfaces. By Day 20 
post-replating, there was 2-fold increase in the gene expression on PU134 surfaces 
compared with matrigel surfaces (p<0.001). Following this, 2-fold decrease in the 
gene expression on PU134 surfaces at Day 25 post-replating was observed.  
Day 10 post-replating represented the peak in the gene expression of alpha-
fetoprotein for either substrate (panel C), with a 2.3-fold increase on matrigel 
surface compared with PU134 surfaces (p<0.001). Following this, independently on 
the substrate, there was a dramatic decrease in the gene expression (5-fold and 2-
fold at Day 15 post-replating on matrigel or PU134 surface, respectively) with no 




replating, a 1.6-fold increase was observed in HLCs maintained on matrigel surfaces 
compared with PU134 surfaces (p<0.05). 
The pattern in the gene expression of E-Cadherin followed a similar trend 
independently of the substrate. As the differentiation progressed, a decrease in the 
gene expression was observed, but more denoted on matrigel surfaces (panel D). At 
Day 15 post-replating, a 1.7-fold increase in the gene expression on PU134 surfaces 
compared with matrigel surfaces was observed (p<0.01). The increased gene 
expression detected on PU134 surfaces compared with matrigel surfaces was 
maintained at late stages in the differentiation procedure, with 2 and 1.6-fold 
increase at Day 20 and 25 post-replating respectively ( p<0.001). 
In conclusion, analysis in the gene expression of hepatocyte and epithelial markers 
indicated that PU134 surfaces preserve the hepatocyte phenotype in HLCs for 
longer time, suggesting the existence of an anti-dedifferentiation strategy 





Figure 36. Combining serum-free differentiation with polymer surfaces. hESCs-derived hepatoblast at Day 9 in the differentiation protocol were removed from the 
culture substrate and replated onto matrigel (MG) or PU134 surfaces (PU134). Phase contrast images showed the morphology of HLCs at different days post-replating 
on either substrate. Independently of the substrate, the resulting homogeneous and compacted population of HLCs displayed by Day 10 post-replating typical 
hepatocyte morphological features, denoted by the acquisition of a more defined nucleus, with cells displaying  a hexagonal morphology and an increase in the cell-to-
cell contact, resembling to cultures of human primary hepatocytes. As differentiation progressed, cells maintained on matrigel surfaces underwent a morphological 
deterioration denoted by a gradual loss of these hepatocyte morphological features and the acquisition of a morphological heterogeneity. The life span of HLCs 
maintained on PU134 surfaces was improved, with enhanced expression of morphological features denoted by the presence of canaliculi-like structures, indicating the 




 Figure 37. Hepatocyte gene expression. The gene expression of hepatocyte markers (Albumin, 
HNF4α, α-fetoprotein) and the epithelial marker E-Cadherin in HLCs maintained on matrigel (MG) or 
PU134 surfaces at Day 5, 10, 15, 20 and 25 post-replating were analysed by quantitative PCR. 
Relative expression refers to fold of induction over hESCs-derived hepatoblast at Day 9 and 
normalised to the housekeeping gene GAPDH. The results represent the mean ± SD of three different 
samples run, each run in triplicate. Levels of significance were measured by student’s t-test where 
p<0.05 is denoted as *, p<0.01 is denoted as ** and p<0.001 is denoted as ***, compared with HLCs 
on MG at the same time points. Abbreviations: HNF4α-Hepatic Nuclear Factor 4α. 
4.2.4.3 Investigating the dedifferentiation stage of HLCs 
Long-term maintenance of stable HLCs in culture is essential if cells are going to be 
employed in research and clinical applications. For this purpose, I assessed the 
dedifferentiation state of the cells maintained on PU134 or matrigel surfaces by 
studying the expression of a well-established hepatocyte marker, HNF4α, and the 
mesenchymal marker vimentin. 
The protein expression of the hepatocyte nuclear factor 4α, HNF4α, was analysed 




showed that independently of the culture substrate employed, at early stages in the 
differentiation protocol most of the HLCs stained positive for HNF4α, as 92% and 
93% of the cells by Day 5 post-replating expressed the protein on matrigel or PU134 
surfaces respectively, increasing to 94% and 95% respectively by Day 10 post-
replating. The presence of PU134 stabilised the expression as the differentiation 
progressed, as 91% and 85% of the cells remained positive at Day 15 and Day 20 
post-replating respectively. However, on matrigel surfaces the expression 
significantly declined and while 78% of the cells still expressed HNF4α by Day 15 
post-replating, only 22% of the cells remained positive by Day 20 post-replating, 
representing 4-fold decrease compared with PU134 surfaces. By Day 25 post-
replating, HNF4α expression was practically absent on matrigel (6% of the cells still 






Figure 38. Immunofluorescence analysis of HNF4α in HLCs. HLCs maintained on matrigel (MG) or PU134 surfaces were collected and fixed throughout the 
differentiation protocol and the expression of the hepatocyte specific lineage transcription factor HNF4α was analysed by immunofluorescence. Results show the 
percentage yield of HLCs expressing HNF4α on either substrate. HNF4α expression was gradually lost in cell maintained on matrigel surfaces and by Day 20 post-
replating 22% of cells still expressed the transcription factor. HNF4α expression remained constant in HLCs maintained on PU134 surfaces, with 4-fold increase in the 
percentage of cells still staining positive by Day 20 post-replating (85%). The corresponding IgG isotype controls demonstrated the specificity of the staining. For each 
condition five random fields of view, containing at least 500 cells, were counted. Images were taken at 20x magnification and the scales bar represents 100 µm. 




These observations were further confirmed by Western Blot. The expression of 
HNF4α in HLCs replated on matrigel surfaces rapidly decreased after Day 10 post-
replating, disappearing by Day 25 post-replating (Figure 39A), while in HLCs replated 
on PU134 surfaces, the expression was maintained up to Day 20 post-replating and 
could be detected by Day 25 post-replating (Figure 39B). Yet, despite Western Blot 
observations supported immunofluorescence analysis, the lower amount of HNF4α 
detected by Western blot compared with immunofluorescence suggested that the 
efficiency of the antibody employed varies with the protein conformation, being 
more efficient against the naïve conformation (immunofluorescence) than unfolded 
conformation (Western Blot).  
 
Figure 39. Analysing HNF4α expression by Western blotting. Cell extracts were collected 
throughout the differentiation protocol and probed with HNF4α antibody using standard western 
blotting. Panel A displays HLCs maintained on matrigel surfaces and panel B displays HLCs 
maintained on PU134 surfaces. As previously observed by immunofluorescence, there was a decrease 
in the expression of HNF4α in cell maintained on matrigel coated surfaces as the differentiation 
progressed, while the expression was maintained constant throughout the differentiation process on 
the presence of PU134 surfaces. β-actin was used as a loading control. Abbreviations: HNF4α-
Hepatocyte nuclear factor 4α. 
The expression of the mesenchymal marker vimentin was analysed by 
immunofluorescence (Figure 40), revealing that at Day 5 post-replating, 36% and 
20% of the cells expressed vimentin on matrigel and PU134 surfaces respectively. 
The percentage of cells replated on matrigel surfaces expressing the mesenchymal 
marker rapidly increased as the differentiation progressed, and by Day 10 post-
replating, there was a ≈2-fold increase in the percentage yield of positive cells, 
reaching 63% and 78% by Day 15 and 20 post-replating respectively. By Day 25 post-




expression of vimentin was delayed. By Day 10 post-replating 23% of HLCs stained 
positive for the protein, reaching 27% and 35% at Day 15 and 20 post-replating. 
However, at late stages in the differentiation approach, 80% of HLCs replated on 
PU134 surfaces expressed vimentin. Analysis in the expression of HNF4α and 
vimentin indicate that PU134 surfaces promote the maintenance of the hepatocyte 






Figure 40. Immunofluorescence analysis of vimentin expression. The expression of the mesenchymal marker vimentin in HLCs maintained on either substrate at 
different time points on the differentiation procedure was analysed by immunofluorescence. Results showed a gradual increase in the percentage of cells maintained on 
matrigel surfaces expressing vimentin as the differentiation progressed, with most of the cells staining positive for the mesenchymal marker by Day 20 post-replating. 
Vimentin expression remained constant throughout the differentiation protocol in HLCs maintained on PU134 surfaces, with a 2-fold decrease in the percentage of 
cells staining positive by Day 20 post-replating compared with cells maintained on matrigel surfaces. The corresponding IgG isotype controls demonstrated the 
specificity of the staining. For each condition five random fields of view, containing at least 500 cells, were counted. Images were taken at 20x magnification and the 




4.2.4.4  Protein expression of hepatocyte markers in HLCs on PU134 and 
matrigel surfaces 
To further characterised the HLCs obtained in the defined polymer surfaces, in addition 
to gene expression analysis, I investigated the protein expression of hepatocyte 
markers including albumin, alpha-fetoprotein, cytochrome P450 3A (CYP3A) and 2D6 
(CYP2D6) by immunofluorescence and Western blotting. HLCs replated on matrigel or 
PU134 surfaces were fixed and stained at Day 5, 10, 15, 20 and 25 post-replating.  
Analysis in the percentage yield of HLCs staining positive for the hepatocyte marker 
albumin (Figure 41), showed that at Day 5 post-replating, 17% and 28% of the cells 
maintained on matrigel or PU134 surfaces respectively expressed albumin. This 
percentage increased at Day 10 post-replating as 44% and 89% of the cells stained 
positive on matrigel or PU134 surfaces respectively. The expression stabilised on 
PU134 surfaces as 91% and 86% of cells stained positive at Day 15 and 20 post-
replating respectively. The peak in the expression of albumin on matrigel surfaces was 
reached at Day 15 post-replating as 82% of the cells stained positive, before a 2-fold 
decrease by Day 20 post-replating as 43% of the cells expressed albumin. At Day 25 
post-replating only 12% of HLCs remained positive on matrigel surfaces compared with 





Figure 41. Immunofluorescence analysis of albumin expression in HLCs. HLCs maintained on matrigel (MG) or PU134 surfaces were fixed throughout the 
differentiation protocol and the expression of the hepatocyte marker albumin was analysed by immunofluorescence. Results show the percentage yield of HLCs 
expressing albumin on either surface. While the percentage of cells staining positive for albumin decreased at late stages of the differentiation on matrigel surface, on 
PU134 surfaces the percentage of positive cells remained constant for most of the differentiation process with a 2-fold increase at Day 20 post-replating (86%) 
compared with cells maintained on matrigel surfaces (43%). The corresponding IgG isotype controls demonstrated the specificity of the staining. For each condition 
five random fields of view, containing at least 500 cells, were counted. Images were taken at 20x magnification and the scales bar represents 100 µm. Abbreviations: 




The immunofluorescence observations were further confirmed by Western Blot (Figure 
42). On matrigel surface (Figure 42A) the peak in the albumin expression was reached 
at Day 15 post-replating, followed to a reduction by Day 20 and Day 25 post-replating. 
However, in HLCs replated on PU134 surfaces (Figure 42B) there was a stabilisation in 
the expression of albumin up to Day 25 post-replating.  
 
 Figure 42. Assessing albumin expression by Western blotting. Cell extracts were collected throughout 
the differentiation protocol and probed with albumin antibody using standard western blotting. Panel A 
displays HLCs maintained on matrigel surfaces and panel B displays HLCs maintained on PU134 
surfaces. As previously observed by immunofluorescence, there was a decrease in the expression of 
albumin on matrigel surfaces as the differentiation progressed, while the expression was maintained 
constant throughout the differentiation process on PU134 surfaces. β-actin was used as a loading control. 
Abbreviations: ALB-Albumin.  
The expression of the foetal hepatocyte marker alpha-fetoprotein (AFP) was 
investigated by immunofluorescence (Figure 43). Results showed that on either 
substrate, by Day 5 post-replating, 72% of the cells stained positive for this protein. 
The percentage yield of HLCs further increased to 83% at Day 10 post-replating on 
matrigel surfaces while it began to decrease on PU134 surfaces (69%). As the 
differentiation progressed, there was a decrease in the percentage of cells staining 
positive, in a steadier manner on PU134 surfaces as 47%, 22% and 9% of the cells 
stained positive at Day 15, 20 and 25 post-replating respectively, while on matrigel 
surfaces, the percentage of cells expressing alpha-fetoprotein was reduced to 32%, 






Figure 43. Analysing α-fetoprotein expression. The expression of the foetal hepatocyte marker alpha-fetoprotein in HLCs maintained on matrigel (MG) or PU134 
surfaces was investigated by immunofluorescence. Results showed that each condition generated similar levels of HLCs expressing alpha-fetoprotein, and the presence 
of this protein decreased as the differentiation progressed. The corresponding IgG isotype controls demonstrated the specificity of the staining. For each condition five 
random fields of view, containing at least 500 cells, were counted. Images were taken at 20x magnification and the scales bar represents 100 µm. Abbreviations: AFP- 




In addition to analysing the expression of these hepatocyte markers, the expression of 
the hepatocyte specific cytochrome P450s, CYP3A and CYP2D6 in HLCs replated on 
matrigel or PU134 surfaces were investigated in at different times during the cell 
differentiation by immunofluorescence.  
Analysis of the percentage yield of cells expressing CYP3A (Figure 44) revealed that as 
the differentiation progressed, the percentage of HLCs replated on matrigel surfaces 
expressing CYP3A decreased. The initial 85% of the cells expressing CYP3A at Day 5 
post-replating, decreased to 80%, 68% and 44% by Day 10, 15 and 20 post-replating, 
respectively. However, in cells maintained on PU134 surfaces, at Day 5 post-replating 
65% of the cells stained positive. This percentage rapidly increased and by Day 10 post-
replating 86% of the cells expressed the protein. The expression was maintained up to 
Day 20 post-replating, when 88% of the cells stained positive (2-fold increase 
compared with matrigel surfaces). By Day 25 post-replating, the expression of the 
protein dramatically decreased on matrigel surfaces, as 9% of the cells stained positive 





Figure 44. Monitoring the expression of CYP3A. Immunofluorescence was used to study the percentage yield of HLCs expressing the functional hepatocyte marker 
CYP3A throughout the differentiation protocol on either surface.  While CYP3A expression in HLCs maintained on matrigel surfaces was gradually lost as the 
differentiation progressed, disappearing after Day 20 post-replating; in HLCs maintained on PU134 surfaces there was a stabilisation in the expression as its presence 
remained constant throughout the differentiation process, with a 2-fold increase in the percentage of cells expressing CYP3A by Day 20 post-replating compared with 
matrigel coated surfaces. The corresponding IgG isotype controls demonstrated the specificity of the staining. For each condition five random fields of view, 
containing at least 500 cells, were counted. Images were taken at 20x magnification and the scales bar represents 100 µm. Abbreviations: CYP3A-Cytochrome P450 




The pattern of the expression was similar for CYP2D6 (Figure 45). From an initial 67% 
and 60% of the cells expressing CYP2D6 at Day 5 post-replating on matrigel and PU134 
surfaces respectively, the percentage increased, reaching a peak of 96% and 94% by 
Day 10 post-replating, respectively. The expression stabilised by Day 15 post-replating 
before a further decrease at Day 20 post-replating when 82% and 85% of the cells 
replated on matrigel or PU134 surfaces respectively stained positive. However, by Day 
25 post-replating only 16% of HLCs replated on matrigel surfaces still expressed the 
protein in contrast to 55% of the cells on PU134 surfaces. 
The analysis in the expression of hepatocyte markers indicated that, in line with the 
reduced dedifferentiation process observed, PU134 surfaces promote the stabilisation 





Figure 45. Analysis of CYP2D6. The expression of the functional hepatocyte marker CYP2D6 in HLCs throughout the differentiation protocol on either substrate was 
analysed by immunofluorescence. Results showed that each condition generated similar levels of HLCs expressing CYP2D6, and the presence of this protein 
dramatically decreased on matrigel surfaces by Day 25 post-replating (16%), while more than half of the cells maintained on PU134 surfaces still expressed CYP2D6 
(55%). The corresponding IgG isotype controls demonstrated the specificity of the staining. For each condition five random fields of view, containing at least 500 cells, 




4.2.4.5 Analysis of cell proliferation in HLCs on PU134 and matrigel surfaces 
To define the cell proliferation in the cultures, I studied the expression of Ki67, a 
robust proliferative marker in cell biology (Scholzen et al 2000). Protein expression was 
examined by immunofluorescence (Figure 46). Analysis of the percentage yield of HLCs 
expressing Ki67 revealed that at Day 5 post-replating 40% and 28% of cells stained 
positive on matrigel and PU134 surfaces respectively. Independent of the substrate, 
there was a 2-fold decrease by Day 10 post-replating, followed by further ≈2-fold 
decrease (6%) on PU134 surfaces, while the yield percentage remained still on matrigel 
surfaces. By Day 20 post-replating, 5% and 6% of the HLC on matrigel and PU134 
surfaces respectively still expressed the proliferative marker. Cell proliferation was not 






Figure 46. Analysis of cell proliferation. The expression of the proliferative marker Ki67 in HLCs maintained on either substrate was analysed by 
immunofluorescence. Results showed that on PU134 surfaces the percentage of cells expressing Ki67 dramatically reduced at early stages on the differentiation 
process when compared with matrigel surfaces (28% by Day 5 post-replating on PU134 surfaces vs 40% on matrigel surfaces). At late stages in the differentiation 
process, there were not significant differences in the percentage yield of HLCs expressing Ki67 on either substrate. The corresponding IgG isotype controls 
demonstrated the specificity of the staining. For each condition five random fields of view, containing at least 500 cells, were counted. Images were taken at 20x 




4.2.4.6 Characterization of the polarisation markers in HLCs on PU134 and 
matrigel surfaces 
The maintenance of the epithelial hepatocyte phenotype and function requires a 
correct cell-to-cell contact (Treyer et al, 2013). Previous observations by 
immunofluorescence indicated that PU134 surfaces stabilised the expression of the 
hepatocyte phenotype, suggesting the maintenance of cell-to-cell contacts. Therefore, 
I aimed to explore the expression of different proteins involved in the maintenance of 
the epithelial phenotype.  
The expression of the epithelial marker E-Cadherin at different times in the 
differentiation approach in HLCs replated on either surface was studied by 
immunofluorescence (Figure 47). Analysis of the percentage yield of cells staining 
positive for E-Cadherin revealed that on matrigel surfaces, the expression decreased as 
the differentiation progressed. At Day 5 post-replating 77% of the cells stained positive 
for the epithelial marker; and the percentage decreased to 67%, 61% and 46% at Day 
10, 15 and 20 post-replating, respectively. Residual expression was observed at Day 25 
post-replating. However, on PU134 surfaces, the expression of the protein was 
maintained through the differentiation. At Day 5 post-replating 84% of HLCs expressed 
the protein. This percentage was maintained at Day 10 and 15 post-replating when 
82% and 84% of the cells stained positive. By Day 20 post-replating 71% of the cells still 
expressed E-Cadherin, which was maintained at Day 25 post-replating as it was still 





Figure 47. Immunofluorescence analysis of E-Cadherin. Cells maintained on matrigel (MG) or PU134 surfaces were fixed throughout the differentiation protocol 
and the expression of the epithelial marker E-Cadherin was analysed by immunofluorescence. Results showed the percentage yield of HLCs expressing E-Cadherin on 
either substrate. The expression of E-Cadherin was gradually lost in HLCs maintained on matrigel surfaces as the differentiation progressed and by Day 20 post-
replating, 46% of the cells still stained positive for E-Cadherin.  On PU134 surfaces there was a stabilisation in the E-Cadherin expression with 71% of the cells 
staining positive by Day 20 post-replating. The corresponding IgG isotype controls demonstrated the specificity of the staining. For each condition five random fields 





In addition to analysing the epithelial marker E-Cadherin, I studied by 
immunofluorescence the expression of zonula occudens-1 (ZO-1), a key component of 
the tight junctions protein complexes involved in establishing cell-to-cell interactions. 
Analysis in the expression of ZO-1 (Figure 48) revealed that, independently of the 
substrate, the majority of HLCs expressed the protein up to Day 20 post-replating, as 
88% and 92% of the cells replated on matrigel or PU134 surfaces, respectively stained 
positive for the marker. The values for the percentage yield of cells replated on 
matrigel surfaces expressing ZO-1 at Day 5, 10 and 15 post-replating were as follows: 
96%, 88% and 87%, respectively; and on PU134 surface were 99%, 93% and 85%, 
respectively. However, no expression was detected on cells replated on matrigel 
surface at Day 25 post-replating. On the contrary, 77% of the cells maintained on 
PU134 surface still expressed the protein, suggesting that ZO-1 stability was improved 





Figure 48. Analysing the expression of zonula occludens-1. HLCs maintained on matrigel (MG) or PU134 surfaces were fixed throughout the differentiation 
protocol and the expression of the tight junction protein zonula occludens-1 (ZO-1) was analysed by immunofluorescence. Results showed that either condition 
generated similar levels of HLCs expressing ZO-1. The presence of this protein disappeared in HLCs maintained on matrigel surfaces by Day 25 post-replating, while 
in HLCs on PU134 surfaces the expression remained high, supporting the stabilisation of the epithelial phenotype on the cells induced by PU134. The corresponding 
IgG isotype controls demonstrated the specificity of the staining. For each condition five random fields of view, containing at least 500 cells, were counted. Images 




All together, these observations suggest that PU134 surfaces promote the 
maintenance of an epithelial phenotype and the establishment of cell-to-cell 
contact required for the maintenance of cell polarity in a better manner than 
matrigel surfaces.  
4.2.4.7 Functional characterisation of HLCs on PU134 and matrigel surfaces 
To observe the functional consequences of the promotion and stabilisation of the 
hepatocyte phenotype induced by PU134 surfaces, I measured the metabolic and 
synthetic capabilities of HLC on PU134 surfaces and compared them with HLCs on 
matrigel surfaces.  
Measuring cytochrome P450 activity in HLCs on PU134 and matrigel surfaces  
Cytochrome P450 activity CYP3A and CYP1A2 in HLCs replated on matrigel or PU134 
surfaces was measured at Day 10, 15 and 20 post-replating (Figure 49). HLCs 
displayed comparable levels of CYP3A activity at Day 10 post-replating on either 
surface (Figure 49A). However, we observed a 6-fold increase at Day 15 post-
replating in HLCs replated on PU134 surfaces compared with matrigel surfaces 
(p>0.05). A further 3-fold increase in the activity of HLCs on PU134 surfaces was 
observed at Day 20 post-replating, with a 30-fold increase comparing with cells 
replated on matrigel surfaces (p<0.001). The values for CYP3A at Day 10, 15 and 20 
post-replating in HLCs replated on matrigel or PU134 surfaces are as follows; 
4,69x105 RLU/ml/mg, 3,55x105 RLU/ml/mg, 7,28x105 RLU/ml/mg, 4,34x106 
RLU/ml/mg, 4,44x105 RLU/ml/mg  and 13,59x106 RLU/ml/mg,  respectively. 
CYP1A2 activity showed a similar trend to CYP3A (Figure 49B). No significant 
differences in the activity of the cells on either surface at Day10 post-replating were 
observed. By Day 15 post-replating, there was a 9-fold increase in the activity on 
PU134 surfaces compared with matrigel surfaces (p<0.001) and 24-fold increase 
when compared with PU134 surfaces at the previous time point. CYP1A2 activity 




difference, p>0.05), but only displaying a ≈2.2-fold increase when compared with 
cells maintained on matrigel surfaces at the same time in the differentiation 
approach (p<0.05). The values for CYP1A2 at Day 10, 15 and 20 post-replating in 
HLCs replated on matrigel or PU134 surfaces are as follows; 5,38x104RLU/ml/mg, 
6,18x104 RLU/ml/mg, 1,65x105 RLU/ml/mg, 1,5 x106 RLU/ml/mg, 6,24x105 
RLU/ml/mg and 1,37x106 RLU/ml/mg,  respectively. 
 
Figure 49. HLCs on PU134 surfaces displayed superior cytochrome P450 activity. Cytochrome 
P450 function 3A (A) and 1A2 (B) were assessed using a commercially available system (pGLO®) in 
HLCs maintained on either substrate at Day 10, 15 and 20 post-replating. Analysis of the function 
revealed similar CYP3A and CYP1A2 activity by Day 10 post-replating independently of the 
substrate used. As the differentiation progressed, a greater increase in CYP3A and CYP1A2 activity 
were observed when PU134 was used as culture substrate, reaching a peak in the activity by Day 20 
post-replating, with a 30-fold and 2-fold increase in CYP3A and in CYP1A2 activity respectively 
compared with matrigel surfaces (MG), which displayed their peak in the activity by Day 15 post-
replating. The results represent the mean ± SD of four individual samples per time point per 
cytochrome p450 analysed. Levels of significance were measured by student’s t-test where p>0.05 is 
denoted as * and p>0.001 is denoted as ***.  
Albumin secretion in HLCs on PU134 and matrigel surfaces 
Albumin protein production and secretion is a critical function of the liver. I 
investigated the secretion of albumin using ELISA in HLCs replated on matrigel or 
PU134 surfaces at Day 10, 15 and 20 post-replating. Figure 50 demonstrates the 
production of albumin in HLCs on both substrates. At Day 10 post-replating, 
consistent with the measure of the basal CYP activity, there were no differences in 
the production of albumin (p>0.05). By Day 15 post-replating, a 2 fold increase in 




observed (p>0.05);  and by Day 20 post-replating, the difference in the production 
of albumin increased to 3.2-fold (p<0.001). The levels of albumin production were 
maintained constant on PU134 surfaces between Day 15 and Day 20 post-replating 
(p>0.05). The values of albumin produced at Day 10, 15 and 20 post-replating on 
matrigel or PU134 surfaces are as follows; 0.539 µg/ml/24hours/mg, 0.858 
µg/ml/24hours/mg, 2.038 µg/ml/24hours/mg, 1.021 µg/ml/24hours/mg, 0.955 
µg/ml/24hours/mg and 3.037 µg/ml/24hours/mg, respectively. 
 
Figure 50. Improvement in the albumin protein secretion on PU134 surfaces. The graph 
displayed shows the level of albumin secreted by HLCs maintained on matrigel (MG) or PU134 
surfaces (PU134) at Day 10, 15 and 20 post-replating. Results revealed a 2-fold increase by Day 20 
post-replating in the secretion of albumin on PU134 surfaces compared with matrigel surfaces. The 
results represent the mean ± SD of three individual samples per time point. Levels of significance 
were measured by student’s t-test where p>0.05 is denoted as * and p>0.01 is denoted as **. 
Drug induction of HLCs on PU134 and matrigel surfaces  
Basal cytochrome P450 activity provides important background information about 
the functionality of the cells. However, the capacity of drugs inducing the 
cytochrome activity represents a hallmark of mature hepatocytes. For this purpose 
48 hours prior to the assessment of the P450 activity, HLCs replated on either 
substrate were cultures on the presence of different drugs, including phenobarbital 




activity was compared with the appropriated vehicle control for each of the 
conditions, PBS for phenobarbital and DMSO/H2O for rifampicin/dexamethasone.  
Cytochrome P450 activity induction with 10 µM of rifampicin combined with 2 µM 
of dexamethasone was analysed at Day 20 post-replating (Figure 51). Analysis of the 
function revealed no CYP3A activity induction in HLCs replated on matrigel surfaces. 
However, on PU134 surfaces, CYP3A activity displayed a 1.8-fold increase compared 
with the vehicle control upon incubation with rifampicin and dexamethasone 
(p<0.05). The values for CYP3A in HLCs replated on matrigel or PU134 surfaces 
induced with 10 µM of rifampicin and 2 µM of dexamethasone are as follows;  
9,9x104 RLU/ml/mg and 6,35x105 RLU/ml/mg,  respectively. 
 
Figure 51. CYP3A induction by rifampicin and dexamethasone. Cytochrome P450 3A activity 
was induced in HLCs at Day 20 post-replating using 10 µM of rifampicin and 2µM of dexamethasone 
for 48 hours, changing the medium and the drug inducers on a daily basis. CYP3A activity was 
measured using a commercially available system (pGLO®). Analysis of the function revealed that 
HLCs maintained on matrigel surfaces (MG) were not susceptible to drug induction. CYP3A activity 
showed a 1.8-fold increase on PU134 surfaces (PU134) in the presence of 10 µM of rifampicin and 
2µM of dexamethasone compared to the appropriate vehicle control. The results represent the mean ± 
SD of three individual samples per time point. Levels of significance were measured by student’s t-
test where p>0.05 is denoted as * in comparison to HLCs supplemented with the vehicle control. 
Abbreviations: Rif-rifampicin, Dex-dexamethasone. 
Cytochrome activity inductor phenobarbital was used at 1 mM, and CYP3A and 1A2 
activity were measured at Day 20 post-replating. Analysis of CYP3A activity (Figure 




susceptible, while on PU134 surfaces, HLCs displayed a 1.6-fold increase in CYP3A 
activity compared to the vehicle control (p<0.05). Similar trend was observed when 
CYP1A2 activity was analysed (Figure 52B), with no cytochrome activity induction 
observed in HLCs replated on matrigel surfaces. However, CYP1A2 activity in HLCs 
replated on PU134 surfaces displayed a 2.3-fold increase to the phenobarbital 
concentration employed compared to the vehicle control (p<0.05). The values for 
CYP3A in HLCs replated on matrigel or PU134 surfaces induced with 1 mM of 
phenobarbital are as follows; 1,85x105 RLU/ml/mg and 8,49x105 RLU/ml/mg, 
respectively; and the values for CYP1A2 on matrigel or PU134 surfaces induced with 




Figure 52. Cytochrome P450 3A4 and 1A2 induction by phenobarbital. Cytochrome P450 3A and 
1A2 activity were induced in HLCs at Day 20 post-replating using 1 mM of phenobarbital, changing 
the medium and the drug inducers on a daily basis. CYP3A (A) and CYP1A2 activity (B) were 
measured using a commercially available system (pGLO®). Analysis of the function revealed that 
HLCs maintained on matrigel surfaces (MG) were not susceptible to drug induction to phenobarbital. 
In HLCs maintained on PU134 surfaces (PU134), there were a 1.5-and 2.3-fold increase in CYP3A 
and CYP1A2 activity respectively when 1mM of phenobarbital was used compared with the 
appropriate vehicle control. The results represent the mean ± SD of three individual samples per time 
point. Levels of significance were measured by student’s t-test where p>0.05 is denoted as * in 




Measuring cell toxicity in response to pharmaceutical grade compounds 
To further characterise HLCs on PU134 or matrigel surfaces I investigated whether 
the cells were able to process pharmaceutical grade compounds to toxic endpoints. 
For this purpose I used two compounds, BMS-827278 and BMS-835981, both 
metabolised by CYP2D6. HLCs replated on either substrate were incubated with the 
compounds for 72 hours prior to the assessment of cell viability, measured at Day 
20 post-replating. Cell viability was compared with the vehicle control, DMSO. 
Analysis of the cells viability (Figure 53) showed that HLCs were sensitive to BMS-
835981 on either substrate as HLCs viability decreased to 2% and 1.5% on matrigel 
or PU134 surfaces respectively. The compound BMS-827278 also induced toxicity in 
HLCs, but it was greater in HLCs replated on PU134 surfaces. On PU134 surfaces, 
cell viability decreased ≈5-fold (Figure 53B) in response to this compound, 
compared with cells replated on matrigel surface, which viability was reduced 0.7-
fold (Figure 53A).  
Analysis of the functional data reveals a stable and greater metabolic function in 
HLCs in the presence of PU134 surfaces. Moreover, HLCs on PU134 surfaces display 
drug inducible CYP activity and toxicity to pharmacological compounds, indicating 






 Figure 53. Cell viability in response to pharmaceutical grade compounds. Functional metabolism 
of HLCs maintained on matrigel  (A) or PU134 surfaces (B) at Day 20 post-replating was established 
by incubation with compunds which requiered CYP metabolic activation and toxic intermediate 
formation. HLCs were cultured for 72 hours with 50 µM of BMS-827278 or BMS-835981. Control 
cultures did not receive the BMS compunds but had their medium supplemented with the appropriated 
vehicle, DMSO. Cell viability was assessed using a commercially available system (pGLO®). Results 
showed a significant reduction in cell viability compared with the appropriate vehicle control, to both 
compounds on the HLCs independently of the culture substratum used, but more pronounced for 
BMS-827278 when PU134 was used as a substrate. The results represent the mean ± SD of six 
individual samples per time point. Levels of significance were measured by student’s t-test where 




Most of the current methods to generate hepatocytes from stem cells rely on the 
use of undefined matrices of animal origin. These substrates can be costly and 
highly variable, affecting cell function and stability, representing a significant barrier 
to applications. Handling of existing biological matrices, commonly used in culturing 
and differentiating stem cells such as matrigel or more defined biological matrices 
including the recombinant proteins vitronectin (Braam et al., 2008) and laminin 
521(Rodin et al., 2014), is effective for short term maintenance, but not for long 
term enough to promote the maturation of HLCs. Therefore, the development of 
defined cell based systems is required if the true potential of stem cells derived 
HLCs is to be realised. Such systems should be simple to use, scalable and highly 
defined, and capable of delivering cells with predictable and reliable performance. 
In an effort to reduce the dependency on biological derived matrices, different 
approaches have relied on the use of polymers, a type of biomaterials with chemical 
and physical properties that make them ideal candidates for medical and biological 
applications. Combinatorial strategies involving biological derived substrates with 
synthetic and defined polymers have been used in the maintenance and 




vitronectin (Mei et al., 2010) and collagen ( Du et al., 2014; Ng et al., 2005). While 
these matrices have shown certain success in supporting hepatocyte differentiation 
of hPSCs still, the presence of undefined components and/or the variable 
composition contribute to variable cell performance, resulting in models of short 
duration, which makes difficult to unravel the complexity behind hepatocyte 
differentiation and dedifferentiation.  
In an attempt to overcome the limitations associated to the use of undefined cell 
culture substrates, interdisciplinary collaborations between chemistry and biology 
have identified synthetic substrates with defined composition and reliable 
performance. Synthetic substrates are scalable, cost effective, and can be 
manufactured into complex three dimensional structures, mimicking the in vivo 
environment. Due to these properties synthetic substrates have been widely used 
to support and drive differentiation of many cell types (Cameron et al., 2013; Li et 
al., 2011; Pernagallo et al., 2008). 
Traditional approaches in the screening, identification and testing of new polymers 
have relied on slow and low throughput approaches, limiting the discovery of novel 
synthetic substrates compatible with biological systems. However, in recent years 
automated and parallel screening systems for polymers have grown enormously. 
High throughput approaches (HTP) such as microarraying has allowed the screening 
of chemical diverse polymers, representing a valuable tool for both, novel material 
discovery and the identification of correlation performance and structure (Hook et 
al., 2010; Meier and Hoogenboom, 2004). 
These HTP approaches allow the synthesis and testing of multiple combinations of 
polymers in short period of time (Zhang et al., 2009), facilitating the identification of 
compatible substrates with multiple applications including bone and cartilage 
regeneration (Khan et al., 2010; Tare et al., 2009), endothelial vascularisation 
(Pernagallo et al., 2012) and culture of pancreatic islet cells (Mei et al., 2010). Hay 
and colleagues employed this microarray technology to perform an unbiased 




hepatocyte differentiation of PSCs. From this screening they identified a a simple 
polyurethane, PU134, formed by polymerizing PHNGAD, MDI and an chain 
extender, that in combination with a robust hepatocyte differentiation approach, 
stabilized hepatocyte phenotype and improved cell function when compared with 
matrigel (Hay et al., 2011). 
The possession of an optimized polymer coating surface that promotes hepatocyte 
function is essential if the true potential of stem cells derived HLCs is to be realized. 
For this purpose, I significantly altered the coating conditions, topography and 
sterilization process to access effects on polymer performance in stabilising 
hepatocyte function and lifespan (Lucendo-Villarin et al., 2014). From this 
optimisation process I observed that the topography of the coated surface is highly 
dependent on the nature of the solvent employed, which had direct implications in 
the function of the cells (Biggs et al., 2008; Dang and Leong, 2007; Engler et al., 
2006; Hamilton and Brunette, 2007; Lim and Donahue, 2007; Teixeira et al., 2003). 
Previously, Sharma and colleagues showed that hepatocyte biology is affected by 
the roughness of the culture substrate, with improved cell spreading in rough 
surfaces when compared with smooth surfaces. However, no significant differences 
were found on the function of the cells between surfaces displaying different 
roughness (Sharma et al., 2009). In this study I have shown an improvement in the 
cell function when a smooth surface of polymer PU134 is employed. Physical 
parameters of the solvent such as the solubility rate, diffusion rate, boiling 
temperature and density can influence the topography of the polymer coated which 
may partly explain the improved polymer surface observed. Whether it is a specific 
characteristic of PU134 or it is share between polyurethanes has still to be resolved. 
In addition to analyze the influence of the polymer surface topography in the cell 
function, the polymer surface optimization procedure revealed that cell 
performance is influenced by the sterilization procedure employed. This may be due 
to the presence of sensitive area(s) within the structure of the polymer to different 
sterilization procedures (Azevedo et al., 2013; Rosu et al., 2005; Yang et al., 2002). 




surfaces, cells displayed a limited life span which was not observed on matrigel 
surfaces. This could be due to the cell attachment supporting factors and cytokines 
presented on matrigel that are absented on the polymer surface. This limited life 
span was resolved by supplementing the maturation media with Knock-Out Serum 
Replacement, KOSR, a defined good manufactured practices (GMP) grade serum-
free formulation that is more stable and consistent in quality than foetal bovine 
serum (Tekkatte et al., 2011). 
The resulting population of HLCs obtained in the optimised polymer surfaces in the 
supplemented maturation media displayed improved life span and hepatocyte 
morphological features, such as canaliculi-like structures and binucleate cells. 
Moreover, polymer surfaces prevented the dedifferentiation of the cells observed 
on matrigel surfaces as denoted by a delay in the expression of the mesenchymal 
marker vimentin (Godoy et al., 2010), accompanied by a stabilisation in the 
expression of the hepatocyte marker HNF4α. Moreover, the maintenance in the 
expression of hepatocyte markers including albumin, HNF4α and cytochrome P450 
3A and 2D6 in the presence of polymer surfaces further supported the anti-
dedifferentiation effect of the polymer surfaces. In parallel, the reduced expression 
of the foetal hepatocyte marker alpha-fetoprotein and the cell proliferative marker 
Ki67 observed on polymer surfaces suggest the possession of a more mature 
hepatocyte phenotype than their matrigel counterparts. 
These observations were supported by analysing hepatocyte functions including 
cytochrome P450 activity and albumin secretion. The improved differentiation 
status of HLCs generated under defined conditions was further confirmed by their 
response to inducers of cytochrome P450 activities and to compounds which 
measure hepatocyte metabolic capacity. Cytochrome P450 3A and 1A2 activity in 
HLCs maintained on polymer surfaces responded to different drug inducers, a 
hallmark of a mature hepatocyte. Consistently with previous observations (Medine 
et al., 2013), I observed that HLCs replated on polymer surfaces displayed 




835981, which require metabolic activation, via CYP2D6, to hepatic toxic endpoints. 
Clearly drug metabolism is a key need of any hepatocyte model and this was in 
contrast to HLCs differentiated using matrigel surfaces which exhibited poorer 
performance, presumably due to incomplete differentiation of the CYP2D6 
metabolic pathway.  
The improved hepatocyte phenotype and cell performance observed on the 
polymer surfaces suggested the maintenance of the cell-to-cell interactions on 
HLCs.  Hepatocytes tightly connect with each other by intercellular protein 
complexes including tight and adherens junctions (Kojima et al., 2003). In 
hepatocytes, tight junctions are localised to the apical end of the basolateral 
membrane surrounding the bile canaliculi, playing key roles in the establishment on 
the epithelial polarityand hepatocyte functions. Tight junctions bind to the cell 
membrane of adjacent cells via homophilic recognition, sealing paracellular spaces 
between hepatocytes thus, keeping bile within the bile canaliculi and away from the 
blood (Anderson et al., 2001; Tsukita et al., 2001), therefore, enforcing transport of 
macromolecules across epithelial cells. The cytoplasmic domain of the 
transmembrane proteins conforming tight junctions such as claudins and occludin 
(Furuse et al., 1998), binds to adaptor proteins such as zona occludent-1 (ZO-1), a 
member of the membrane associated guanalate kinase that binds to actin 
filaments, which suggest a role of tight junctions in the organization of the actin 
cytoskeleton (Tsukita et al., 2001).  
Adherent junctions represent another protein complex involved in the cell-to-cell 
contact. Adherent junctions are Ca2+ dependent homophilic cell adhesion protein 
complexes involve in the maintenance of cell-to-cell contact and epithelial polarity 
in hepatocytes, providing mechanical integrity to tissues (Gumbiner, 1996). They 
form continuous adhesion belts localised near the apical end of the cells, just below 
tight junctions. E-Cadherin, a transmembrane protein primarily expressed on 
epithelial cells, represents the best characterised cadherin member of adherent 




other signalling elements through several peripheral membrane proteins, including 
catenins, vinculin and α-actinin (Gumbiner, 1996; Takeichi, 1995; Tsukita et al., 
2001; Yonemura et al., 1995) , thus providing a role for E-cadherin in the 
establishment of hepatocyte polarity.  
Therefore, I analysed the expression of key proteins involved in cell-to-cell 
interactions: zonula occludens-1 and E-Cadherin. The maintenance and stabilisation 
in the expression of these proteins in HLCs maintained on the polymer surface 
suggested an improved hepatocyte polarity in the cells, which is essential in the 
maintenance of hepatocyte function (Müsch, 2013). This could partly explain the 
improved metabolic function observed in the presence of polymer surface. 
Additionally, it has been reported that tight junctions play a key role in the in the 
hepatitis C virus (HCV) entry (Ploss et al., 2010), and it has been shown that HLCs 
obtained on the serum-free differentiation approach employing matrigel surfaces 
(Szkolnicka et al., 2014) efficiently supports HCV entry and replication (Zhou et al., 
2014). Therefore, the improved cell-to-cell interactions observed in the presence of 
polymer surfaces suggest that these HLCs would support HCV infection in a better 
manner than their matrigel counterpart. However, this has to be addressed in the 
future. 
 
In conclusion, data presented here demonstrate the influence of optimised polymer 
surfaces possess on the cell function, highlighting the nutritional requirements 
needed when working with defined media and synthetic substrates. In addition, 
extensive characterisation of HLCs on the PU134 surface reveals the differentiation 
properties that the polymer surface possesses in promoting hepatocyte function 
whilst preserving the phenotype. The mechanism behind this improved cell 
phenotype and performance induced by PU134 surfaces will be discussed in the 
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The liver is a highly organised tissue. Liver cell function requires right structural 
support and contact with neighbouring cells and extracellular matrix (ECM). The 
acinus represents the basic functional unit of the liver and it is form by cords of 
hepatocytes radiating from the central vein and lined by sinusoidal capillaries. While 
hepatocytes represent the parenchymal cells of the liver, bile duct epithelial cells, 
liver sinusoidal endothelial cells, hepatic stellate cells and Kupffer cells compose the 
non-parenchymal fraction. The ECM of the liver is produced by epithelial and 
stroma cells found within the tissue itself. It is located in the Space of Disee, 
between the hepatocytes and the liver sinusoidal endothelial cells. The composition 
of ECM in the liver varies in a gradient manner, paralleled by those of soluble 
factors; and it consists mostly of fibronectin, proteoglycans and collagens, mainly 
type I and minor quantities of types III, IV, V, and VI (Bissell et al., 1987; 1990; 
Martinez, 1995). Laminin is mainly found in the niche of the hepatic progenitor cells 
(Lorenzini et al., 2010). Liver development, like any another organ, requires an 
extensive network of signals from the ECM and nearby mesoderm acting in a time- 
and/or dose-dependent manner. These factors interact with protein membrane 
receptors including the integrin family of proteins (Hynes, 1992; Ruoslahti, 1991; 
Schwartz and Schaller, 1995), activating signalling pathways that drive liver 
development. The liver microenvironment changes with the development, 
especially after birth, when the nutritional supplies change from placental to enteral 
nutrition, activating mature hepatocyte functions (Morelli, 2008). 
5.1.1 Extracellular signalling and transcription factors involved in liver 
development 
The liver specifies form the anterior portion of the definitive endoderm. These cells 
are separated from the surrounding septum transversum mesenchyme by a 
basement membrane (Medlock and Haar, 1983), and lie adjacent to the nascent 




fibroblast growth factors (FGFs) from the cardiac mesoderm, and bone 
morphogenetic proteins (BMPs) from the septum transversum mesenchyme 
(Calmont et al., 2006; Jung, 1999; Rossi et al., 2001). While FGF signalling activates 
MAPK and phosphoinositide 3-kinase, PI3K/AKT pathways (Bottcher, 2005; 
Schlessinger, 2004), which are involved in hepatic specification and hepatic growth 
respectively (Calmont et al., 2006); BMPs binding to serine/threonine kinase 
receptors (Heldin et al., 1997; Shi and Massagué, 2003) activates Smad signalling 
pathway by inducing the phosphorylation of Smad1, Smad5 and Smad8, which is 
then able to complex with Smad4 thus, regulating gene transcription in the nucleus.  
In response to the inductive cues from the heart and mesenchyme, junctional 
complexes between the pre-hepatic cells are lost. Cells forming the hepatic 
endoderm transits from a simple cuboidal to a pseudostratified columnar 
epithelium forming the liver bud that is composed of hepatoblasts (Bort et al., 
2006). During this process, the base membrane separating the pre-hepatic cells and 
the STM, which is rich in laminin, nidogen, collagen IV, fibronectin and sulphate 
proteoglycans (Shiojiri and Sugiyama, 2004), is progressively disrupted (Baker et al., 
2007; Zaret, 2002) inducing the delamination and migration of the pre-hepatic cells 
from the foregut into the surrounding STM, as cords, to form the nascent liver bud 
(Bort et al., 2006; Margagliotti et al., 2008; Medlock and Haar, 1983; Shiojiri and 
Sugiyama, 2004). During this process, the homeodomain protein Hhex plays an 
important role in the hepatic proliferation and migration into the STM (Bort et al., 
2006). 
These processes of delamination and migration are characterised by modification 
and remodelling of the surrounding ECM. Transcription factors including Prox1 and 
Oncecut regulate the expression of extracellular matrix (ECM) proteins and ECM 
remodelling enzymes such as the matrix metalloproteinase (MMPs) -14, expressed 
in hepatic progenitors, and MMP-2, expressed predominantly in the surrounding 
mesenchyme (Margagliotti et al., 2007; Medico et al., 2001; Papoutsi et al., 2007). 




response to an extensive network of signals, including coordinate paracrine 
signalling from the surrounding hepatic mesenchyme such as FGF8 and BMP4 (Berg 
et al., 2007; Calmont et al., 2006; Jung, 1999; Rossi, 2001; Sekhon et al., 2004; Shin 
et al., 2007; Yanai et al., 2008), in conjunction with Wnt/β-catenin signalling 
(Behbahan et al., 2011; Monga et al., 2003; Tan et al., 2008). Hepatocyte growth 
factor (HGF) is also involved in hepatoblast migration and proliferation (Birchmeier 
et al., 2003; Bladt et al., 1995; Block et al., 1996; Medico et al., 2001; Michalopoulos 
and Bowen, 1993; Moumen et al., 2007; Sachs et al., 2000; Schmidt et al., 1995), via 
activation of the small GTPase Arf6 (Suzuki et al., 2006) and binding to its tyrosine 
kinase receptor c-Met, respectively (Iida et al., 2003; Ishikawa et al., 2001).  
Specification of the hepatoblasts into the hepatocyte lineage is a process regulated 
by an extended network of transcription factors and cytokines, favoured by the 
presence of a gradient of TGFβ signalling, that is negatively modulated by the 
transcription factors Onecut-1 (OC-1) and Onecut-2 (OC-2) (Clotman, 2005), that act 
in coordination with Jagged-Notch signalling pathway in supporting biliary 
differentiation (McCright et al., 2002; Tanimizu, 2004). 
Hepatocyte growth and maturation extended beyond birth. During this process, the 
liver switches its functional role as the main hematopoietic system in the body to a 
metabolic organ at around birth (Nagao et al., 1986; Noda et al., 1994). Important 
factors involved in this hepatocyte maturation include oncostatin M (OSM), 
glucocorticoid (Kamiya et al., 1999) and hepatocyte growth factor (HGF). 
Stimulation of foetal hepatocytes with glucocorticoids alone revealed that HGF 
triggers hepatocyte maturation, while OSM enhances the effect of glucocorticoid in 
promoting cell differentiation towards hepatocyte lineage. Binging of OSM to the 
oncostatin M receptor complex, OSMR, composed of a OSMR β chain and a 
common signal transducer gp130, induces the activation of two main signalling 
pathways: STAT-3 and Ras pathways, which are involved in the expression of 
hepatocyte differentiation markers induced by OSM (Ito et al., 2000) and the 




hand, HGF has been proposed to promote hepatocyte specification, proliferation 
and maturation by stimulating the expression of important transcription factors in 
the hepatocyte biology including C/EBPα (Suzuki, 2003). TNFα signalling ensures a 
correct balance between HGF and OSM signalling, allowing the liver to grow to the 
appropriate size before differentiating (Kamiya and Gonzalez, 2004). In addition, 
during the postpartum transition from placenta to enteral nutrition, as a result of 
the gut colonisation by intestinal flora, the neonatal liver is exposed to bacterial-
derived secondary metabolites such as lithocholic acid (LCA) and manaquinones 
(vitamin K2) (Avior et al., 2015), which activates the pregnane X receptor (PXR), a 
nuclear receptor controlling expression of cytochrome P450 enzymes such as 2C9 
and 3A4 (Ichikawa and Horie, 2006; Staudinger et al., 2001).  
In addition to cytokines, extracellular matrix receptors are also involved in the 
hepatocyte development. Integrins represent one of the major receptors for 
components of the extracellular matrix. It has been reported that integrin α3β1 is 
important for the attachment of hepatocytes to laminins, which are present in both, 
the early foetal liver (Baloch et al., 1992; Couvelard et al., 1998)  and around the 
perisinusoidal spaces in the adult liver (Bissell et al., 1987; Maher et al., 1988). In 
addition, hepatocyte binding to fibronectin, one of the major components of the 
ECM in the liver, occurs via α5β1 integrin (Gullberg et al., 1990). The importance of 
cell-to-ECM interactions is illustrated by the fact that hepatoblasts deficient for β1-
integrin are unable to colonize the liver bud (Fässler and Meyer, 1995). Moreover, it 
has been shown that during liver bud growth HGF and TGFβ signalling act in parallel 
converging on β1-integrin regulating and controlling hepatic architecture 
(Weinstein et al., 1994). In addition, α1β1 integrin plays an essential role during 
regeneration after toxic liver injury, as revealed in mice deficient for this 
heterodimeric integrin which shows defects in cell survival (Duncan et al., 2013). 
Together, this data demonstrate the importance of a correct cell-to-ECM 




5.1.2 Liver enriched factors and extracellular microenvironment regulate 
hepatic phenotype 
In mature hepatocytes, the expression of characteristic genes of the hepatocyte 
phenotype is controlled by a complex inter-regulatory network of liver-enriched 
transcription factors, (LEFs), including C/EBPα, and the hepatocyte nuclear factors 
(HNFs) 1α, 3α-γ, 4α and 6 (Kuo et al., 1992; Qu et al., 2007; Zaret, 2001; 2002), 
which can act individually or forming multi-input motifs by collectively binding to 
set of genes in hepatocytes. The expression of a broad range of genes associated 
with the hepatocyte biology including metabolism, urea cycle, serum plasma 
proteins and drug processing genes, are controlled by these transcription factors 
(Cereghini, 1996; Gonzalez, 2007; Johnson, 1990). Previous studies indicate that 
HNF1α, -4α and -6 strongly correlate with the hepatocyte performance. These 
factors are at the centre of a network of transcription factors that regulates 
developmental and metabolic functions in hepatocytes, by binding to promoters of 
genes encoding a large population of transcription factors and cofactors (Kuo et al., 
1992; Zaret, 2002). This includes genes encoding for cell adhesion and functional 
proteins, important in hepatocyte epithelial structure, ensuring the correct 
development of the foetal liver architecture and maintenance of the phenotype in 
the adult (Chen et al., 1994; Li et al., 2000). HNF1α and HNF4α binding to one 
another’s promoters form a multicomponent loop that induces the expression of 
the other factor (Boj et al., 2001; Ferrer, 2002; Thomas, 2001). In addition, HNF6 
acts as a master regulator for feed-forward motifs in hepatocytes, including 
induction of the expression of phosphoenolpyruvate, a key enzyme in 
gluconeogenesis, by binding together with HNF4α to the gene promoter (Odom, 
2004). C/EBPα and HNF1α expression are essential to ensure complete hepatocyte 
maturation and metabolic hepatic functions including regulation of glucose and 
glycogen metabolism (Pontoglio et al., 1996; Wang et al., 1995). C/EBPα, which 
expression is induced by HGF  (Rastegar et al., 2000; Soriano et al., 1995; Suzuki et 
al., 2003; Tomizawa et al., 1998; Yamasaki et al., 2006), inhibits hepatoblast 




phase-specific E2F-p107 complex (Harris, 2001; Timchenko et al., 1997). Finally, 
FoxA factors -1, -2 and -3 (HNF3α-γ) possess overlapping DNA binding properties 
regulating numerous hepatic functions (Friedman and Kaestner, 2006). 
The microenvironment surrounding the hepatocytes also plays an important role in 
the cell biology. The extracellular matrix within the healthy liver is composed of a 
series of macromolecules including collagens (types I-VI) and non-collagenous 
glycoproteins such as laminins, fibronectin and proteoglycans. The dynamic of the 
ECM in the liver depends upon ECM synthesis and the proteolytic degradation 
activity performed by metalloproteinases (MMP), which have emerged as essential 
mediators in defining how cells interact with their surrounding microenvironment. 
The regulation of MMPs activity is a tightly controlled process and it takes place at 
transcriptional, post-transcriptional, and at protein levels (Kessenbrock et al., 2010), 
being the tissue inhibitors of metalloproteinases (TIMPs) the main regulators of 
MMP activity (Kessenbrock et al., 2010; Visse and Nagase, 2003). The role of MMPs 
and TIMPs in the extracellular matrix remodelling reveals the importance of 
equilibrium in maintaining liver homeostasis. 
The expression of ECM and extracellular matrix receptors varies during liver 
diseases. This is manifested in the deposition of matrix and scarring with a 
progressive loss of liver functions. Recent data indicate a pivotal for integrins in the 
progression of fibrosis and cirrhosis. Upon injury of hepatocytes or bile duct 
epithelial cells, there is an activation of stellate cells by pro-inflammatory and pro-
fibrogenic cytokines including; transforming growth factor beta 1 (TGFβ-1), platelet-
derived growth factor (PDGF), fibroblast growth factor (FGF), and connective tissue 
growth factor (CTGF). This results in increased production and secretion of 
interstitial collagens and other ECM components (basement membrane collagens, 
non-collagenous glycoproteins, proteoglycans, and growth factors), leading to an 
impaired balance between fibrogenesis and fibrolysis, which eventually results in 
distorted liver architecture and a loss of function (Bataller and Brenner, 2005; 




upregulation of laminin-binding integrins α6β1, α2β1, and αvβ8 (Levine et al., 2000) 
and fibronectin-binding α5β1 (Znoyko et al., 2006) have been reported. The 
importance of integrins in liver homeostasis is revealed by studies suggesting that 
changes in particular integrin expression levels on the cell surface may indicate 
cellular abnormalities or malignant transformation (Rathinam and Alahari, 2010). As 
such, several studies have revealed the correlation between an abnormal 
expression of integrins with pathologies such as viral hepatitis, cholestatic liver 
disease and alcoholic and non-alcoholic liver diseases. Reports have linked integrin 
activity with the impaired balance of fibrogenesis and fibrolysis. For example, αvβ6 
and αvβ8 integrin activities activate the latent form of TGFβ-1, which is a potent 
regulator of ECM expression by hepatic stellate cells (HSC) (Munger et al., 1999). 
Conversely, enhanced ECM-degrading proteases MMP-2, -3 and -9 activity have 
been shown to be associated with an engagement of αvβ3 and αvβ5 (Bendeck et 
al., 2000; Jackson, 2002). An increased expression of β1 integrin on hepatocyte 
membranes has been observed in human alcoholic liver diseases (Chedid et al., 
1993), and in patients with advanced alcoholic liver fibrosis or cirrhosis, the serum 
level of β3 integrin was increased (Yamauchi et al., 1993).  
 These observations demonstrate the importance of the extracellular environment 
and extracellular matrix and their receptors in hepatocyte biology. Identification of 
key extracellular factors, including extracellular matrix proteins, matrix associated 
receptors, involved in the stabilisation of the hepatocyte phenotype represents an 
important target in hepatocyte biology.    
5.1.3 Translating stable hepatocyte phenotype to the clinic. 
Human pluripotent stem cells (hPSCs) represent an unlimited source of somatic 
cells. As such, they hold great promise for disease modelling, basic scientific 
research, drug development and cell based therapy. However, the use of animal 
derived research grade reagents during the isolation, establishment and 




Therefore, the establishment of PSCs lines using Good Manufacture Practices (GMP) 
is essential if stem cell derived somatic cells are to be scale and used clinically. 
Traditional successful methods in the isolation of ICM from blastocyst such as 
immunosurgery (Kim et al., 2005) require the use of animal derived reagents, which 
are not desirable when developing defined culture systems. As such, alternative 
animal free and clinical grade isolation techniques including mechanical (Amit and 
Itskovitz-Eldor, 2002; Hovatta, 2006; Liu et al., 2009b; Touboul et al., 2010), laser-
assisted-dissection and isolation of hESCs from plated blastocyst outgrowth have 
been reported (Cortes et al., 2008). Culture definition is also required for the 
establishment and maintenance of clinical grade hESC lines. The use of MEFs has 
been progressively replaced by human fibroblasts (Fong and Bongso, 2006; Richards 
et al., 2002); or hESCs-derived feeder cells (Ellerström et al., 2006). However, these 
feeder systems are not defined neither scalable. Therefore, feeder-free defined 
culture systems have been developed, which may involve the use of recombinant 
(Rodin et al., 2010) or synthetic (Villa-Diaz et al., 2010; Zhang et al., 2009) ECM. 
Animal and human derived serum containing media have proved to be successful in 
the derivation and maintenance of several hESCs (Ellerström et al., 2006; Reubinoff 
et al., 2000; Richards et al., 2002b; Thomson, 1998). Still, the fact that serum is a 
complex mixture containing unknown compounds with variable composition 
between batches is reflected in their capability of maintaining undifferentiated 
hESCs. Therefore, development of defined and xeno-free sera is required for GMP 
production of hPSCs. As such, companies have released new defined clinical grade 
sera and media, including Knock-Out Serum Replacement and E8™ medium. 
In the next section I investigate the stabilisation of the HLCs maintained on the 
defined polyurethane PU134 surface under serum-free conditions, identifying key 
genes and their effect in the cell performance. In addition, these findings are 





5.2 Results  
5.2.1 Identifying target genes involved in the stabilization promoted by 
PU134 
hESCs-derived hepatocyte-like cells (HLCs) maintained on PU134 surfaces display a 
robust, stable and superior hepatocyte phenotype and function than their matrigel 
counterparts. As such, I aimed to identify the mechanism behind this process. I 
therefore employed PCR array technology to screen for candidate genes involved in 
the stabilisation of the hepatocyte phenotype. The RT² Profiler PCR array employed 
analysed the expression of 84 genes important for extracellular matrix components, 
cell-to-cell and cell-to-matrix interactions. For this purpose, gene profile expression 
was compared between HLCs differentiated on matrigel and PU134 surfaces at Day 
20 post-replating, when the greatest difference in HLC cell performance was 
displayed.  
PCR array analysis (Figure 54) revealed increased expression (>3-fold) of 6 genes on 
PU134 surfaces compared to matrigel surfaces: a disintegrin-
like and metalloprotease with thrombospondin type 1 motif no. 13, ADAMTS13, 
neural cell adhesion molecule 1, NCAM1, catenin (cadherin associated protein) 
delta 2, CTNND2, thrombospondin-2, THBS2, metalloproteinase 10, MMP10 and 
metalloproteinase 13, MMP13 (Figure 54 and Table 7, Supplementary Information). 
The fold of increase in the expression for each of the identified genes were as 
follows; 3.85-fold in ADMTS13, 3.52-fold in NCAM1, 4.1-fold in CTNND2, 3.3-fold in 
THBS2, 3.38 and 5.7-fold increase in MMP10 and MMP13 respectively (Figure 55). A 
3-fold increase was set as a threshold in order to discard stochastic differences and 
differences in genes with high Ct values (>30 cycles) (Supplementary Table 1). 
The output of the array was validated by quantitative PCR, whereby one of the 
candidate genes, ADAMTS13, was not amplified as expected (1.6-fold) and 
therefore, was excluded from further studies. The fold of increase in the gene 




4.6-fold in CTNND2, 4.8-fold in THBS2, 3.6 and 3.8-fold increase in MMP10 and 
MMP13 respectively (Figure 56). These results highlighted the importance of 
confirming the outputs of the PCR array as the expression of one of the identified 
genes, ADAMTS13, was not amplified as indicated in the PCR array. 
 
Figure 54. Gene expression in HLCs on PU134 and matrigel surfaces. A PCR array for the major 
extracellular matrix components and matrix associated receptors expressed on human cells was 
performed in HLCs maintained on matrigel and PU134 surfaces at Day 20 post-replating. Gene 
expression was performed using RT
2
 Profiler PCR array (Qiagen) according to the manufacturer’s 
instructions. The gene expression was analysed by RT
2
 Profiler PCR array Data Analysis version 5.0 
(Qiagen). The scatter plot represents 3-fold change in gene expression. The graph plots the log10 of 
normalized gene expression levels in a control condition (x-axis) versus and experimental condition 
(y-axis). Symbols outside the boundary area indicate fold-differences larger than a threshold (3 fold). 





Figure 55. Up-regulated genes identified on the PCR array. The graph represents the identified 
genes which expression was upregulated more than 3-fold change in HLCs maintained on PU134 
surfaces compared to HLCs maintained on matrigel surfaces. 
 
 
Figure 56. qPCR confirmation of the PCR array. Confirmation of the up-regulated genes 
previously identified on the PCR array was performed by quantitative PCR in HLCs maintained on 
matrigel or PU134 surfaces at Day 20 post-replating. Relative expression refers to fold of induction 
over HLCs maintained on matrigel surfaces at Day 20 post-replating and normalised to the 
housekeeping gene GAPDH. The results represent the mean ± SD of three different samples run, each 
run in triplicate. Levels of significance were measured by student’s t-test where p<0.01 is denoted as 
** and p<0.001 is denoted as ***.  
5.2.2 Testing gene function by gene knockdown 
In order to understand the importance of each gene in hepatocyte function, I 




transfected at Day 13 and 14 post-replating with specific siRNAs against the target 
genes at an optimised concentration. At Day 15 post-replating, gene knockdown 
was assessed by quantitative PCR (Figure 57), revealing that the efficiency in the 
gene knockdown was dependent on the siRNA employed.  NCAM1 and CTNND2 
gene expression levels were decreased by ≈25% (p<0.05), THBS2 levels fell by ≈75%, 
MMP10 was decreased by ≈40%, and MMP13 levels fell by ≈60% (p<0.001) 
compared to the scrambled siRNA control.  
 
Figure 57. Knock-down optimisation of the candidate genes expression. HLCs maintained on 
PU134 surfaces were transfected at Day 13 and 14 post-replating with 80 µM of specific small 
interference RNA (siRNA) against the candidate genes identified on the PCR array. The transfection 
was performed using Lipofectamin 2000® (Invitrogen) at 1 in 10 ratio (µg RNA), following 
manufacturer’s instructions. Cells were harvested at Day 15 post-replating for further analysis. 
Relative expression refers to fold of induction over transfected scrambled siRNA control (random 
sequences that are not complementary with any gene in the genome) and normalised to the 
housekeeping gene GAPDH. The results represent the mean ± SD of three different samples run, each 
run in triplicate. Levels of significance were measured by student’s t-test where p<0.05 is denoted as 
*, p<0.01 is denoted as ** and p<0.001 is denoted as ***.  
5.2.2.1 Phenotype implies metabolic function 
Next I assessed the effect that gene knockdown had on the hepatocyte phenotype. 
For this purpose, I analysed the gene expression of two well established hepatocyte 
genes and hepatocyte functions.   
The effect gene knockdown was assessed by measuring two key hepatocyte genes, 




gene expression (Figure 58A) revealed that in response to the gene knockdown of 
CTNND2 and MMP13, HNF4α expression decreased ≈25% and ≈65%, respectively 
(p<0.001) compared with gene expression levels observed upon transfection of a 
scrambled siRNA control. In contrast, MMP10 gene knockdown resulted in a 1.68-
fold increase in HNF4α gene expression (p<0.001). Transfections with siRNAs to 
NCAM1 or THBS2, demonstrated little effect on HNF4α gene expression, in 
comparison to the scrambled siRNA control (p>0.05). 
Albumin gene expression (Figure 58B) was significantly decreased in response to the 
gene knockdown of CTNND2, THBS2 and MMP13 by ≈60%, ≈50% and ≈65% 
(p<0.001). No significant differences were observed in response to the gene 
knockdown of NCAM1 and MMP10. 
  
Figure 58. Effect in the expression of hepatocyte markers upon target gene expression 
knockdown. Graph represents the gene expression of the hepatocyte markers HNF4α and albumin 
analysed by quantitative PCR in hESCs-derived HLCs at Day 15 post-replating on PU134 surfaces 
upon transfection with siRNAs to the target genes. Results revealed that HNF4α gene expression 
significantly decreased upon knocking down CTNND2 and MMP13 gene expression (A) and albumin 
gene expression significantly reduced when CTNND2, THBS2 or MMP13 gene expression was 
knocked down (B). Relative expression refers to fold of induction over cells transfected with 
scrambled siRNA control and normalised to the housekeeping gene GAPDH. The results represent the 
mean ± SD of three different samples run, each run in triplicate. Levels of significance were measured 





5.2.2.2 Influence of the knockdown in the expression of targeted gene 
products in the function of HLCs maintained on PU134.  
In addition to studying gene expression, I also studied the effect that gene 
knockdown had in HLC function. Analysis of the cytochrome P450 3A function 
(Figure 59) revealed a statistically significant decrease in CYP3A activity in response 
to THBS2 and MMP13 knockdown. CYP3A function was reduced by ≈25% and ≈30%, 
respectively (p<0.01). No significant differences were observed in the CYP3A 
function in cells transfected with siRNAs to NCAM1, CTNND2 and MMP10 (p>0.05). 
Measurement in the secretion of albumin upon knocking down gene expression was 
performed using ELISA (Figure 60). In response to CTNND2 and MMP13 knockdown, 
albumin secretion decreased by ≈30% and ≈50%, respectively (p<0.05). No 
statistically significant differences were observed in response to NCAM1, THBS2 and 
MMP10 knockdown (p>0.05). 
These results demonstrated that THBS2, MMP13 and CTNND2 influence the 
hepatocyte function in HLCs maintained on PU134 surfaces, serving as a gene 
signature associated with stable HLC phenotype 
 
Figure 59. Cytochrome P450 3A activity was influenced upon knockdown in the expression of 
target gene products. CYP3A activity was assessed using a commercially available system (pGLO
®
) 
in HLCs maintained on PU134 surfaces at Day 15 post-replating upon transfection with siRNAs to the 
target genes. Analysis of the function of the cells revealed that, knocking-down the expression of 




induction over the activity displayed by cells transfected with a scrambled siRNA control. The results 
represent the mean ± SD of three individual samples per condition. Levels of significance were 
measured by student’s t-test where p>0.01 is denoted as ** and p>0.001 is denoted as ***. 
 
Figure 60. Albumin secretion was influenced upon target gene expression knockdown. The 
secretion of albumin in HLCs maintained on PU134 surfaces at Day 15 post-replating upon 
transfection with siRNAs to the target genes was analysed using a commercial available ELISA kit for 
human albumin. Analysis of the results revealed that knocking-down the expression of CTNND2 or 
MMP13 significantly decreased the secretion of albumin. Relative expression refers to fold of 
induction over the albumin secreted by cells transfected with a scrambled siRNA control. The results 
represent the mean ± SD of three individual samples per condition. Levels of significance were 
measured by student’s t-test where p>0.05 is denoted as *. 
5.2.3 Translating PU134 technology to GMP grade hESC lines 
The manufacture of stem cell derived somatic cells is likely to play an important part 
in developing cell based therapies in the future. To be able to deliver clinical grade 
materials, highly defined biological processes are required. In this vein, I employed 
two hESC lines which were derived under GMP conditions, Man 11 and Man 12. 
5.2.3.1 Pluripotency characterisation of GMP hESC lines Man 11 and Man 12 
Prior to Man hESCs hepatocyte differentiation on PU134 surfaces, I performed a 
detailed characterisation of the undifferentiated and pluripotent state of both GMP 
cell lines. Morphological analysis, examination of transcription factors ascribed to 




examined. In addition, the pluripotency capacity of the cells was measured by 
studying their ability to spontaneously differentiate into the three germ layers, and 
their ability to differentiate into hepatocytes using direct differentiation (Szkolnicka 
et al, 2014). 
Both cell lines were cultured in feeder free in mTeSR1™ media (MT), and hESC 
identity was assessed. Morphological analysis of Man 11 and Man12 grown in MT 
demonstrated tightly packed dome-like colonies with well-defined edges and little 
spontaneous cellular differentiation. Both cell lines displayed the characteristic 
hESC morphology defined by the possession of a large nucleus to cytoplasm ratio 
with a well-defined and pronounced nucleoli (Figure 61A). Further to morphological 
analysis, the stem cell nature of the hESCs cultured in MT was investigated by 
analysing protein expression of two transcription factor associated with ‘stemness’, 
Oct 4 (Octamer 4) and Nanog, using immunofluorescence (Figure 8B). Analysis of 
the yield percentage of hESC displaying pluripotent markers revealed that while 
99% of Man 11 cells expressed Oct 4 and Nanog, in Man 12 cells these proteins 
were presented in 98% and 99% of the cells respectively (Figure 61B). The high level 
of expression of Oct 4 and Nanog confirmed the undifferentiated state of the hESCs.  
hESC identity was further confirmed by analysing the expression of stem cell surface 
markers by flow cytometry (Figure 61C). Both cell lines expressed background levels 
of the differentiation marker SSEA-1 with 1.3% and 0.9% of Man 11 and Man 12 
cells stained positive. SSEA-4 was expressed by 97% and 98% of Man 11 and Man 12 
cells. While 97% and 92% of Man 11 hESC line expressed TRA-1-60 and TRA-1-81 
respectively, the expression of these markers was detected in 95% and 98% of the 
Man 12 hESC line, respectively.  
In addition, both cell lines were able to spontaneously form three germ layers 
(Figure 61D). hESCs from both cell lines formed cell types that were positive for 
alpha-fetoprotein (endoderm), alpha-smooth muscle (mesoderm) and β-tubulin III 





The ability to directly differentiate to HLCs on matrigel surfaces was confirmed in 
both cell lines using a serum-free differentiation approach previously described 
(Figure 17). Monolayers of HLCs were fixed at day 18 in the differentiation 
procedure and stained with antibodies to HNF4α and albumin by 
immunofluorescence. Analysis of the percentage yield of HLCs expressing the 
hepatocyte markers revealed that 87% and 95% of Man 11 HLCs stained positive for 
HNF4α and albumin respectively, while the expression of these markers were 
present in 84% and 99% of Man 12 HLCs, respectively (Figure 62). 
All together, the data here presented demonstrate the undifferentiated and 
pluripotent nature of both GMP grade hESC lines.  
  
Figure 61. Analysis of GMP hESC lines Man 11 and Man 12. A) hESC lines Man11 and Man12 
maintained in mTeSR1™ medium displayed morphological features typical of hESC, maintaining a 
large nucleus to cytoplasm ratio. hESCs formed colonies with well-defined edges and little to no 
differentiation observed between the colonies. Images were taken at 4x magnification (top) or 10x 
magnification (bottom), and scale bar represents 200 µm and 100 µm respectively. B) Pluripotent 
marker expression in both hESC lines was analysed by immunofluorescence, with 99% and 98% of 
the Man11 and Man12 expressing Oct 4 respectively, and 99% of both cell lines expressing Nanog. 
IgG controls demonstrated the specificity of immunostaining. For each condition five random fields of 
view, containing at least 500 cells, were counted. Images were taken at 20x magnification and the 
scale bar represents 100 µm.  C) Cell surface marker expression of SSEA1, SSEA-3, SEEA-4, TRA-
1-60 and TRA-1-81, but not SSEA1, was assessed by flow cytometry. The results represent the mean 
± SD of three independent samples per cell line. E) hESC pluripotency was measured by spontaneous 




tubulin III (β-tub III) (green) were detected by immunostaining. IgG control demonstrated the 
specificity of immunostaining. Images were taken at 20x magnification and the scale bar represents 
100 µm.  
  
Figure 62. Man 11 and Man 12 directed differentiation to HLCs. Immunofluorescence analysis of 
hepatocyte lineage markers on A) Man 11 and B) Man 12 HLCs on matrigel at Day 18 on the 
differentiation approach, demonstrating an efficient differentiation to a hepatocyte fate. The 
corresponding IgG controls indicated the specificity of the staining. For each condition five random 
fields of view, containing at least 500 cells, were counted. Images were taken at 20x magnification 
and the scales bar represents 100 µm. Abbreviations: HNF4α-Hepatocyte nuclear factor 4α, ALB-
Albumin, IgG-Immunoglobulin G.  
5.2.3.2 HLCs derived from GMP hESC lines Man 11 and Man 12 are 
supported on PU134 surface. 
Next, I tested whether hepatocyte differentiation of both GMP hESC lines was 
supported on PU134 surfaces. For this purpose Man 11 and Man 12 hESCs-derived 
hepatoblasts were replated onto matrigel or PU134 surfaces in the presence of the 
serum-free maturation media containing KOSR. The resulting population of cells 
were characterised at different times during the differentiation procedure. 





5.2.3.3 Hepatocyte differentiation on PU134 surface of Man 11 HLCs 
Characterisation of the Man 11 HLCs maintained on matrigel or PU134 surfaces 
were firstly performed by analysing the morphology of the cells at Day 5, 10 and 15 
post-replating (Figure 63A). Phase contrast images of the resulting population of 
HLCs demonstrated that either substrate supported cell attachment. At Day 5 and 
10 post-replating there were no gross differences in the morphology of the cells 
replated on either substrate. The compacted and homogeneous resulting 
population of cells displayed typical primary hepatocyte morphological features, 
with hexagonal morphology, well-defined nucleus and clear cell-to-cell contacts 
(panels A, B, D and E). As the differentiation progressed, these features were 
preserved on matrigel surfaces, but improved on PU134 surfaces, with cells 
displaying canaliculi like structures (black arrows, panel F). 
In addition to cell morphology, functional analysis of the cells, including CYP3A 
activity, albumin and alpha-fetoprotein (AFP) secretion were performed to further 
characterise the resulting cells. 
Cytochrome P450 3A function was measured at Day 5, 10 and 15 post-replating 
(Figure 63B). Man 11 HLCs maintained on matrigel surfaces displayed the peak in 
the CYP3A function at Day 10 post-replating after a 1.5-fold increase compared to 
Day 5 post-replating and prior to a 3-fold decreased by Day 15 post-replating. 
CYP3A function in HLCs replated on PU134 surfaces displayed comparable CYP3A 
function at Day 5 and 10 post-replating, prior to a 1.6-fold increase by Day 15 post-
replating, with a 2.7-fold increase compared with HLCs replated on matrigel 
surfaces (p<0.01), representing the peak in the activity on PU134 surfaces.  The 
values for CYP3A at Day 5, 10 and 15 post-replating in HLC replated on matrigel or 
PU134 surfaces are as follows; 5,1x104 RLU/ml/mg, 4,6x104 RLU/ml/mg, 8x104 







Figure 63. Man 11 hepatocyte differentiation compatible with PU134. The serum-free hepatocyte 
differentiation protocol compatible with PU134 surfaces was successfully applied on the GMP hESC 
line Man 11. At Day 9, hESCs-derived hepatoblast were removed from the culture substrates and 
replated onto matrigel (MG) or PU134 surfaces (PU134). (A) Phase contrast images show the 
morphology of HLCs at different days post-replating on either substrate. Independently of the 
substrate, compacted populations of Man 11 HLCs were maintained for at least 15 days post replating, 
exhibiting typical hepatocyte morphological features, denoted by the acquisition of a more defined 
nucleus, with cells displaying a hexagonal morphology and an increase in the cell-to-cell contact 
resembling to cultures of human primary hepatocytes. These features were clearer in HLCs 
maintained on PU134 surface (white and black arrows). The images were taken at 10x magnification 
and scale bar represents 100 µm. B) Man 11 HLCs maintained on PU134 surfaces displayed a 




was assessed using a commercially available system (pGLO
®
) in HLCs maintained on either surface 
at Day 5, 10 and 15 post-replating. Analysis of the function revealed that cells on matrigel surfaces 
displayed a better activity at early stages in the differentiation process, with a peak in the activity by 
Day 10 post-replating. On PU134 surfaces (PU134), the activity increased at Day 15 post-replating, 
with a 3-fold increase compared with matrigel surfaces (MG). The results represent the mean ± SD of 
three individual samples per time point per cytochrome p450 analysed. Levels of significance were 
measured by student’s t-test, where p>0.01 is denoted as **.   
Albumin and alpha-fetoprotein (AFP) are two important secreted proteins in the 
hepatocyte biology. While albumin is expressed on both mature and immature 
hepatocytes, AFP secretion is characteristic of immature hepatocyte phenotype. 
Therefore, measurement of the secretion of both proteins represents a good 
indicator of the function and the mature stage of the cells.  
Analysis in the secretion of both proteins in Man 11 HLCs replated on matrigel or 
PU134 surfaces was performed using ELISA at Day 15 post-replating, when 
improved CYP3A activity was observed on PU134 surfaces compared to matrigel 
surfaces (Figure 64). Analysis in albumin secretion revealed a ≈39-fold increase in 
Man 11 HLCs maintained on PU134 surfaces compared to HLCs on matrigel surfaces 
(Figure 64A). Measurement of secreted AFP did not display any statistically 
significant differences between both substrates. The values of albumin secreted at 
Day 15 post-replating on matrigel or PU134 surfaces are as follows; 1.74 
ng/ml/24hours/mg and 68.38 ng/ml/24hours/mg respectively; and the values of 
alpha-fetoprotein secreted at Day 15 post-replating on matrigel or PU134 surfaces 






Figure 64. Improvement in the serum protein secretion in Man 11 HLCs on PU134. The graphs 
displayed show the levels of albumin (A) and alpha-fetoprotein (B) secreted by Man 11 HLC 
maintained on matrigel (MG) or PU134 surfaces at Day 15 post-replating, revealing an improvement 
in the albumin secretion in the presence of PU134 surfaces while cells secreting comparable levels 
between both surfaces of the foetal hepatocyte marker AFP. The results represent the mean ± SD of 
three individual samples per time point. Levels of significance were measured by student’s t-test 
where p<0.05 is denoted as ns and p>0.01 is denoted as **. 
5.2.3.4 Hepatocyte differentiation on PU134 surface of Man 12 hESCs-
derived HLCs 
Analysis of the morphology of Man 12 HLCs replated on either surface was used as a 
first step to characterise the HLCs at Day 5, 10, 15 and 20 post-replating (Figure 
65A). Phase contrast images of the resulting population of HLCs demonstrated that 
either substrate supported cell attachment. Up to Day 10 post-replating cells did 
not show gross morphological differences between either substrate, with the 
resulting populations of HLCs displaying typical primary hepatocyte morphological 
features, with a high homogeneity with hexagonal cellular shape, well-defined 
nucleus and clear cell-to-cell contacts (panels A, B, E and F). As the differentiation 
progressed, HLCs maintained on matrigel surfaces lost hepatocyte morphological 
features, displaying morphological heterogeneity, with cells rounding up and 
detaching (panels C-D). On PU134 surfaces, HLCs morphology was improved up to 
20 days post-replating, with cells displaying canaliculi-like structures (black arrows, 
panels G-H). 
In addition to cell morphology, cytochrome P450 3A activity in Man 12 HLCs was 
measured at different times during the differentiation procedure (Figure 65B). HLCs 
maintained on matrigel surfaces displayed the peak in the CYP3A function at Day 10 
post-replating after a 2.9-fold increase compared to Day 5 post-replating. Following 
this, CYP3A function decreased ≈1.3-fold at Day 15 post-replating prior to a further 
≈2.4-fold decrease by Day 20 post-replating. On the other hand, HLCs maintained 
on PU134 surfaces displayed increased levels of CYP3A function as the 
differentiation progressed. At Day 10 post-replating, a 2.1-fold increase compared 




15 post-replating. Following this, CYP3A activity increased 1.2-fold at Day 20 post-
replating, with a 3.3-fold difference compared with matrigel surfaces at Day 20 
post-replating (p<0.01), representing the peak in the activity on PU134 surfaces. 
The values for CYP3A at Day 5, 10, 15 and 20 post-replating in HLC replated on 
matrigel or PU134 surfaces are as follows; 2,6x104 RLU/ml/mg, 2,1x104 RLU/ml/mg, 
7,6x104 RLU/ml/mg, 4,6x104 RLU/ml/mg, 5,9x104 RLU/ml/mg, 7,3x104 RLU/ml/mg, 
2,5x104 RLU/ml/mg and 8,2x104 RLU/ml/, respectively. 
 
Figure 65. Man 12 hepatocyte differentiation compatible with PU134. The serum-free hepatocyte 
differentiation protocol compatible with PU134 surfaces was successfully applied on the GMP hESC 
line Man 11. At Day 9, hESCs-derived hepatoblast were removed from the culture substrates and 




morphology of HLCs at different days post-replating on either substrate. Independently of the 
substrate a compacted population of HLCs was maintained for at least 20 days post replating, 
exhibiting typical hepatocyte morphological features, denoted by the acquisition of a more defined 
nucleus, with cells displaying a hexagonal morphology and an increase in the cell-to-cell contact 
resembling to cultures of human primary hepatocytes. These features were clearer in HLCs 
maintained on PU134 surface (white and black arrows).The images were taken at 10x magnification 
and scale bar represents 100 µm. B) Man 12 HLCs maintained on PU134 surfaces displayed a 
superior cytochrome p450 3A function. CYP3A activity was assessed using a commercially available 
system (pGLO®) in HLCs maintained on either surface at Day 5, 10, 15 and 20 post-replating. 
Analysis of the function revealed that cells on Matrigel surfaces (MG) displayed a better activity at 
early stages in the differentiation process, but decreasing as the differentiation progressed. The 
converse was true on PU134 surfaces (PU134), reaching a peak in the activity by Day 20 post-
replating with a 4-fold increase compared with matrigel surfaces, which display their peak in the 
activity by Day 10 post-replating. The results represent the mean ± SD of three individual samples per 
time point per cytochrome p450 analysed. The results represent the mean ± SD of three individual 
samples per time point per substrate. Levels of significance were measured by student’s t-test where 
p>0.01 is denoted as **. 
The function and mature stage of the cells was investigated by measuring albumin 
and AFP secretion using ELISA (Figure 66). For this purpose, secretion of both 
proteins were analysed in Man 12 HLCs replated on either substrate at Day 15 and 
20 post-replating, when improved CYP3A function was observed on PU134 surfaces. 
Analysis in albumin secretion (Figure 66A) revealed a stabilisation in its secretion on 
PU134, with no statistically significant difference between both analysed days 
(p<0.05). In addition, improved albumin secretion was detected when compared to 
matrigel surfaces, with ≈1.8 (p>0.05) and ≈5.4-fold increase (p>0.001) at Day 15 and 
20 post-replating respectively. The values of albumin secreted at Day 15 and Day 20 
post-replating on matrigel or PU134 surfaces are as follows; 109.4 
ng/ml/24hours/mg,  49.67 ng/ml/24hours/mg, 195.46 ng/ml/24hours/mg and 
267.34 ng/ml/24hours/mg, respectively.    
The maturity stage of the cells was studied by analysing AFP secretion in either 
substrate at both days in the differentiation approach. Analysis in the secretion of 
AFP (Figure 66B) on matrigel surfaces revealed a ≈3.4-fold decrease by Day 20 post-
replating compared to Day 15 post-replating; and a ≈4.9-fold decrease on PU134 
surfaces by Day 20 post-replating compared to Day 15 post-replating, with no 




possession of a mature phenotype when PU134 surface was used as a culture 
substrate. The values of alpha-fetoprotein secreted at Day 15 and Day 20 post-
replating on matrigel or PU134 surfaces are as follows; 127.4 ng/ml/24hours/mg,  
36.9 ng/ml/24hours/mg, 171.9 ng/ml/24hours/mg and 35.2 ng/ml/24hours/mg, 
respectively.  
  
Figure 66. Improvement in the serum protein secretion in Man 12 HLCs on PU134 surfaces. The 
graphs displayed show the levels of albumin (A) and alpha-fetoprotein (B) secreted by Man 11 HLC 
maintained on matrigel (MG) or PU134 surfaces at Day 15 and 20 post-replating, revealing an 
improved albumin secretion in the presence of PU134 surfaces while a reduced AFP secretion as the 
differentiation progressed. The results represent the mean ± SD of three individual samples per time 
point. Levels of significance were measured by student’s t-test where p>0.05 is denoted as *, p>0.01 
is denoted as ** and p>0.001 is denoted as ***. 
In conclusion, this data demonstrate that PU134 surface supports functional 
hepatocyte differentiation of the GMP hESC lines Man 11 and Man 12 in a greater 
manner than matrigel surfaces, with differences in the life span between both GPM 
hESC lines.  Man 12 HLCs performed best in culture, demonstrating stable albumin 
production and a reduction in AFP secretion over a five day period compared to 





5.2.4 Gene expression profile of target genes on GMP grade HLCs on 
PU134 surface 
In order to study whether up-regulation in the expression of the target genes 
previously identified in the PCR array was also observed in GMP grade HLCs on 
PU134 surface, I analysed using quantitative PCR the expression of the target genes 
at Day 15 post-replating on Man 11 and Man 12 HLCs (Figure 67).  
Analysis of the gene expression revealed that in Man 11 HLCs on PU134 surfaces 
(Figure 67A), the expression of CTNND2, THBS2 and MMP13 were upregulated by 
1.57, 3 and 1.8-fold, respectively compared with matrigel surfaces (p<0.01). No 
statistically significant differences in the gene expression of NCAM1 and MMP10 
were observed (p>0.05). 
In Man 12 HLCs (Figure 67B), analysis of the gene expression revealed a statistically 
significant increase in THBS2 and MMP13 of 2.4 and 5.9-fold, respectively on PU134 
surfaces compared with matrigel surfaces (p<0.001). NCAM1 expression decreased 
2-fold on PU134 surface (p<0.001). No statistically significant differences in the 
gene expression of CTNND2 and MMP10 were observed (p>0.05). 
Altogether, this data suggest a role for MMP13, CTNND2 and THBS2 in the 
stabilisation of the GMP grade HLCs function. 
 
Figure 67. Gene signature of the GMP grade hESC lines derived HLCs. Graphs representing the 
gene expression analysed by quantitative PCR of candidate genes previously identified on the PCR 




of candidate gene revealed an increased expression of THBS2 and MMP13 in both cell populations 
and CTNND2 in Man 11 HLCs compared with matrigel surface. Relative expression refers to fold of 
induction over HLCs replated on matrigel surfaces and normalised to the housekeeping gene GAPDH. 
The results represent the mean ± SD of three different samples run, each run in triplicate. Levels of 





Differentiation and maintenance of stem cell derived somatic cells represents a 
cutting-edge technology with revolutionary potential applications in the study of 
human biology, drug screening and regenerative medicine. However, the delivery of 
reliable and stable human models is a major barrier, limiting current endeavours as 
most of the current approach use non-defined and biological derived media and/or 
substrates to differentiate and maintain hPSCs-derived somatic cells. As such, the 
development of defined differentiation systems free of xenobiotic materials or 
undefined additives is required to achieve this objective. Previously, Hay and 
colleagues (Hay et al., 2011) employed an inter-disciplinary approach, blending 
polymer chemistry with an efficient hepatocyte differentiation approach (Hay et al., 
2008a) to identify defined synthetic matrices that supported cultures of PSCs-
derived hepatocytes. They identified a simple polyurethane 134, PU134, as a 
suitable extracellular matrix support to obtain reliable, stable and functional stem 
cells derived HLCs.  
Identification of the PU134 surface was performed in a serum containing media, 
which compromised the reliability of the resulting HLCs. In an attempt to reduce the 
functional variability associated with the use of serum in the differentiation 
approach, which compromised reproducibility between experiments, and in 
collaboration with other members of the group, I developed a serum-free 




cells (Szkolnicka et al., 2014). In addition to develop a serum-free differentiation 
approach, I fine-tuned the polymer surface to obtain functional and stable HLCs in 
the serum-free hepatocyte maturation media (Lucendo-Villarin et al., 2014). 
However, the resulting cells displayed limited life span, which was solved by 
supplementing the serum-free maturation media with defined components that 
preserve cell viability and function.      
The improved tissue integrity displayed by HLCs maintained on this synthetic and 
defined substrate suggested the existence of a mechanism(s) induced by the PU134 
surfaces in promoting and stabilising cell polarity, which is essential in the 
maintenance of hepatocyte function (Müsch, 2013). Therefore, in order to identify 
the mechanism behind this stabilisation process promoted by PU134 surfaces, I 
employed a focused survey of human extracellular matrix proteins, cell membrane 
components and receptors, using PCR array technology in HLCs maintained on 
either substrate at Day 20 post-replating, when the biggest phenotypic and 
functional differences were observed between HLCs maintained on either 
substrate. From this screening I identified five genes which expression was 
enhanced in cells differentiated in the defined culture environment. Those genes, 
which appear to be new markers of hepatocyte differentiation, could be broadly 
divided in to 2 categories, as extracellular matrix remodellers (MMP10 and 13) or 
cell-cell and cell-matrix interactors (THBS2, CTNND2 and NCAM1). 
Matrix metalloproteinases (MMPs) are a family of proteins known to display 
substrate specificity for particular extracellular matrices (ECMs), emerging as 
essential mediators in defining how cells interact with their surrounding 
microenvironment (Kessenbrock et al., 2010). MMPs are essential for normal 
remodelling of the extracellular matrix, tissue morphogenesis, and wound healing 
(Iredale, 2007), and their activity is regulated by post translational modifications 
and by the tissue inhibitor of matrix metalloproteinases (TIMPs) (Iredale, 2007; 
Kessenbrock et al., 2010; Visse and Nagase, 2003). MMP13, the main interstitial 




(Knäuper and López, 1996; Quinn et al., 1990) and it has been reported to promote 
recovery from liver cirrhosis by converting the secretion of precursor HGF to the 
mature HGF form, thus, activating a signalling cascade involved in liver regeneration 
(Endo et al., 2011). Our analysis indicated that both MMP13 and -10 gene 
expression was increased over cultures differentiated in an undefined manner. It is 
possible that differences in gene expression may reflected the capacity of the cell to 
remodel the ECM, which is known to be important in the maintenance of 
hepatocyte phenotype (Freije and Diez, 1994; Garcia-Irigoyen et al., 2014; Muller et 
al., 1988). 
The second group of identified genes that were expressed at greater levels in cell 
populations differentiated under defined conditions includes genes which code for 
proteins involved in cell-to-cell and cell-to-matrix interactions: THBS2, CTNND2 and 
NCAM1.  
THBS2 and CTNND2 are known to regulate cell adhesion, organisation and 
migration, in response to growth factor stimulation (Ezaki et al., 2007; Fujiyoshi and 
Ozaki, 2010; Liu et al., 2009). THBS2, an extracellular matrix protein involved in the 
organogenesis of branches organs, affects the metalloproteinase 2 (MMP2) activity 
by inhibiting conversion of the MMP zymogen to the activated form (Bein and 
Simons, 2000), which expression is increased during the resolution of liver injury at 
the end stages of cirrhosis (Han, 2006; Roeb et al., 2005; Takayama et al., 2013). 
CTNND2, an adhesive junction associated protein of the armadillo/beta catenin 
superfamily, possesses a role in cell adhesion and cell movement (Kosik et al., 
2005). In addition, it is also involved in the formation of stable junctional structures, 
thereby establishing cell polarity in epithelial cells by mediating localisation of 
zonula occludens-1 (ZO-1) in the lateral membrane, which is required for E-
Cadherin-mediated formation of proper cell junctions (Fujiyoshi and Ozaki, 2010). 
Along similar lines, NCAM1, an integral membrane glycoprotein that can promote 




1990; Hall et al., 1990), has been identified as important factor in cell motility, 
essential to normal liver development and regeneration (Tsuchiya et al., 2014). 
In order to study the role that these genes had in the hepatocyte biology under 
defined conditions, I modulated their expression by employing siRNA technology.  
From this study, besides its role in collagen remodelling, MMP13 was identified as a 
potential regulator of hepatocyte phenotype influencing cytochrome P450 activity 
and human albumin secretion. In addition to MMP13, I reported a novel finding: a 
decreased expression of THBS2 and CTNND2, two genes with proposed roles in cell 
attachment, organisation and migration, led to reduced cytochrome P450 function 
and albumin secretion, respectively, proposing a new role for these genes in the 
hepatocyte biology (Lucendo-Villarin et al., 2015).   
As a result of these findings, further experiments focused on the functional gene 
signature for MMP13, THBS2, and CTNND2. For these studies, I employed two hESC 
lines which had been derived under GMP conditions and maintained serum-free, 
displaying an undifferentiated and pluripotent state as demonstrated by the 
expression of stem cell morphological features and markers and their ability to 
differentiate into cells of the three germ layers.  
Prior to study the gene signature of the target genes in the GMP grade derived 
HLCs, I studied the hepatocyte differentiation efficiency of these cells on polymer 
surfaces. The defined conditions efficiently supported hepatocyte differentiation of 
both GMP grade cell lines in a greater manner than the biological derived surface, 
with differences in the life span between the cell lines, which can be due to 
genotypic differences. Of note the Man 12 HLCs performed best in culture, 
demonstrating stable albumin production and a reduction in AFP secretion over a 
five day period, indicating a greater grade of maturity in the cells in the presence of 
the PU134 surface. 
For comparison studies, I analysed the expression of the targeted genes in GMP 




differentiation of both GMP lines yielded cell populations which expressed 
increased levels of MMP13, THBS2 and CTNND2 and thereby, supporting data 
derived from the research grade hESC line.  
In addition to the roles previously described, it has been reported that the protein 
encoded by CTNND2 promotes the disruption of E-cadherin to favour cell spreading 
upon stimulation by HGF (Lu et al., 1999). In rats, THBS2 has been implicated in the 
cell surface properties of mesenchymal cells with regards to cell adhesion and 
migration (Zou et al., 2013). Finally, it has been shown a role for the protein 
encoded by MMP13 in the degradation of newly-formed matrix in the early phases 
of rat liver fibrosis (Yan et al., 2005). Interestingly, this in vitro study has revealed 
new roles for the targeted genes in hepatocyte biology. Whether these findings can 
be translated to an in vivo system has yet to be elucidated. 
Numerous hepatocyte differentiation protocols have been established using 
synthetic substrates in two and three-dimensional cultures, and encouragingly, the 
stem cell derived HLCs exhibited typical hepatocyte characteristics. Takayama and 
colleagues employed a Nanopillar plate technology (Takahashi et al., 2010)  to 
obtain spheroids of HLCs displaying hepatocyte functions, including albumin 
production and urea secretion with cells displaying metabolism against hepatotoxic 
drugs. Despite the promising results observed, the assembly of spheroids required 
overlays of matrigel (Takayama et al., 2013). Ware and colleagues combined iPSC 
technology with a previously developed micropatterned co-culture platform 
(Khetani and Bhatia, 2008) to obtain functional HLCs capable of DILI prediction. 
However, the use of research cell lines and rat collagen coated culture platforms 
limited their use in therapeutic and clinical application (Ware et al., 2015). 
Sivertsson and colleagues employed a perfused three-dimensional bioreactor in the 
hepatocyte differentiation and maturation of hESCs, demonstrating an 
enhancement in the display of hepatocyte markers and hepatocyte signalling 
pathways when compared to two-dimensional systems. Still, the technical 




(Sivertsson et al., 2012). On the other hand, the polymer technology here employed 
possesses advantages compared with other methods as the simple polymer 
chemistry employed is cost-effective, ensuring low variability between polymer 
batches and can be efficiently employed in three-dimensional systems (Medine et 
al., 2013). In addition, HLCs obtained on the PU134 surface display an extended life 
span with improved hepatocyte phenotype and function than their matrigel 
counterparts.   
 
In conclusion, dependable differentiation from pluripotent stem cells requires 
defined culture parameters as the conditions offered by the differentiation 
approach compatible with the use of the defined polymer PU134 surface employed 
in this study.  Such systems will permit informative and mechanistic analysis of 
human biology. The novel gene signature identified in these studies is one example, 
which may also serve as important gold standard parameters for quality control and 






















CHAPTER SIX  















6.1 Conclusions  
Current sources of hepatocytes including; primary human hepatocytes, hepatoblast, 
hepatic cell lines and animal derived hepatocytes possess significant limitations 
meaning that they are not able to satisfy demand. The aim of my thesis was to 
produce hepatocyte-like cells (HLCs) from a renewable and scalable source, human 
embryonic stem cells.  
Human embryonic stem cells (hESCs) are able to self-renew indefinitely whilst 
remaining pluripotency (Thomson, 1998). As a result, they can differentiate into 
cells types from all three germ layers. Therefore hESCs represent a promising source 
of somatic cells to study human hepatocyte biology. Despite encouraging outcomes, 
most of the current hepatocyte differentiation approaches are performed in 
undefined microenvironments which influence the function and stability of the 
derivative cells.  
During my project I have tackled culture definition and stability by establishing a 
serum-free differentiation process on defined polymer matrix, permitting long-term 
culture of functional HLCs. To elucidate the mechanism of action of the 
polyurethane 134, I employed PCR array and loss of function analysis. From these 
experiments I identified a novel genetic signature, MMP13, CTNND2 and THBS2, 
which predicted stable hepatocyte phenotype from research and GMP grade hESC-
HLCs. While the results are promising further refinements are necessary to permit 
technology translation to industry and the clinic. 
6.2 Future perspectives 
As discussed above the production of hESC-HLCs in a defined environment 
represents a good starting point to improve the technology. The key areas where 
the current state of the art would benefit from are: 




Although current differentiation approaches from pluripotent stem cells generate 
HLCs displaying hepatocyte markers and function, they still express features 
remaining foetal hepatocytes. The HLC population generated in this study expressed 
mature liver markers, cytochrome P450 activity 3A and D6 and albumin. However, a 
recent study performed by Baxter and collegaues showed that the activity of these 
enzymes are already displayed in foetal hepatocytes (Baxter et al., 2015). As such, in 
order to identify reliable markers of hepatocyte maturity, Rowe and colleagues 
performed a comparative proteomic and functional analysis between foetal 
hepatocytes isolated at different times during the gestation period, and 
commercially available fresh human hepatocytes. From this study, the authors 
recommended a simple set of proteins, including cytochrome P450 2A6, glutathione 
S transferase P, and alcohol dehydrogenases as specialized indicators of hepatocyte 
differentiation (Rowe et al., 2013). Additionally, a recent from Godoy and 
colleagues employed bioinformatics to perform a comparative gene regulatory 
network analysis between different pluripotent stem cell derived HLC populations, 
identifying groups of genes associated with mature hepatocyte functions. In 
comparison, HLCs expressed the majority of those genes. However, there were 
many genes which did not approach the levels of primary hepatocytes. In these 
studies we identified three problematic clusters including colon, fibroblast and stem 
cell-associated transcription factors. Moreover, increased expression of genes 
controlling proliferation and dedifferentiation (e.g. FoxQ1 and YBX3) may be 
responsible for not obtaining fully differentiated phenotype (Godoy et al., 2015). 
These studies suggest that the culture conditions may be responsible for the HLCs 
not reaching mature hepatocytes. As shown, HLCs, like cultures of primary human 
hepatocytes, display a loss in the expression of key ‘liver‘ genes and the 
transcription factors controlling liver functions. This study provides a ‘blue-print’ to 
eliminate non-desired cell traits; however, care must be taken when selecting genes 
to over express or suppress. For example, depletion of the colon-associated 




biology, may also disrupt HNF4α DNA occupancy, and HNF4α driven gene 
expression (Verzi et al., 2013).  
 
2. The influence of the microbiome on cell maturity 
Liver development is a process that extends beyond birth, when there is a switch 
from placental to enteral nutrition. Fatty acids from the breastfeeding become the 
main energy source, and those are further metabolised by the gut microbiome to 
secondary metabolites which instruct liver development in the neonate (Morelli, 
2008).  In line with this, Avior and colleagues recently demonstrated that a 
secondary metabolite, lithocholic acid (LCA), or the use of Vitamin K may drive 
maturation of HLCs. They demonstrated that these additives synergise, regulating 
the activity of a key nuclear factor, PXR, improving cytochrome P450 enzymes 2C9 
and 3A4 expression and function (Avior et al., 2015). These studies demonstrated 
that microbial-derived cues are essential for maturing HLCs, and therefore future 
work should focus on secondary metabolites generated by the gut microbiome. 
 
3. Tissue engineering to deliver three dimensional and better organised 
organoids  
Correct hepatocyte development and homeostasis requires signals from the 
neighbouring cells and extracellular matrix. Most of the current differentiation 
approaches, while promising, lack the appropriate niche and three dimensional 
structural. Therefore the development of co-culture strategies employing relevant 
cell types, and three dimensional structures are required. In this vein, Takebe and 
colleagues developed an innovative approach. In the presence of endothelial and 
mesenchymal cells, PSC-HLCs self-organised into three dimensional liver-like tissue 
structures. These liver buds were injected into a mouse liver and successfully 




demonstrated liver function outside the relevant organ as PSC-liver buds were also 
injected and successfully engrafted in a mice cranial window model and into the 
mesentery, being the latest a more realistic target site for future transplantations. 
As such, these findings represent an example of successful generation of 
vascularised PSC- derived organoids (Takebe et al., 2013).  This study represents a 
proof-of-concept of how cell-to-cell interactions are important in hepatocyte 
differentiation. Additionally, a recent paper by Celiz and colleagues demonstrates 
that polymer screening technology could be used to identify polymer(s) that 
support stem cell self-renewal and stem cell differentiation to cells representative 
of the three germ layers. They identified a polymer (HPhMA-co-HEMA) compatible 
with the use of defined media which potentially can fulfil culture requirements for 
stem cell scale up, differentiation and application (Celiz et al., 2015). 
 
4. The role of matrix remodelling on cell phenotype 
The defined differentiation approach described in this study identifies a novel gene 
signature associated with stable hepatocyte function, revealing the matrix 
remodelling capacity and the establishment of cell-to-cell interactions of the cells 
under defined conditions. Interestingly, MMP13 and THBS2 play important roles in 
hepatocyte biology. MMP13 represents the main interstitial metalloproteinase 
degrading collagen II during recovery of liver fibrosis (Endo et al., 2011).  THBS2 is 
known to regulate cell adhesion, organisation and migration (Liu et al., 2009). 
Moreover, THBS2 inhibits the conversion of MMP2 zymogen to the activated form 
(Bein and Simons, 2000). As such, the action of both proteins regulates the liver 
homeostasis by modulating extracellular matrix deposition. Further description of 
their mechanism of action, with regards to long-term stabilization of the 
hepatocellular phenotype and function, represent an interesting area for future 





5. Use of microfluidics to scale up the production 
Microfluidics allows constant perfusion of cells under low levels of fluid shear stress. 
As such, these systems represent a suitable format to study cell differentiation and 
tissue formation. Recently, Giobbe and colleagues reported a microfluidic system on 
a chip to differentiated PSC into HLCs displaying drug response to toxicological 
compounds (Giobbe et al., 2015). Berger and colleagues have described successful 
microfluidic systems employing co-cultures of PSC derived HLCs and stroma cell, 
reporting enhanced maturity and polarity (Berger et al., 2015). Moreover, these 
systems are compatible with synthetic polymers, which prove opportunities to 
develop cost effective and scalable culture systems.    
 
6. The use of bioprinting to scale up the production 
Bioprinting represents an attractive technology to produce PSC derived HLCs in 
isolation or in combination with non-parenchymal cells. Of note, the recently 
reported Organovo’s exVive3D liver tissue (Organovo®; USA) has been shown to 
secrete fibrinogen, albumin and transferrin in proportion to levels observed in in 
whole liver (Visk, 2015). With regard to PSCs, valve-based cell printers have been 
already employed to deliver viable hESC populations in programmable patterns, and 
offer promise in the quest to deliver in vitro derived organoids for clinical and 
research applications  (Faulkner, 2013). 
 
In conclusion, my study demonstrates that differentiation from pluripotent stem 
cells requires defined culture parameters. This system has permitted me to study in 
more detail HLC differentiation and has yielded a better understanding of the basic 
biology. In future, and in combination with the above disciplines, PSC HLCs 
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Supplementary Figure 1. SNP analysis of H9 cells. Log 2 ratio represents the allele signals from the 
probes by two channels (red and green), counting the intensities of these alleles, representing how 
much different or similar the alleles are. The B allele ratio counts how much of the B alleles 
contribute to the while alleles intensity, indicating if there is any change in the genotype.  As indicated 
in the red boxes ( Panels A and B), there is a split in the straight red line, indicating the presence of a 























Supplementary Table 1. RT2 Profile PCR Array. The accuracy of the results depend on the 
threshold cycle for each of the genes. A- means that the gene’s average threshold cycle is relatively 
high (> 30) in either the control or the test sample, and is reasonably low in the other sample (< 30). 
B- means that the gene’s average threshold cycle is relatively high (> 30), meaning that its relative 
expression level is low. C-means that the  gene’s average threshold cycle is either not determined or 
greater than the defined cut-off value (default 35), meaning that its expression was undetected, making 
this fold-change erroneous. 
 
RT2 PROFILER PCR ARRAY-HUMAN EXTRACELLULAR MEMBRANE COMPONENTS AND ASOCIATED 


































ADAMTS1 4.854308 4.001948 0.034571 0.062416 1.8055 1.8055 OKAY 
ADAMTS13 13.388739 11.440248 0.000093 0.00036 3.8597 3.8597 A 
ADAMTS8 13.039285 12.644685 0.000119 0.000156 1.3146 1.3146 B 
CD44 2.329808 2.078464 0.198911 0.236766 1.1903 1.1903 OKAY 
CDH1 2.916024 3.118729 0.132492 0.115125 0.8689 -1.1509 OKAY 
CLEC3B 13.426055 12.758982 0.000091 0.000144 1.5878 1.5878 B 
CNTN1 11.391376 10.257768 0.000372 0.000817 2.1941 2.1941 OKAY 
COL11A1 5.583059 4.272228 0.020861 0.051752 2.4808 2.4808 OKAY 
COL12A1 9.282489 8.290053 0.001606 0.003195 1.9895 1.9895 OKAY 
COL14A1 7.672686 6.592752 0.004901 0.010361 2.1139 2.1139 OKAY 
COL15A1 6.734712 6.161742 0.00939 0.013968 1.4876 1.4876 OKAY 
COL16A1 8.907474 8.309277 0.002082 0.003153 1.5138 1.5138 OKAY 
COL1A1 1.132694 0.211449 0.456063 0.86367 1.8937 1.8937 OKAY 
COL4A2 2.911102 2.773548 0.132945 0.146244 1.1 1.1 OKAY 
COL5A1 3.318939 2.436436 0.100207 0.184739 1.8436 1.8436 OKAY 
COL6A1 5.077306 4.200056 0.02962 0.054407 1.8369 1.8369 OKAY 
COL6A2 5.631223 5.099271 0.020176 0.029172 1.4459 1.4459 OKAY 
COL7A1 11.181996 10.160147 0.00043 0.000874 2.0305 2.0305 OKAY 
COL8A1 14.978788 12.416075 0.000031 0.000183 5.9082 5.9082 B 




CTNNA1 2.577209 2.426659 0.167565 0.185996 1.11 1.11 OKAY 
CTNNB1 5.234586 5.110498 0.02656 0.028946 1.0898 1.0898 OKAY 
CTNND1 3.981209 3.977116 0.063319 0.063499 1.0028 1.0028 OKAY 
CTNND2 9.16369 7.130899 0.001744 0.007135 4.092 4.092 OKAY 
ECM1 6.31031 6.862964 0.012601 0.008591 0.6818 -1.4668 OKAY 
FN1 -2.255304 -2.806925 4.774349 6.997914 1.4657 1.4657 OKAY 
HAS1 13.211213 12.82552 0.000105 0.000138 1.3065 1.3065 B 
ICAM1 3.844587 4.14428 0.069609 0.056552 0.8124 -1.2309 OKAY 
ITGA1 3.358126 2.431646 0.097522 0.185354 1.9006 1.9006 OKAY 
ITGA2 3.342377 3.929539 0.098593 0.065628 0.6657 -1.5023 OKAY 
ITGA3 4.061134 4.35002 0.059907 0.049036 0.8185 -1.2217 OKAY 
ITGA4 10.700162 9.642069 0.000601 0.001252 2.0822 2.0822 OKAY 
ITGA5 3.220991 2.462139 0.107247 0.181477 1.6921 1.6921 OKAY 
ITGA6 3.877713 4.413846 0.068029 0.046914 0.6896 -1.4501 OKAY 
ITGA7 10.503223 9.338918 0.000689 0.001544 2.2413 2.2413 OKAY 
ITGA8 7.537291 8.061834 0.005383 0.003742 0.6952 -1.4385 OKAY 
ITGAL 13.672973 11.856826 0.000077 0.00027 3.5214 3.5214 B 
ITGAM 13.52038 13.701747 0.000085 0.000075 0.8819 -1.134 B 
ITGAV 3.036623 3.060722 0.121867 0.119848 0.9834 -1.0168 OKAY 
ITGB1 1.096662 1.166646 0.467597 0.445456 0.9526 -1.0497 OKAY 
ITGB2 11.32439 12.098721 0.00039 0.000228 0.5847 -1.7104 A 
ITGB3 6.709127 7.232763 0.009558 0.006648 0.6956 -1.4376 OKAY 
ITGB4 7.782731 8.041465 0.004541 0.003796 0.8358 -1.1964 OKAY 
ITGB5 5.040115 4.893022 0.030393 0.033655 1.1073 1.1073 OKAY 
KAL1 7.871863 7.308391 0.004269 0.006309 1.4778 1.4778 OKAY 
LAMA1 8.17998 9.575856 0.003448 0.00131 0.38 -2.6315 OKAY 
LAMA2 7.747082 6.952568 0.004655 0.008074 1.7345 1.7345 OKAY 
LAMA3 5.07801 5.165841 0.029605 0.027857 0.9409 -1.0628 OKAY 
LAMB1 2.184283 2.253012 0.220022 0.209786 0.9535 -1.0488 OKAY 
LAMB3 4.175411 5.211378 0.055345 0.026991 0.4877 -2.0505 OKAY 
LAMC1 1.759972 1.754205 0.295254 0.296436 1.004 1.004 OKAY 
MMP1 4.130322 4.224059 0.057102 0.05351 0.9371 -1.0671 OKAY 
MMP10 7.803641 6.04239 0.004476 0.015173 3.3899 3.3899 OKAY 
MMP11 8.765227 8.530261 0.002298 0.002705 1.1769 1.1769 OKAY 
MMP12 12.335765 13.062276 0.000193 0.000117 0.6044 -1.6546 B 
MMP13 10.509822 7.987264 0.000686 0.003941 5.746 5.746 OKAY 
MMP14 5.926664 6.177311 0.01644 0.013818 0.8405 -1.1897 OKAY 




MMP16 7.416048 6.151237 0.005855 0.01407 2.403 2.403 OKAY 
MMP2 6.498155 6.080997 0.011063 0.014772 1.3353 1.3353 OKAY 
MMP3 9.541153 9.05852 0.001342 0.001875 1.3973 1.3973 OKAY 
MMP7 6.158659 5.371202 0.013998 0.024161 1.726 1.726 OKAY 
MMP8 16.815915 16.16106 0.000009 0.000014 1.5745 1.5745 B 
MMP9 8.570126 8.25599 0.002631 0.003271 1.2433 1.2433 OKAY 
NCAM1 6.78335 4.966589 0.009078 0.031982 3.5229 3.5229 OKAY 
PECAM1 12.434322 11.80038 0.000181 0.00028 1.5518 1.5518 B 
SELE 16.815915 16.550459 0.000009 0.00001 1.202 1.202 C 
SELL 14.128418 13.71298 0.000056 0.000074 1.3337 1.3337 B 
SELP 15.731125 16.286926 0.000018 0.000013 0.6803 -1.47  B 
SGCE 5.702236 5.200974 0.019207 0.027186 1.4155 1.4155 OKAY 
SPARC 1.04553 0.727454 0.484467 0.603969 1.2467 1.2467 OKAY 
SPG7 6.86904 5.974256 0.008555 0.015906 1.8593 1.8593 OKAY 
SPP1 1.415048 0.375946 0.374997 0.7706 2.0549 2.0549 OKAY 
TGFBI 0.724891 0.330266 0.605043 0.79539 1.3146 1.3146 OKAY 
THBS1 4.340047 4.292355 0.049376 0.051036 1.0336 1.0336 OKAY 
THBS2 9.409283 7.760355 0.001471 0.004612 3.136 3.136 OKAY 
THBS3 9.512634 8.843686 0.001369 0.002177 1.5899 1.5899 OKAY 
TIMP1 0.672729 0.858124 0.627319 0.55167 0.8794 -1.1371 OKAY 
TIMP2 2.515796 3.324184 0.174852 0.099844 0.571 -1.7513 OKAY 
TIMP3 3.019186 2.478653 0.123349 0.179412 1.4545 1.4545 OKAY 
TNC 2.482001 1.961975 0.178996 0.256677 1.434 1.434 OKAY 
VCAM1 6.162104 5.560844 0.013964 0.021185 1.517 1.517 OKAY 
VCAN 4.37732 4.08778 0.048117 0.058811 1.2223 1.2223 OKAY 
VTN 1.465153 0.746327 0.362197 0.596119 1.6458 1.6458 OKAY 
ACTB -2.417753 -2.275571 5.34338 4.841894 0.9061 -1.1036 OKAY 
B2M -0.832032 -0.459519 1.780191 1.375083 0.7724 -1.2946 OKAY 
GAPDH -1.227067 -1.249671 2.340906 2.377873 1.0158 1.0158 OKAY 
HPRT1 5.610511 5.330445 0.020468 0.024853 1.2143 1.2143 OKAY 
RPLP0 -1.965691 -1.805202 3.905998 3.494781 0.8947 -1.1177 OKAY 
HGDC 16.815915 15.867506 0.000009 0.000017 1.9297 1.9297 B 
RTC 2.69829 2.468113 0.154076 0.180727 1.173 1.173 OKAY 
RTC 2.700373 2.540182 0.153853 0.171921 1.1174 1.1174 OKAY 
RTC 2.72024 2.576645 0.151749 0.16763 1.1047 1.1047 OKAY 
PPC 0.666397 0.624545 0.630078 0.648624 1.0294 1.0294 OKAY 
PPC 0.831618 0.607965 0.561899 0.656122 1.1677 1.1677 OKAY 
PPC 0.830463 0.624092 0.562349 0.648828 1.1538 1.1538 OKAY 
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